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ABSTRACT 
 
Imprinted genes have been extensively documented in eutherian mammals and 
exhibit significant interspecific variation, both in the suites of genes that are imprinted 
and in their regulation between tissues and developmental stages.  Much less is known 
about imprinted loci in metatherian (marsupial) mammals, wherein studies have been 
limited to a small number of genes imprinted in eutherians.  In this dissertation, I used 
ChIP-seq and RNA-seq approaches to conduct the first ab initio search for imprinted 
autosomal genes in fibroblasts, fetal brain, and placenta of a metatherian mammal, the 
gray short-tailed opossum, Monodelphis domestica, and the first chromosome-wide 
study of paternally imprinted metatherian X chromosome inactivation. 
Evidence from a few genes in diverse species suggests that metatherian X-
chromosome inactivation is characterized by exclusive, but incomplete (leaky), 
repression of genes on the paternally derived X chromosome.  Herein I show that the 
majority of opossum X-linked genes exhibit paternally imprinted expression with 100% 
maternal-allele expression, whereas ~14% of genes escape inactivation, exhibiting 
varying levels of biallelic expression.  In addition, I have shown that transcriptionally 
opposing histone modifications correlate strongly with opossum XCI.  However, the 
opossum did not show an association between X-linked gene expression and promoter 
DNA methylation.   
In generating the first genome-wide profile of histone modification states for a 
metatherian mammal, and coupling it with in-depth gene expression analyses, I 
  iii 
identified the first set of genes imprinted in a metatherian that are not imprinted in 
eutherian mammals and described transcriptionally opposing histone modifications and 
differential DNA methylation at the promoters of a subset of these genes.  My findings 
suggest that metatherians use multiple epigenetic mechanisms to mark imprinted genes 
and support the concept that lineage-specific selective forces can produce sets of 
imprinted genes that differ between metatherian and eutherian lines.  Overall, these 
studies furnish a comprehensive catalog of parent-of-origin expression status for both 
autosomal and X-linked genes in a metatherian, Monodelphis domestica, and open new 
avenues for illuminating the mechanisms and evolution of imprinted gene regulation in 
mammals generally.   
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CHAPTER I  
INTRODUCTION  
 
1.1 Monodelphis domestica as a Model Organism 
Modern mammals comprise three major clades.  The subclass Prototheria are 
egg-laying mammals, of which the platypus and a few species (the number is debated) of 
echidnas are the only living representatives.  The Methatheria ("marsupials") and 
Eutheria (so-called "placental" mammals) together form the subclass Theria, which are 
live-bearing mammals.  The term placental mammal is somewhat misleading because all 
therian mammals form a placenta during fetal development, although the degree of 
placental growth and elaboration is greater in eutherian species.   
The gray, short-tailed opossum, Monodelphis domestica, is a small, rapidly 
breeding metatherian species that has been developed as a laboratory animal for more 
than 30 years.  Live specimens have been collected from five geographically distant 
areas in Brazil and Bolivia and been used to develop five laboratory strains, each of 
which have been maintained with detailed pedigree information.  The history of the 
laboratory opossum, the maintenance and locations of breeding colonies, and the overall 
structure of the genetic diversity present in laboratory stocks have been well documented 
(VandeBerg & Williams-Blangero 2010).  M. domestica is widely utilized as a model 
organism for a variety of research fields including but not limited to genetics, 
neurobiology, comparative immunogenetics, evolutionary biology, physiology, 
reproductive endocrinology, developmental biology, and environmental carcinogenesis 
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(Samollow 2006; Kammerer et al. 2010; Moustakas et al. 2011; Grant et al. 2012; Noor 
et al. 2013).  The initial draft sequence and assembly of the M. domestica genome was 
released in October 2004, with the most current assembly (Mondom5) constructed and 
released in October of 2006.  Through comparative genomic analysis, Mondom5 has 
produced insights into therian genome evolution and function, X-chromosome 
inactivation, and the evolution of non-coding sequences (Mikkelsen et al. 2007b).  
General information about the genome assembly and annotation is presented in Table 1. 
 
 
Table 1.  M. domestica genome (Mondom5) characteristics (derived from Mikkelsen 
et al. 2007b). 
 
Chromosome 
Sequence 
Size 
(Mb) 
Estimated 
Total Size 
(Mb) 
% 
G+C 
Annotated 
CpG Islands 
Annotated 
Ensembl 
Genes 
1 745 748 37.8 4,067 4,951 
2 538 542 38.0 3,779 4,125 
3 524 528 37.3 2,505 3,014 
4 432 435 37.7 2,356 3,221 
5 301 305 37.2 1,285 1,817 
6 289 292 38.1 2,117 1,853 
7 257 261 36.7 1,097 1,168 
8 309 313 37.8 2,161 1,946 
X 76 79 40.9 478 561 
Total 3475 3503 --- 19,845 22,656 
 
 
 
The metatherian and eutherian lineages diverged from their most recent common 
ancestor ~173 – 193 million years ago (Kumar & Hedges 1998; van Rheede et al. 2006; 
Meredith et al. 2011).  Due to this sister-group relationship metatherians and eutherians 
share basic genetic structures and processes that reflect elemental or ancestral 
mammalian characteristics; however, each group has evolved its own distinctive variants 
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of these characteristics creating opportunities for comparative examination of ancestrally 
shared but divergent genomic characteristics (Samollow 2008).  In this light, the 
opossum genome has proven extremely useful for investigating evolutionary processes 
that have shaped the structure and function of mammalian genomes generally, such as 
those that drive the maintenance and diversification of conserved non-coding elements; 
relationships between recombination rate, nucleotide composition, and the distribution of 
repetitive element families; and the birth, proliferation, and death of transposable 
element families.  The same comparative paradigm should prove fruitful for 
investigating the origins, structures, and evolutionary development of imprinted genes as 
well. 
1.2 Genomic Imprinting 
Genomic imprinting, generally, is a phenomenon whereby certain genes, 
chromosomal regions, or whole-chromosomes show parent-of-origin-specific differential 
allelic expression rendering the organism functionally hemizygous at the imprinted locus 
or region.  In addition, maternal- or paternal-allele exclusive expression varies between 
imprinted loci, as well as between developmental stages and tissues in many cases 
(Dindot et al. 2008) and can exhibit “leaky” expression of the silenced allele (discussed 
below).  Imprinted loci have been found in eutherian and metatherian mammals, but not 
in prototherians, birds, or other vertebrates (Ferguson-Smith 2011). 
The failure of proper imprinting can result in mis-segregation of chromosomes 
during meiosis, abnormal gene expression, developmental abnormalities, and disease 
states.  Nine human imprinting syndromes have been identified:  Beckwith-Weidemann, 
  4 
Angelman, Prader-Willi, Russel-Silver, maternal and paternal derived uniparental 
disomy of chromosome 14, pseudohypoparathyroidism type 1b, transient neonatal 
disease, and maternal hypomethylation syndromes (Lawson et al. 2013).  Considerably 
increased frequencies of these and other imprinting-related diseases have been observed 
in offspring resulting from cloning of cattle (Surani et al. 1984), swine (Shen et al. 
2012), and horses (Hinrichs et al. 2006), as well as in children conceived by means of 
assisted reproduction techniques (Thompson & Williams 2005).  These increases have 
been linked to improper regulation and/or resetting of epigenetic modifications during 
embryogenesis (Amor & Halliday 2008).  Furthermore, the failure of imprinting that 
results in Beckwith-Wiedmann syndrome correlates positively with the formation of 
Wilm’s tumor, a cancer affecting the kidneys (Rivera & Haber 2005).   
Normally, the expression of imprinted genes is maintained throughout the life of 
an individual and imprints are erased and reset according to the sex of the respective 
parent during gametogenesis, allowing transmission of the sex-specific imprinting 
pattern to the next generation.  How these genes are targeted for imprinting and how the 
imprint is maintained through early zygotic and embryonic development is unknown.  
The lack of knowledge concerning the spectrum of imprinted genes in mammals and the 
molecular mechanisms that target genes for proper establishment and maintenance of 
imprinting represents a wide gap in our understanding of the scope of imprinting and 
how imprinting irregularities lead to physiologic dysfunction. 
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1.3 Occurrence of Imprinted Genes in Metatherian and Eutherian Mammals   
Estimates of the number of imprinted genes vary between humans and mice.  
Simulation studies, based on the molecular and genomic characteristics of known 
imprinted genes, have predicted ~1% of human and ~2.5% of murine genes are either 
maternally or paternally imprinted (Luedi et al. 2005; Luedi et al. 2007).  
Notwithstanding this high estimate, only 79 and 123 imprinted genes have been 
characterized in human and mouse, respectively, and of those, only 72 have 
corresponding homologs in both species, with 44 (~61%) sharing imprinted status 
(Morison et al. 2005).  In addition, Hamed et al. (2012) examined 25 imprinted genes 
present in mouse and human for which strong experimental data exists and found that 
the vast majority (23 of 25) show the same expression pattern in both species whether 
maternally or paternally imprinted.  The strong conservation of the expression states of 
these shared imprinted genes indicates that their allele-specific, imprinted expression is 
under selection and is biologically important for proper development in both species.  
Taken together, the diversity of the suites and expression states of imprinted genes not 
only illustrates the difficulty in finding and describing imprinted genes but also reveals 
the magnitude of variation present among the suites of imprinted genes found in 
different species.   
In metatherians, only 19 of the genes that are known to be imprinted in mouse 
and/or human have been studied with regard to parent-of-origin differential expression 
(Table 2) (Renfree et al. 2008).  Of these 19, only 11 have been examined in M. 
domestica, with five showing an imprinted state.  Importantly, it has been shown that not 
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all imprinted genes in metatherians exhibit complete imprinting.  “Leaky” expression 
from the imprinted (repressed) allele has been observed for Igf2, Ins, Peg1/Mest, and 
Peg10 (reviewed in Renfree et al. 2008).  Notably, leaky expression has also been 
 
 
Table 2.  Imprinted genes of three metatherian species: tammar wallaby (Macropus 
eugenii), gray, short-tailed opossum (M. domestica), and Virginia opossum 
(Didelphis virginiana). 
 
Gene Species 
Imprinted 
Allele 
Evidence of  
Leaky 
Expression DMR Reference 
PEG1/MEST M. eugenii Maternal Yes No (Suzuki et al. 2005) 
PEG10 M. eugenii Maternal Yes Yes (Suzuki et al. 2007) 
H19 M. eugenii Paternal No Yes (Smits et al. 2008) 
IGF2 M. domestica M. eugenii Maternal 
Yes 
 
No 
Yes 
 
Yes 
(Suzuki et al. 2005; 
Ager et al. 2008b; 
Lawton et al. 2008) 
IGF2R 
D. virginiana 
M. domestica 
M. eugenii 
Paternal No No (Killian et al. 2000) 
 
INS M. eugenii Maternal Yes No (Ager et al. 2007) 
HTR2A M. domestica Paternal No No (Das et al. 2012) 
L3MBTL M. domestica Maternal No No (Das et al. 2012) 
MEG3 M. domestica No metatherian homolog - - 
(Weidman et al. 
2006a; Weidman et 
al. 2006b) 
NNAT M. domestica No metatherian homolog - - (Evans et al. 2005) 
SNRPN M. eugenii No - - (Rapkins et al. 2006) 
UBE3A M. eugenii No - - (Rapkins et al. 2006) 
DIO3 M. eugenii No - - (Edwards et al. 2008) 
CDKN1C M. eugenii No - - (Suzuki et al. 2005; Ager et al. 2008a) 
DLK1 M. domestica M. eugenii 
 
No - - 
(Weidman et al. 
2006a; Weidman et 
al. 2006b; Edwards et 
al. 2008) 
PLAGL1 M. domestica No - - (Das et al. 2012) 
IMPACT M. domestica No - - (Das et al. 2012) 
COPG2 M. domestica No - - (Das et al. 2012) 
GRB10 M. eugenii No - - (Stringer et al. 2012) 
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observed from genes on the inactive paternally inherited X chromosome in metatherian 
females, wherein X-chromosome inactivation occurs as a paternally imprinted 
phenomenon (Cooper et al. 1993; Samollow et al. 1995; Hornecker et al. 2007) (see 
below and Chapter 2 for further discussion of X-chromosome inactivation).Additionally, 
imprinted genes in humans and mice are often found in clusters and are regulated by 
localized, differentially methylated regions (DMRs) (Hore et al. 2007b).  Genes in these 
clusters may be under the control of a single regulatory sequence (imprinting control 
region: ICR) or be independently regulated (Lopes et al. 2003).  To date, only one 
imprinted gene cluster has been found in metatherians, IgfR/H19, and only three, 
Igf2/H19 and Peg10, of the eight known imprinted genes in metatherians show evidence 
of a DMR (Suzuki et al. 2007; Lawton et al. 2008; Smits et al. 2008).   
These characteristics not only illustrate the difficulty of finding and describing 
imprinted genes in different species, but also reveal the magnitude of variation present 
among the suites of imprinted genes and the mechanisms employed to establish and 
maintain the imprinted state.  M. domestica provides us with an excellent opportunity for 
comparative analysis to expand our knowledge of the variety of imprinted genes and 
breadth of imprinting mechanisms found in mammals and, thereby, to gather new 
information with which to fill these gaps in our knowledge of the evolutionary origins, 
adaptive benefits, and biologic importance of the imprinting phenomenon. 
1.4 Genomic Imprinting in Other Species 
In addition to its presence in mammals, the phenomenon of genomic imprinting 
has also been described in insects (Khosla et al. 2006; Anaka et al. 2009) and to some 
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extent in other vertebrates and invertebrates (Martin & McGowan 1995; Bean et al. 
2004) and plants (Tourte et al. 1980; Alleman & Doctor 2000).  Findings from these and 
other studies have indicated that disparate organisms utilize similar epigenetic processes 
to label and/or control the expression of imprinted genes, namely DNA methylation, 
histone modifications, and non-coding RNAs (further discussed below) (Lippman & 
Martienssen 2004; Grewal & Elgin 2007), provides evidence that the molecular 
mechanisms underlying genomic imprinting are derived from ancient regulatory systems 
that share common ancestry.  In further support of this hypothesis, it has been shown that 
ICRs present in both mouse and human can also silence adjacent genes in transgenic 
Drosophila, although not in a parent-of-origin-specific manner (Lyko et al. 1997; Lyko 
et al. 1998).  These findings indicate that the mechanisms utilized to control the 
expression of imprinted genes are present in disparate species, highlight the need to 
investigate the regulation of imprinted genes in many species which will result in a 
better understanding of imprinted and monoallelic expression in all organism, and 
support the concept of genomic imprinting as a model for the study of the mechanisms 
of gene regulation in general. 
1.5 DNA Methylation and Imprinting Control  
DNA methylation, usually in the form of methylated cytosine bases, is 
characteristic of most imprinted genes in eutherians and believed to be integral to the 
proper function and maintenance of the imprinted state.  Methylated cytosines are 
commonly found at CpG dinucleotides, which themselves are often located within CpG 
islands, areas of the genome that are strongly enriched for CpG dinucleotides.  CpG 
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islands often occur within or are proximate to the promoters of genes and ICRs (Fatemi 
et al. 2005; Saxonov et al. 2006; Feil & Berger 2007).  The establishment and 
maintenance of cytosine methylation is controlled by DNA methyltransferases 
(DNMTs). 
DNMTs comprise a class of enzyme that catalyzes the transfer of a methyl group 
to cytosine residues, especially at CpG dinucleotides, of DNA.  The three major 
subclasses of DNMTs are DNMT1, DNMT2, and DNMT3.  DNMT1 is a maintenance 
methylase, as it has a strong preference for hemi-methylated DNA, at which it 
methylates the unmethlylated cytosine residue of the DNA double helix following 
replication of the methylated parent DNA strand (Pradhan et al. 1999).  DNMT2 shows 
only weak methyltransferase activity, and its absence is not known to be associated with 
methylation or developmental defects in mammals (reviewed in Bestor 2000; Xu et al. 
2010).  DNMT3 has two further subclasses, A and B, which are recognized as de novo 
methylases.  These are the responsible for establishing DNA methylation at previously 
unmethylated cytosine residues (Okano et al. 1999).  Loss-of-function mutations in these 
methylases or chemical mutagenesis that causes changes in DNA methylation patterns 
adversely affect imprinted genes, leading to bi-allelic expression or absence of 
expression of either allele (Li et al. 1992). 
One of the best examples of the complexity of genomic imprinting, as well as 
one of the best-studied imprinting clusters, is the IGF2/H19 imprinted cluster.  IGF2 
codes for Insulin-like Growth Factor 2 and is vital for proper fetal growth and 
development, and H19 is a non-coding RNA with unknown function.  They are 
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reciprocally imprinted with IGF2 expressed solely from the paternal strand and H19 
expressed solely from the maternal strand (Bartolomei et al. 1991; DeChiara et al. 
1991).  The imprinted cluster is located on chromosome 11 in humans and consists of 
IGF2, H19, a CTCF binding site at a DMR located between the two genes, and a 
downstream enhancer element.   
The proposed model of the transcriptional regulation of this imprinted cluster 
involves the parent-of-origin specific methylation of the DMR affecting the binding of 
patterns of CTCF which in turn affects the interaction of the downstream enhancer with 
the promoters of IGF2 and H19 (Bell & Felsenfeld 2000; Hark et al. 2000; reviewed in 
Sha 2008).  More specifically, methylation of the DMR at the imprinted cluster on the 
paternal chromosome prevents binding of the CTCF protein.  However, CTCF binds the 
unmethylated DMR on the maternal chromosome, acting as an insulator that prevents the 
downstream enhancer from interacting with the promoter of IGF2 on the maternal 
chromosome.  This causes the enhancer to interact with the promoter of H19 instead, 
directing its transcription in a maternally specific manner.  On the paternal chromosome, 
the absence of CTCF at the DMR allows the enhancer to interact with the promoter of 
IGF2, rather than the promoter of H19, resulting in the transcription of IGF2 in a 
paternally specific manner.  It has been shown that the silencing of paternal H19 is 
dependent on the upstream DMR on the paternal chromosome, indicating that the 
absence of CTCF binding alone is insufficient to silence the paternal H19 gene 
(Srivastava et al. 2000).  Interestingly, there is another DMR (DMR1) located at the 
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promoter of the IGF2 gene; however, its role in the transcription or imprinting status of 
IGF2 has yet to be determined.   
Although there is much evidence to support the model described above, more 
recent work has shown that it is likely an oversimplification of the complex 
transcriptional regulation of the IGF2/H19 imprinted cluster.  Arney (2003) highlights 
the variation in expression of IGF2/H19 in different tissues as well as the complex array 
of cis-acting elements including insulators, silencers, and enhancers that are often 
utilized in a dermal-layer-specific, tissue-specific, or developmental-stage-specific 
manner indicating a more complex mechanism for the control of transcriptional 
regulation of this imprinted cluster.  In addition, Zampieri et al. (2012) have shown that 
post-translational modifications of chromatin-associated proteins (i.e. PARP1) can form 
complexes with CTCF and/or DNMT1 affecting their function and thus the DNA 
methylation patterns at their binding and/or target sites.  Taken together, these studies 
demonstrate that there is still much to learn about even the most well studied imprinted 
genes/clusters and the complex mechanisms that are utilized to control their expression 
states. 
1.6 Histone Modifications and Imprinting Control 
Along with DNA methylation, histone modifications are correlated with 
promoters of imprinted genes and ICRs (Fournier et al. 2002; Barlow 2011).  DNA is 
packaged into nucleosomes consisting of ~147 base pairs (bp) of DNA wrapped around 
a histone octamer that comprises 2 copies each of histone proteins 2A, 2B, 3, and 4.  The 
N-terminal domains of each histone, especially H3 and H4, are potential sites for post-
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translational modifications including methylation, acetylation, ubiquitination, 
phosphorylation, and sumoylation (reviewed in Kouzarides 2007).  More than 40 histone 
modifications and their correlations to transcriptional states have been examined in detail 
(Ernst & Kellis 2010).  The changes in chromatin structure resulting from these histone 
modifications, individually or in combination, are a major source of interest, because 
they affect access of components of the translational machinery to promoter regions, 
thereby enhancing or inhibiting transcription rates (Strahl & Allis 2000).  Modified 
histones show varying levels of positive and negative correlation with several kinds of 
genomic elements and structures, especially promoters, and both coding and non-coding 
sequences of the gene bodies themselves (Ernst & Kellis 2010; Kharchenko et al. 2011; 
Encode Project Consortium et al. 2012; Gifford et al. 2013). 
At imprinted loci, tri-methylation of the fourth lysine (K) residue on histone 3 
(H3K4me3) is associated with promoter regions on chromosomes containing the actively 
transcribed allele, independent of maternal or paternal origin.  Similarly, H3K9me3 is 
correlated with the transcriptionally silent allele.  In addition, these two modified states 
have been shown to be mutually exclusive at identical sites at the promoters of active 
versus inactive alleles (Mikkelsen et al. 2007a).  Another example of imprinting, X-
chromosome inactivation in metatherians and trophoblast cells of eutherians, is also 
associated with histone modifications, especially histone acetylation and H3K27me3 
suggesting that these marks might also be important for establishing imprinting 
expression patterns at metatherian autosomal loci (Wakefield et al. 1997; Monk et al. 
2006; Bernstein et al. 2007). 
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1.7 X-Chromosome Inactivation 
X-chromosome inactivation (XCI) is a process in therian mammals that results in 
the inactivation of one of the two X chromosomes in each cell of the female embryo 
early in development.  In eutherians this event is random with regard to parental origin 
in the embryo proper, so that about half the cells of the adult female possess an active 
maternal X chromosome (Xm) only, while the other half have only an active paternal X 
chromosome (Xp).  However, in extra-embryonic tissues, i.e. trophoblast derivatives of 
mice and cattle, evidence suggests that the Xp is exclusively inactivated (Xue et al. 
2002; Okamoto & Heard 2006).  Unlike the situation in eutherians, XCI is decidedly 
non-random in metatherians, resulting in all cells of the adult female possessing an 
active Xm and inactive Xp.  The inactive Xp chromosome is enriched for hypoacetylated 
H4 and H3K27me3 relative to those of the active Xm, which is enriched for activating 
marks such as H3K4me3 and H3 acetylation (although this latter modification remains 
poorly characterized) (Keohane et al. 1998).  These data indicate that histone 
modifications are correlated with XCI in metatherians, and strongly suggest that histone 
modifications can be utilized to identify candidate-imprinted regions in the opossum 
model (Delaval et al. 2007; Feil & Berger 2007; Mikkelsen et al. 2007a). 
1.8 Specific Aims and Structure 
 The aim of my doctoral research was to search for imprinted loci in M. domestica 
and use the findings to make observations concerning genomic imprinting as a paradigm 
for gene expression in therians.  In order to conduct this search, I utilized certain 
epigenetic marks (i.e. histone modifications and DNA methylation) that have been 
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shown to be associated with imprinted genes in eutherians, and genetic crosses designed 
to enrich for stock-specific single nucleotide polymorphisms (SNPs) that allowed me to 
track parent-of-origin-specific allelic expression at the mRNA level.  I chose to utilize 
next-generation sequencing technologies to conduct genome-wide analyzes of chromatin 
states and gene expression.  By means of these approaches, both individually and in 
combination, I have provided the first genome-wide analysis of epigenetic states in any 
marsupial species to date and described the correlation of these epigenetic states with 
both X-linked and autosomal gene expression.  I also discovered the first marsupial-
specific imprinted genes; conducted the first in-depth, chromosome-wide analysis of 
gene expression of the opossum X chromosome; and correlated monoallelic and parent-
of-origin-specific gene expression with activating and repressive histone modifications 
and DNA methylation states.  These data not only add to the suite of imprinted genes in 
marsupials, but also gives insights into how genes are targeted for imprinting, and how 
the imprinted state is maintained.  Taken together, these observations lay the foundations 
on which we can begin to address broader questions of why the phenomenon of genomic 
imprinting exists and the evolutionary implications of such a phenomenon. 
To give the remaining chapters context, I would like to briefly explain the overall 
structure of the dissertation.  Chapters II and III are modified versions of submitted 
manuscripts on the subjects of X-chromosome inactivation and genomic imprinting in 
fibroblast cell lines, respectively, and are organized in manuscript form.  Chapter IV 
covers the topic of genomic imprinting in tissues, for which the vast majority of data are 
collected with several verification experiments pending and a manuscript is in 
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preparation.  Chapter V contains extended methods for the preceding chapters and 
Chapter VI gives concluding remarks and discussion.
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CHAPTER II 
PATERNALLY IMPRINTED X-CHROMOSOME INACTIVATION (XCI) AND 
ESCAPERS OF XCI 
 
 
2.1 Introduction 
X-chromosome inactivation (XCI) is a chromosome-wide phenomenon whereby 
most genes on one of the two of X chromosomes of Therian females are rendered 
transcriptionally silent early in development (Straub & Becker 2007; Payer & Lee 2008).  
There are two basic forms of XCI: random XCI (rXCI) and paternally imprinted XCI 
(pXCI).  In rXCI, the choice of X chromosome to be inactivated in any given cell is 
more-or-less random with regard to the parental source (Heard et al. 1997).  Once 
achieved, the inactive state is developmentally stable and clonally inherited throughout 
subsequent somatic cell divisions, so that the somatic cells of the adult female are 
approximately equally distributed between those bearing an inactive paternally-derived 
X (Xp) and those bearing an inactive maternally-derived X (Xm).  In mouse, rXCI 
occurs in epiblast cells, which develop from the inner cell mass of the early embryo 
(Latham 2005; Okamoto & Heard 2006).  However, cells of the mouse trophectoderm 
layer, which ultimately give rise to extra-embryonic structures including the placenta, 
display pXCI, in which the Xp is inactivated in all cells, while the Xm always remains 
active (Huynh & Lee 2001, 2005; Heard & Disteche 2006).  pXCI has also been 
observed in placental tissues of other eutherian mammals, including rat (Wake et al. 
1976) and cow (Xue et al. 2002; Dindot et al. 2004).  However, this pattern is not 
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ubiquitous in eutherians, as rXCI has been observed in horse and mule placental tissues 
(Wang et al. 2012), and, notwithstanding a series of conflicting past reports, appears to 
be the characteristic pattern in human placenta (Moreira de Mello et al. 2010).  The 
varying patterns of XCI in trophectoderm-derived tissues of eutherians may have 
adaptive consequences, although the relatively sparse data show no clear phylogenetic 
clustering.  Thus, while XCI may have important consequences in the development and 
maintenance of fetal support structures, the molecular mechanisms underlying its inter-
specific divergence appear to be evolutionarily labile.   
In contrast to the eutherian pattern, data from several metatherian (marsupial) 
species show that females from this branch of mammals exhibit pXCI in late fetal and 
adult stage somatic cells (Payer & Lee 2008; Deakin et al. 2009).  However, there are 
varying reports that some genes on the inactive Xp exhibit ‘leaky’ or ‘partial’ expression 
(incomplete repression).  The particular genes that exhibit leaky expression can differ 
across species, while within a species the level of paternal-allele expression varies across 
tissue types, developmental stages, and in vivo vs. cultured cells (VandeBerg et al. 1987; 
Cooper et al. 1990; Cooper et al. 1993; Samollow et al. 1995; Koina et al. 2005; 
Hornecker et al. 2007).  Unfortunately, only five marsupial X-linked genes have been 
examined with regard to parent-of-origin specific allelic expression, and the limited data 
derived from different subsets of these five loci in disparate species and interspecific 
hybrids have not enabled many locus-by-locus comparisons among species.  More 
importantly, the data do not allow an extrapolation of the expression patterns of these 
few genes to the full X chromosome for any individual species.  Thus, it remains unclear 
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whether pXCI in marsupials is a concerted, chromosome-wide phenomenon, or a 
piecemeal process that occurs on a region-by-region basis (Cooper et al. 1990; Riggs 
1990).   
Most, but not all genes on the inactive eutherian X chromosome are strongly 
transcriptionally repressed.  Nevertheless, in humans ~15% of X-linked genes located 
outside the pseudo-autosomal region (PAR) are expressed from both alleles (Disteche et 
al. 2002; Carrel & Willard 2005), whereas in mice only ~3% of X-linked genes located 
outside of the PAR are biallelically expressed (Yang et al. 2010).  Non-pseudoautosomal 
genes expressed from both X chromosomes are designated as rXCI escapers, as opposed 
to monoallelically expressed non-escapers, which are subject to full repression through 
the rXCI mechanism.  Based on the a small number of loci examined in marsupials 
(obtained by non-quantitative isozyme polymorphism, RT-PCR, and RNA-FISH 
approaches), it appears that genes that escape XCI are common in marsupials, and that 
homologous genes can show substantially different paternal-allele expression patterns in 
different species.  However, the spotty overlap of gene sets examined in different 
marsupial species precludes estimation of the proportion of all Xp genes that escape 
inactivation.  Inasmuch as Xp expression for these genes was assayed in various tissues 
and developmental stages, these differences could reflect both tissue- and species-
specific variability. 
Mirroring our limited knowledge regarding patterns of Xp-allelic expression in 
marsupials, information concerning molecular mechanisms of pXCI is also rudimentary.  
The recently discovered Rsx locus, which is expressed exclusively from the inactive Xp 
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of the gray, short-tailed opossum, Monodelphis domestica, appears to be the functional 
analog of the eutherian XIST gene, insofar that its non-coding transcript is suggested to 
act in cis to repress activity of genes on the Xp (Grant et al. 2012).  Remarkably, despite 
their analogous functions, Rsx and XIST show no obvious sequence homology, 
indicating that they arose independently in metatherians and eutherians.  Much less is 
known about the regulation of expression at the level of individual X-linked genes in 
marsupials.  To date, single-gene bisulfite sequencing of CpG islands around selected X-
linked genes has identified no differentially methylated regions (DMRs) (Kaslow & 
Migeon 1987; Loebel & Johnston 1996; Hornecker et al. 2007), suggesting that DNA 
methylation plays little or no role in marsupial XCI.  Two recent chromosome-level 
immunofluorescence staining studies have shown distinctive epigenetic profiles for the 
active X (Xa) and inactive X (Xi) in two distantly related marsupials.  In the brushtail 
possum, Trichosurus vulpecula (Australasian family Phalangeridae), differential 
methylation signals on the Xa and Xi correlated well with the locations of active and 
repressive histone modification marks (Rens et al. 2010).  For M. domestica (American 
family Didelphidae), histone modifications on the X chromosomes showed suggestive 
evidence that the Xi is associated with the repressive histone mark H3K27me3 
(Mahadevaiah et al. 2009; Chaumeil et al. 2011).  However, the relatively low resolution 
of these studies makes it impossible to discriminate the locations of modified histones 
beyond the chromosome-band level, so does not permit the recognition of correlations 
among individual X-linked gene-expression levels and histone modification status. 
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To investigate rigorously the many unknowns in marsupial XCI requires a 
systematic, quantitative, chromosome-wide survey of allelic expression patterns and 
epigenetic states in a defined set of tissues and developmental stages from one or more 
marsupial species.  To initiate this effort we performed RNA-seq analysis in offspring 
from two parental stocks and their reciprocal crosses in fetal brain and extra-embryonic 
membranes (EEM) of the opossum; assayed levels of DNA methylation at promoters in 
fetal brain and EEM; and examined H3K4me3 and H3K27me3 histone modifications in 
female fetal brain.  The results of this study comprise the first comprehensive catalog of 
X-linked gene expression from the active Xm and inactive Xp in a marsupial species and 
the first chromosome-wide assessment of potential epigenetic mechanisms of pXCI in a 
marsupial at the individual gene level.   
2.2 Results  
2.2.1 Transcriptome-Wide Quantification of Parent-of-Origin Allele-Specific 
Expression in Opossum Fetal Brain and EEM  
To determine the relative expression levels of genes from the Xm and Xp of female 
opossums, we performed Illumina RNA-seq on embryonic day 13 (between day 12 – 13 
post-coitus) fetal brain and paired extra-embryonic membranes (EEM, counterpart of 
eutherian placenta) (Figure 1A,B) from reciprocal F1 hybrid and parental crosses of LL1 
and LL2 stocks (Figure A1 and Table B1).  Fetuses are born on embryonic day 14 and 
approximate 11-12 day mouse embryos in overall development (Smith 2001).  For a 
detailed description of opossum fetal development see Mate et al. (1994).  In total, we 
obtained 76.5 billion bp of sequence, >80% of which were uniquely mapped to the 
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opossum reference genome (MonDom5) (see the table on p. 98 in Chapter V).  The 
mapped reads covered more than 10,000 expressed genes with FPKM ≥ 1 in both tissues 
(Fragments Per Kilobase of transcript per Million mapped reads), and 68,000 exonic 
SNPs were called from all samples combined (Figure A2).  Parent-of-origin allele 
expression ratios were quantified in each sample from the relative numbers of reads 
containing the reference and alternative alleles at high-quality SNP positions. 
 
 
Figure 1.  Locations and allelic expression profiles of genes on the opossum X 
chromosome in fetal brain and extra-embryonic membranes (EEM). (A) Opossum 
embryonic day 13 (E13) fetus and EEM. (B) E13 fetus with EEM removed. Solid white 
line is the approximate incision line used to isolate fetal brain. The arrow shows the 
tissue used for the EEM analysis. (C) The allelic expression percentages for opossum 
X-linked genes in E13 female fetal brain (left panel) and EEM (right panel). On the x-
axis are allelic expression percentages: 0~100% maternal expression to the left and 
0~100% paternal expression to the right. The y-axis is the physical location of each 
gene along opossum X chromosome (centromere on top). The red bar is drawn 
according to the maternal-allele expression percentage and the blue bar is the paternal 
expression percentage. Among the 176 and 134 expressed X-linked genes with 
informative SNPs in fetal brain and EEM, respectively, 152 in fetal brain and 110 in 
EEM had 100% (or close to 100%) maternal expression, and therefore reflect pXCI 
(nonescaper) genes The names of 24 genes that escape pXCI with > 10% paternal 
expression (escaper genes) are labelled in the middle panel. The non-coding Rsx 
transcript shows 100% expression from the paternal allele in both tissues. (Figure A2 
and Table B1). 
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Figure 1 Continued. 
 
2.2.2 Fourteen Percent (24/176) of Opossum X-Linked Genes Escape pXCI  
Three-hundred-twelve X-linked gene models (including 19 X-linked genes on chrUn, 
see tables on pp. 101 and 102) were covered in female fetal brain samples with sufficient 
expression levels to call de novo SNPs (Table B1).  Of these, 176 genes had a total of 
512 informative heterozygous SNPs that could be used to quantify expression of the Xm 
and Xp alleles.  Among the 176 informative genes, 24 escaped pXCI with more than  
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Figure 2.  Pyrosequencing analysis of maternally vs. paternally derived allele 
expression ratios for 24 imprinted X-inactivation escaper genes from in opossum 
female fetal brain and EEM. (A-D) SNP genotyping and pyrosequencing 
verification for escaper gene YIPF6 in opossum fetal brain and EEM. Sanger 
sequencing genotyping confirmed that exonic SNP OMSNP0155110 was 
informative in all four F1 embryos: A0579E3 and A0579E4 in LL1 (dam) x LL2 
(sire) cross (A); A0571E1 and A0571E4 in the reciprocal F1 cross LL2 (dam) x LL1 
(sire) (B). Biallelic expression was verified by both RNA-seq (left) and allele-specific 
pyrosequencing strategies (right) (C, D). Therefore, YIPF6 is an escaper of pXCI in 
both tissues. The results for all 24 escaper genes, a non-escaper gene and an 
autosomal control gene can be found in Figure A2 and Table B2. (E) The opossum 
X chromosome is drawn in the middle panel with names and physical locations 
labelled for the 24 escaper-genes identified from RNA-seq data. For each gene, the 
mean and standard deviation of paternal-allele expression as a percentage of total 
expression were plotted for fetal brain (green) and EEM (purple). All 24 escaper-
genes escape pXCI in both tissues with six genes showing significantly higher 
paternal leakage in fetal brain as compared to EEM (PLXNA3, DKC1, YIPF6, 
FRMD7, FAM122B and RBMX). Only one gene showed significantly higher 
paternal leakage in EEM (HMGB3). Statistical significance was assessed by Mann-
Whitney U-test (ns: P-value > 0.05; *: P-value < 0.05; **: P-value < 0.01; ***: P-
value < 0.001).  
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10% paternal-allele expression (escaper genes).  These genes and the percentage of total 
transcript that is derived from the Xp allele are listed in Figure 1C. 
The remaining 152 genes (non-escaper genes) were subject to pXCI with 100% or 
nearly 100% maternal-allele expression.  Only 2% (3/152) of non-escaper genes showed 
detectable weak paternal expression (>3% paternal expression with >2 paternal allele 
counts in at least two informative individuals): MSN (5.2% paternal expression), 
BCAP31 (6.2%) and PDZD11 (3.3%).  In the EEM samples, 134 of 242 covered genes 
had informative SNPs, and the same 24 genes escaped pXCI with >10% paternal leakage 
(Figure 1C).  Only 3% (4/120) of the non-escaper genes in EEM samples displayed 
detectable weak paternal expression: TAZ (5.0%), FAM3A (4.5%), BCAP31 (5.7%), and 
TIMM8A (5.4%) (Table B1).  To confirm the informative X-linked SNPs and XCI status 
independently, SNPs in escaper genes were validated in multiple samples using Sanger 
sequencing and allele-specific pyrosequencing (see table on p. 103 and Table B2).  This 
resulted in a 100% validation rate of the RNA-seq expression data (Figure 2A-D; Figure 
A2).  Thus, the majority of X-linked genes show 100% monoallelic maternal expression 
in both tissues, and the escaper genes are conserved between fetal brain and EEM. 
2.2.3 pXCI Profile and Comparison Between Fetal Brain and EEM 
In mouse, X-inactivation patterns are dramatically different between fetal brain 
(rXCI) and EEM (pXCI), but this is not the case in opossum.  Approximately 85% of 
opossum X-linked genes are subject to complete paternal allele repression through pXCI 
in both fetal brain and EEM, and the same set of 24 escaper genes is shared between the 
two tissues (Figure 1C).  In terms of the level of paternal leakage, there was no 
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significant difference between the two tissues for 17 of the 24 escaper genes (Figure 2E).  
Of the remaining seven genes, six (PLXNA3, DKC1, YIPF6, FRMD7, FAM122B and 
RBMX) had significantly greater paternal expression in fetal brain than in EEM, and one 
(HMGB3) showed significantly higher paternal expression in EEM than in brain (Mann-
Whitney U-test, P-value < 0.05).  In addition, the maternal/paternal allele-specific 
expression (M/P) ratio for escapers was considerably greater than 1.0 for most (22/24) of 
these genes, indicating that the maternal allele was the one preferentially expressed.  
However, for two genes, FRMD7 and HMGB3, paternal-allele expression exceeded that 
of the maternal allele (M/P < 1.0) (Figure 2E). 
2.2.4 Genes that Escape pXCI Have Higher Total Expression in Females 
In therian mammals, the disparity in X-linked gene dosage between XX females and 
XY males is 'compensated' by X-chromosome inactivation.  For X-linked opossum 
genes that are subject to complete pXCI (non-escaper genes), only the maternal copy is 
expressed in both sexes, leading to similar total expression levels in males and females.  
Assuming that the expression level of the maternal allele is the same in both sexes 
without any sex differences or feedback compensation mechanism, higher total 
expression in females is expected for escaper genes with paternal leakage, and the 
female/male expression ratio should correlate with the degree of paternal leakage (Figure 
3A).  To determine if this is true for opossum escaper genes, we compared the 
distribution of female/male expression ratios for escaper genes, non-escaper genes, non-
informative X-linked genes (a small minority of which could be unidentified escaper  
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Figure 3.  Comparison of paternal X-linked gene expression percentage and 
female/male expression ratios. (A) Diagram showing individual alleles and total 
expression in female and male samples for a hypothetical escaper gene. In females 
(top panel), escaper genes have a maternal allele (G, in red) and a paternal allele 
(A, in blue). The maternal allele is fully active and the paternal allele accounts for 
20% of the total expression. In males (middle panel), there is one maternal allele 
(G, in red). Assuming maternally derived allele expression is the same in females 
and males, the estimated female/male total expression ratio would be (80% + 
20%)/80% = 1.25 (bottom panel). For non-escaper genes, the paternal allele is 
repressed in females so the female/male expression ratio is 1. (B) Boxplot of 
female/male total expression ratios for imprinted X inactivation escaper genes 
(Esc), non-escaper genes (Nesc), X-linked genes with no informative SNPs (X-linked 
NI) and autosomal genes (Auto) in fetal brain (green) and EEM (purple). The 
median female/male expression ratio is 1.3 for escaper genes and 1.0 for the other 
three groups of genes in both tissues. (C) Scatterplot of allele-specific expression 
ratio and female/male total expression ratios for escaper genes in fetal brain (left) 
and EEM (right) with normalized FPKM > 5. The y-axis is the female/male total 
expression ratio (log2 scale); the x-axis is (maternal + paternal)/maternal-allele 
expression in females (log2 scale). A linear relationship is observed for escaper 
genes in both fetal brain (green squares) and EEM (purple squares). 
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genes that could slightly inflate the female/male expression ratio of this class), and 
autosomal genes in both fetal brain and EEM samples (Figure 3B). 
As expected, the median female/male expression ratio is much higher (1.3) for 
escaper genes (~1.0 for the other three groups of genes in both tissues), and the 
distribution for escaper genes is significantly different from the other three groups (P-
value < 0.001, Kolmogorov-Smirnov Test).  These results indicate that XCI escaper 
genes have significantly higher expression levels in females than in males (Figure 3B).  
To assess the correlation between increased female expression and the degree of paternal 
leakage, we plotted female/male total expression ratios against (maternal + 
paternal)/maternal-allele expression percentage in females.  A linear relationship was  
observed in both fetal brain (Pearson’s r = 0.88, P-value = 4.4x10-8, Figure 3C) and 
EEM (Pearson’s r = 0.96, P-value = 1.5x10-13, Figure 3C) suggesting that the higher 
expression of escaper genes in females is due to leaky expression of alleles from the 
'inactive' Xp.   
2.2.5 Histone Modification Profiling by ChIP-Seq  
To study histone state profiles of pXCI in opossum, we performed native ChIP-seq 
experiments in fetal brain for two critical epigenetic marks that correlate with X-linked 
gene expression in eutherian mammals: the “on-mark” (H3K4me3; tri-methylation of 
lysine 4 on histone H3) and the “off-mark” (H3K27me3; tri-methylation of lysine 27 on 
histone H3).  H3K4me3 is found at promoter regions, CpG islands, and is often 
associated with active transcription in all eukaryotes.  H3K27me3 is located throughout 
the gene body and associated with repressed transcription.  If histone modifications are  
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Figure 4.  Depletion of H3K27me3 marks at opossum XCI escaper genes. (A) 
Expected histone modification profile for non-escaper genes assuming pXCI is 
regulated by H3K4me3 (mark-of-activation, or on-mark) and H3K27me3 (mark-of-
repression, or off-mark). For non-escaper genes, the maternal allele is active, 
therefore the on-mark is present at the promoter and the off-mark is absent (left 
panel). In contrast, the paternal allele is repressed, with the off-mark covering the 
gene region and a lack of on-mark at the promoter region (middle panel). In 
females, with two parental alleles, both on- and off-marks will be observed for non-
escaper genes (right panel). Males will have only an active, maternally derived 
allele. (B) Expected histone modification profile for escaper genes. Since both 
parental alleles are active, the on-mark is present at the promoter and the off-mark 
is absent (left and middle panels). In females, with two parental alleles, the on-mark 
is present and the off-mark is depleted for escaper genes (right). (C-F) H3K4me3 
and H3K27me3 histone modification profile in four X-chromosome regions in 
female fetal brain samples from ChIP-seq experiments. The top three diagrams in 
each panel are plots of genome gap locations (black bars), significant H3K27me3 
peaks, and H3K27me3 coverage (red bars), respectively. Gene models are shown in 
the middle panel, color-coded according to pXCI status (blue: escaper; red: non-
escaper; gray: unknown due to lack of an informative SNP). The bottom three 
diagrams of each panel show CpG island locations (blue bars), significant 
H3K4me3 peaks, and H3K4me3 coverage profile (green bars). For non-escaper 
genes (FAM3A, SEPHS2, MTM1 and GPR50), the H3K4me3 mark is present at the 
promoter CpG island, suggesting active transcription of the maternal allele; the 
H3K27me3 peaks cover almost the entire gene body, consistent with repression of 
the paternal allele. For the escaper genes (FLNA, RPL10, G6PD, IKBKG, YIPF6, 
MTMR1, CD99L2 and HMGB3), H3K4me3 mark is present at the promoter CpG 
island, suggesting active transcription; H3K27me3 marks are depleted across the 
gene body, consistent with the biallelic expression from both parental allele. This 
pattern was seen for all 23 escaper genes with an H3K4me3 peak at the promoter 
region (Figure A4 and Table B3).  
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correlated with transcriptional states and possibly playing important roles in pXCI 
regulation for non-escaper genes in opossum, the promoter of the active maternal allele 
would be expected to be enriched for H3K4me3 and the repressed paternal allele 
enriched for H3K27me3 across the promoter and gene body.  Overall, we should observe 
both the on-mark and off-mark simultaneously at X-linked non-escaper genes in females 
(Figure 4A).  For escaper genes with biallelic expression, the on-mark should be present 
and the off-mark absent, resulting in depletion of H3K27me3 marks compared to the 
non-escaper genes (Figure 4B).  Biallelically expressed autosomal genes are expected to 
have the same profile as the X-linked escaper genes. 
In ChIP-seq data from female fetal brain, 23 of the 24 escaper genes showed 
significant H3K4me3 peaks at the promoter region, overlapping the promoter CpG 
islands.  As expected, all 23 genes with an on-mark peak were depleted of H3K27me3 
peaks beginning at the promoter and spanning the gene body, whereas the both 
H3K4me3 and H3K27me3 marks were present at flanking non-escaper genes (Figure 
4C-F and Figure A4).  In control male fibroblast cell lines, the H3K4me3 mark was 
present for expressed X-linked genes, and the H3K27me3 marks were absent for all 
expressed X-linked genes (Figure A4 and Table B3), which is consistent with the fact 
that males only have one X chromosome and it is active.  The remarkable association 
between escape of pXCI and depletion of H3K27me3 marks suggests that the 
H3K27me3 modification is critical for the repression of the paternal allele of opossum 
X-linked genes, and depletion of H3K27me3 is a hallmark of escaper genes.  To 
evaluate enrichment of on-marks (H3K4me3) we quantified peak intensity as 'fold-
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enrichment' relative to background level (Table S3).  The fold-enrichment was 
significantly higher for escaper genes than for non-escaper genes (P-value = 4.6x10-5, 
Kolmogorov-Smirnov test) and non-informative X-linked genes (P-value = 0.004, 
Figure 5A), but there was no significant difference between escaper genes and autosomal 
genes (P-value > 0.05).  This finding is consistent with the hypothesis that biallelically 
expressed genes have stronger on-mark peaks due to the presence of the on-mark on 
both parental chromosomes (Figure 4A).  For the off-mark (H3K27me3), the average 
percentages of gene body length covered by significant peaks were calculated for 
escaper genes, non-escaper genes, non-informative X-linked genes, and 100 randomly 
selected autosomal genes (Figure 5B).  The off-mark peaks were completely absent on 
escaper genes, and most autosomal genes lacked off-mark peaks, with a small subset of 
non-expressed genes having 100% off-mark coverage.  In contrast, most non-escaper 
genes and non-informative X-linked genes were virtually covered with off-mark peaks 
(Figure 5B).   
To further validate whether the parent-of-origin allele-specific histone modification 
profile was consistent with our hypothesis, we examined three escaper genes (FLNA, 
YIPF6 and FAM122B) and five non-escaper genes (OCRL, PNCK, GPC4, ITM2A and 
PDZD11) that had informative SNPs overlapping the H3K4me3 peaks.  For all three 
escaper genes, we observed ChIP-seq reads containing both SNP alleles, indicating that 
the on-mark was present on both parental X chromosomes (Figure 5C-E and Figure A5).  
For the five non-escaper genes, only maternal-allele-containing reads were found at the 
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Figure 5.  Histone modification is correlated with maternal vs. paternal-allele 
expression of X-linked escaper and non-escaper genes. (A) H3K4me3 peak fold-
enrichment for pXCI escaper genes (Esc), non-escaper genes (Nesc), X-linked genes 
with no informative SNPs (X-linked NI) and autosomal genes (Auto) in female fetal 
brain samples. Escaper genes show significantly higher enrichment than non-
escapers or NI genes, because both parental alleles are expressed, similar to 
autosomal genes. Statistical significance was assessed by Kolmogorov-Smirnov test 
(ns: P-value > 0.05; **: P-value < 0.01; ***: P-value < 0.001). (B) Barplot of 
percentage of H3K27me3 peak coverage in the gene region for pXCI escaper genes 
with on-mark peaks (Esc), non-escaper genes (Nesc), X-linked genes with no 
informative SNPs (X-linked NI) and 100 randomly selected autosomal genes (Auto) 
in female fetal brain samples. Average coverage is 0.7% for escaper genes, 
indicating the depletion of the off-marks. Among the X-linked NI genes, 11 have the 
similar histone modification profiles as the escaper genes, which are potential 
escapers of pXCI in opossum (Table B4). (C-E) Allele-specific H3K4me3 
modification for escaper gene FLNA in female fetal brain ChIP-seq data from LL1 
x LL2 cross. (C) Top to bottom: 5’-end gene model, CpG island location (blue bar), 
and H3K4me3 peak/coverage profile (green bars). There is a SNP (X_3105991) 
under the H3K4me3 peak with sufficient coverage to infer individual parent-of-
origin allele-specific histone modification. (D) Sanger sequencing genotyping results 
for the fetuses A0579E10 and A0579E11 (used for ChIP-seq experiments) and their 
parents confirmed that this SNP is informative in both F1 offspring. (E) Highly 
skewed H3K4me3 reads from the maternal allele (64%) and paternal allele (34%) 
at X_3105991, suggest both parental alleles are active. This is consistent with the 
allele-specific expression profile at SNP OMSNP0154784 in the RNA-seq data and 
SNP OMSNP0154775 from the allele-specific pyrosequencing results. (F-H) Allele-
specific H3K4me3 modification for nonescaper gene OCRL in female fetal brain 
ChIP-seq data from LL1 x LL2 cross. (F) Top to bottom: 5’-end gene model, CpG 
island location (blue bar), and the H3K4me3 peak/coverage profile (green bars). 
There is a SNP (OMSNP0155910) under the H3K4me3 peak with sufficient 
coverage to infer individual allele histone modifications. (G) Sanger sequencing 
genotyping results in the two embryos (A0579E10 and A0579E11) and their parents 
confirmed that this SNP is informative in both embryos. (H) From the ChIP-seq 
data, we observed 100% of the H3K4me3 reads from the maternal allele at 
OMSNP0155910, suggesting the on-mark is only present at the maternal allele. This 
is consistent with the maternal-specific expression at OMSNP0155910 and 
OMSNP0155911 in the RNA-seq data. Allele-specific ChIP-seq quantification for 
two additional escaper genes (YIPF6 and FAM122B) and four additional non-
escaper genes (PNCK, GPC4, ITM2A and PDZD11) in female fetal brain can be 
found in Figure A5. 
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SNP positions, consistent with allele-specific epigenetic modification resulting in 
monoallelic-maternal expression (Figure 5F-H and Figure A5).  From the overall and 
allele-specific histone modification profiles of escaper and non-escaper genes in fetal 
brain, we conclude that histone modifications are an important epigenetic feature of 
pXCI in opossum and could possibly be involved directly in pXCI regulation. 
2.2.6 Absence of Promoter CpG Island DNA Methylation in Both Escaper and Non-
Escaper Genes 
In addition to histone modifications, in eutherian mammals differential DNA 
methylation of promoters is a key regulatory mechanism for XCI.  Promoter CpG islands 
are methylated exclusively on the inactive allele of X-linked genes (Lock et al. 1986).If 
DNA methylation plays the same role in opossum XCI, differential methylation (on the 
inactive paternal allele) would be present at non-escaper genes, while little or no 
methylation would be expected for escaper genes, consistent with their biallelic 
expression.  Lack of methylation is also expected at promoters of all expressed X-linked 
genes in males, because males have only one (active) X chromosome.  To study whether 
promoter DNA methylation is correlated with XCI status in opossum, we quantified 
DNA methylation percentages at promoter CpG islands for 24 X-linked genes using 
bisulfite sequencing and PyroMark assays.  Promoters of all five escaper genes assayed 
(FLNA, FAM122B, MTMR1, CD99L2 and TAF1) were unmethylated in female samples, 
showing less than 1% average methylation across all CpG sites in the promoter regions, 
which is consistent with biallelic expression (Figure 6A, Figure A6 and Table B5).  
Surprisingly, non-escaper genes also lacked differential methylation in females. 
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Figure 6.  Promoter CpG islands are unmethylated at both escaper and non-
escaper genes. (A-C) Bisulfite sequencing of the promoter CpG islands for an 
escaper gene FLNA (A) and two non-escaper gene, OCRL (B) and IDS (C) in 
opossum female fetal brain and EEM. Each panel shows multiple CpG sites at the 
promoter for the corresponding gene/tissue. Yellow boxes depict methylated CpGs 
and blue boxes are unmethylated CpGs. A SNP was found in the FLNA promoter 
and the transmission direction could be inferred, enabling quantification of 
methylation on each allele. The maternal allele is G (green boxes) and the paternal 
allele is A (red boxes). The promoter CpG islands were not methylated in these 
tissues. (D) Profile of promoter CpG island methylation status in 5 escaper genes 
(labeled in blue), 17 non-escaper genes (in red) and Rsx (in orange) using the 
PyroMark assay in female and male fetal brain and EEM samples. Each red bar 
represents the methylation percentage at one CpG site, from 0% to 100%. The raw 
pyrograms for selected genes are shown in Figure A6 and Figure A7. All five 
escaper genes (FLNA, FAM122B, MTMR1, CD99L2 and TAF1) lacked methylation, 
with 1.0% average methylation across all genes/tissues. 16 of the 17 non-escaper 
genes (FAM3A, AMMECR1, BCAP31, LAS1L, LONRF3, ELF4, RAP2C, GPC4, 
DDX26B, GPR50, ATP7A, FNDC3C1, PLS3, KCTD12B, KLF8 and IL13RA1) also 
lacked methylation, with 1.6% average methylation across all genes/tissues (Table 
B5). AMOT has ~ 40% methylation across promoter CpG sites, but there is no 
difference between female and male samples. 
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For 18 of the 19 assayed non-escaper genes, promoter CpG islands were unmethylated in 
both fetal brain and EEM tissues of both sexes (OCRL, IDS, FAM3A, AMMECR1, 
BCAP31, LAS1L, LONRF3, ELF4, RAP2C, GPC4, DDX26B, GPR50, ATP7A, 
FNDC3C1, PLS3, KCTD12B, KLF8 and IL13RA1), with an overall average methylation 
percentage of 1.6% (Figure 6B-D, Figure A6 and Table B5).  The remaining gene 
(AMOT) exhibited about 40% methylation across promoter CpG sites, but there was no 
difference between the sexes (Figure 6D).  Thus, promoter CpG islands are 
unmethylated for both escaper and non-escaper genes, and there is no correlation 
between promoter CpG DNA methylation and X-inactivation status in opossum. 
2.2.7 Allele-Specific Expression and Epigenetic Profile for the Non-Coding Rsx 
Gene 
In eutherians, an X-linked non-coding transcript (Xist) is transcribed exclusively 
from the inactive X chromosome (Xi) in females and coats the Xi in cis to repress the 
expression of genes from this chromosome.  Recently, a female-specific non-coding 
transcript (Rsx) with Xist-like functional properties was discovered in a number of adult 
tissues in opossum.  DNA-RNA duplex FISH results showed indirect evidence that Rsx 
transcripts coat the Xi in a manner similar to those from Xist (Grant et al. 2012).  Here, 
we independently confirmed, in different tissues and developmental stages, that Rsx is 
indeed expressed exclusively in females.  Three informative SNPs between LL1 and 
LL2 stocks were found in the non-repetitive region in exon 3, and we were able to 
directly quantify the parent-of-origin allelic expression level for Rsx in female E13 fetal 
brain and EEM (Figure 7A).  Only paternal allele reads were detected in both tissues,  
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Figure 7.  Allele-specific expression, allele-specific methylation and histone 
modification profile for the non-coding RNA Rsx. (A) Exon models for the Rsx 
gene, with three SNPs between LL1 and LL2 lines indicated (blue triangles). (B) 
Allele-specific expression analysis of RNA-seq data for SNP1 in fetal brain and 
SNP2, 3 in EEM in female individuals. Monoallelic-paternal expression was found 
at all three SNP positions in both tissues. (C-D) H3K4me3 and H3K27me3 histone 
modification profile at the Rsx-containing region in female fetal brain (C) and 
control male fibroblast samples (D) from ChIP-seq experiments. In each panel, 
plotted from the top to the bottom, are the genome gap locations (black bars), 
significant H3K27me3 peaks (red bars), H3K27me3 coverage (red), gene models, 
CpG island locations (blue bars), significant H3K4me3 peaks (green bars) and 
H3K4me3 coverage (green). The escaper gene (PHF6) in this region is labeled in 
blue, the non-escaper gene (HPRT1) is labeled in red. and Rsx is labeled in orange. 
In females, the on-mark (H3K4me3) was present at the Rsx promoter (in blue box), 
which is consistent with the active transcription of the paternal allele, whereas in 
males the Rsx on-mark peak is missing, consistent with absence of transcription. 
However, H3K27me3 marks were depleted in the gene body in both sexes 
suggesting that, unlike non-escaper genes, expression of Rsx is not regulated by the 
H3K27me3 modification. (E, F) Bisulfite sequencing of Rsx promoter region in 
female (E) and male (F) fetal brain and EEM samples. Each panel shows multiple 
CpG sites at the promoter for the corresponding sex/tissue. Yellow boxes depict 
methylated CpGs and blue boxes depict unmethylated CpGs. Two SNPs found in 
this region (position 11 and 25) were genotyped in both parents by Sanger 
sequencing to infer the transmission direction and quantify methylation of the two 
alleles. In males, the promoter CpG island was 100% methylated across all 25 CpG 
sites in both tissues, consistent with silencing of Rsx in males; in females, the 
maternal allele is methylated and the paternal allele is unmethylated in both tissues, 
consistent with monoallelic-paternal expression of Rsx. These findings suggest that 
the Rsx-allele expression is regulated by differential allelic methylation, but not 
influenced by histone modification states. 
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indicating that the expression of Rsx is exclusively from the Xp (Figure 7B).  The 
histone modification profile for Rsx shows the presence of the on-mark (H3K4me3) in 
females but not in males, which is consistent with female-specific expression (Figure 
7C,D).  If repression of the maternal Rsx allele is correlated with the off-mark 
(H3K27me3), similar to non-escaper genes, then the off-mark peak should be present in 
both females and males.  However, we did not observe any off-mark peaks across the 
entire Rsx gene body in either sex (Figure 7C,D).   
To assess the Rsx DNA methylation profile, we searched for and annotated a 
novel CpG island at the proposed Rsx promoter, which is associated with an H3K4me3  
peak.  We quantified the DNA methylation percentage at all 23 CpG sites within the Rsx 
promoter CpG island in fetal brain and EEM of both sexes.  Unlike other X-linked genes 
that are subject to pXCI, the Rsx CpG island was unmethylated in males but 
differentially methylated in females in both tissues; maternal alleles showed 100% 
methylation and paternal alleles showed 0% methylation (Figure 7E-F, Figure A6 and 
Table B5), which is consistent with exclusive paternal-allele expression.  Therefore, we 
propose that Rsx parent-of-origin allelic expression is regulated by differential promoter 
DNA methylation, but does not involve the H3K27me3 histone modification mechanism 
that is associated with X-linked escaper and non-escaper gene expression. 
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2.3 Discussion  
2.3.1 XCI Completely Silences Most Paternal X-Linked Alleles in Opossum, but a 
Substantial Fraction Escape Inactivation in Fetal Brain and EEM 
Unlike mouse and rat females which display random X-chromosome inactivation 
(rXCI) in both embryonic and adult tissues and paternally-imprinted X inactivation 
(pXCI) in extra-embryonic tissues and placenta, pXCI is characteristic of both somatic 
tissues and extra-embryonic membranes (EEM) in marsupials.  Results from five 
previously assayed opossum X-linked genes suggest that pXCI is incomplete with locus-
, species-, and tissue-specific levels of paternal allele leakage (incomplete repression).  
However, it is unclear whether this incomplete pXCI status is the general pattern for all 
X-linked genes or is a biased reflection of the small number of genes examined.  To 
address this question, we performed RNA-seq analyses of fetal brain and EEM samples 
from animals from two opossum laboratory lines and their reciprocal F1 offspring.  
Parent-of-origin allele-specific expression was quantified chromosome-wide to 
determine relative expression of SNP alleles unambiguously attributable to each of the 
parents.   
Of the X-linked genes examined, 86% (152/176) showed ~100% monoallelic 
maternal expression, and 14% (24/176) exhibited strong maternal-allele expression 
accompanied by leaky expression from the paternally derived allele.  Most of the latter 
(22/24) showed a paternal-allele contribution of less than 50% to the total mRNA for 
each respective gene.  These results demonstrate conclusively for the first time that the 
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large majority of genes on a marsupial X-chromosome is subject to complete pXCI with 
only a small minority (14%) of partial escapers in E13 fetal brain and EEM.   
2.3.2 The pXCI Pattern is Remarkably Similar Between Opossum Fetal Brain and 
EEM 
In some eutherian mammals, such as mouse and rat, rXCI takes place in somatic 
cells, whereas pXCI occurs in trophectoderm, resulting in distinctly different patterns of 
XCI gene silencing and escape in the embryo proper and its extra-embryonic 
membranes.  In contrast, the X-inactivation status is remarkably similar between 
opossum E13 fetal brain and EEM with exactly the same set of escaper genes in both 
tissues and similar paternal-allele expression for each gene as well (conserved escape).  
Similarity of the XCI profiles of fetal brain and EEM and the lack of tissue-specific 
escapers could be consequences of both tissues being derived from adjacent regions of 
the unilaminar blastocyst in early marsupial development, as opposed to their origins 
from discrete inner cell mass and trophectoderm structures in eutherians (Reviewed by 
(Zeller & Freyer 2001) (Selwood & Johnson 2006); see also (Mate et al. 1994). 
2.3.3 DNA Methylation and Histone Modification Profiles Reveal Potential 
Regulation Mechanisms of pXCI in Opossum  
Previous epigenetic studies of pXCI at the cytogenetic level in marsupials have 
suggested strongly that histone modifications are critical in the regulation of pXCI 
(Koina et al. 2009; Mahadevaiah et al. 2009; Rens et al. 2010; Chaumeil et al. 2011); 
however, there are inconsistent results concerning the role of DNA methylation in 
regulation (Loebel & Johnston 1993, 1996; Rens et al. 2010).  To acquire base-pair 
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resolution to infer histone states at the individual-gene level, we performed the first 
genome-wide ChIP-seq analyses in opossum and found both H3K4me3 (on-marks) and 
H3K27me3 (off-marks) to be strongly correlated with the inactivation status of X-linked 
genes.  Depletion of H3K27me3 was observed only for escaper genes, consistent with 
expression from both alleles of these genes.  In addition, promoter DNA methylation 
was absent for all but one gene examined, and methylation level was not correlated with 
parent-of-origin allele-expression for any X-linked genes.   
We also characterized transcription of Rsx, the recently discovered Xist-like gene 
that is expressed exclusively from the Xp in adult opossum female cells.  As previously 
reported in adult tissues, Rsx expression was found to be extremely female-biased in 
fetal brain and EEM, and we directly demonstrated monoallelic expression of the 
paternally derived Rsx allele in both tissues.  Beyond this, we profiled histone 
modifications across the gene as well as DNA methylation at the promoter.  H3K27me3 
peaks were not found on the Rsx gene body, and, in contrast to escaper genes, the CpG 
island at the Rsx promoter is differentially methylated in females, with 100% 
methylation of the maternal allele and virtually no methylation of the paternal allele.  
These findings suggest the functional convergence of the epigenetic regulatory 
mechanisms of Rsx and Xist despite the absence of sequence homology between these 
two non-coding transcripts.  It remains unresolved whether Rsx and Xist have a single 
common origin in a distant ancestor, or whether this is a case of true evolutionary 
convergence. 
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2.3.4 Predicting XCI Status of Genes Using Escaper/Non-Escaper Characteristics 
The histone data also allow us to predict escaper genes that do not have informative 
SNPs.  In this study, about 60% of the expressed X-linked loci examined, or 176 genes, 
had informative SNPs in the reciprocal crosses from which we discovered 24 pXCI 
escaper genes in E13 fetal brain and EEM.  These escaper genes share four major 
characteristics: 1. By definition, they display biallelic expression in allele-specific RNA-
seq and pyrosequencing results; 2. The H3K27me3 marks are depleted across the entire 
gene body, consistent with biallelic expression; 3. Fold-enrichment of H3K4me3 peaks 
is significantly higher for escaper genes than for non-escapers; and 4. Almost all escaper 
genes show significantly higher expression in females relative to males.  Among 136 
expressed X-linked genes without informative SNPs, we searched for candidate escaper 
genes using to the second, third, and fourth characteristics (H3K27me3 peak coverage < 
5%, H3K4me3 fold-enrichment > 8, and female/male expression ratio > 1.05) and found 
11 additional candidate-escaper genes (Table B4).  Three of these candidate escapers 
were confirmed as genuine escapers in fibroblast cell lines with informative SNPs (data 
not shown).  Overall, these results comprise the first comprehensive catalog of pXCI 
status in opossum fetal brain and EEM, and show that between 10 and 15% of X-linked 
genes escape pXCI.   
2.3.5 A Model for pXCI Regulation in Opossum 
Based on our data, we propose the following model for the epigenetic regulation 
of pXCI in opossum.  At some stage of germ line development or gametogenesis, the 
Rsx promoter is methylated in female opossums, but not in males, resulting in an 
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imprinted (silenced) Rsx on maternally derived X chromosomes.  After fertilization, this 
imprint results in paternal-specific expression of Rsx in the developing embryo.  The Rsx 
transcript coats the paternal X chromosome in cis (similar to the Xist transcript on 
eutherian X chromosomes), and recruits the polycomb group (PcG) proteins and other 
factors to target H3K27 for methylation on the paternally derived X chromosome.  For 
reasons yet to be determined, escaper genes are avoided during this chromatin 
remodeling process and remain active on both parental chromosomes.  In eutherian 
mammals, the promoter CpG islands of X-linked genes that are subject to imprinted 
expression in the placenta are methylated on the paternal allele only, presumably to 
strengthen/stabilize their repression (Lock et al. 1987).  In opossum, we did not observe 
promoter DNA methylation of X-linked genes (except Rsx), suggesting a de-coupling of 
histone modification and promoter DNA methylation.  In summary, was propose that 
pXCI in opossum arises from a Xist-like regulating mechanism via the non-coding Rsx 
gene and H3K27me3 the histone modifications, but promoter DNA methylation does not 
play a direct role.   
2.3.6 Presence of Y-Linked Homologs 
No extensive sequence data from the opossum Y chromosome have been published, 
but two genes, ATRX and RSP4, have been shown to have X- and Y-linked homologs in 
M. domestica (Jegalian & Page 1998; Carvalho-Silva et al. 2004).  Thus, the possibility 
that some X-linked escaper genes found in our study could have undetected Y-linked 
homologs must be considered.  In another marsupial, the tammar wallaby (family 
Macropodidae, Australia), ten homologs of X-linked genes have been detected and 
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mapped to the Y chromosome (Murtagh et al. 2012).  In our study, six of these genes 
were found to have informative SNPs, and all six escaped pXCI in both fetal brain and 
EEM.  Interestingly, four opossum escaper genes (ATRX, PHF6, HCFC1 and RBMX) 
have very similar levels of expression in males and females (female/male ratio < 1.2) in 
fetal brain or EEM, unlike the other escaper genes, which have higher expression in 
females.  If these genes have retained their active Y-linked homologs in opossum, their 
expression from the Y chromosome could equalize dosage between the sexes, and at 
least partially explain the lack of inactivation at these loci in females.   
2.3.7 Evolution of pXCI in Therian Mammals 
The idea that the eutherian and metatherian patterns of XCI are descended from an 
ancient form of XCI in the common therian ancestor has long been attractive for its 
parsimony (Cooper et al. 1971; Riggs 1990; Wakefield et al. 1997).  The occurrence of 
pXCI in extra-embryonic tissues of rodents suggests that the marsupial pXCI pattern 
might represent the primitive state from which rXCI later arose in the cells of the inner 
cell mass, the uniquely eutherian developmental structure that gives rise to the embryo 
proper.  However, the discovery that marsupials lack the Xist locus (Duret et al. 2006; 
Davidow et al. 2007; Hore et al. 2007a; Shevchenko et al. 2007) casts doubt on the 
evolutionary relationship between pXCI and rXCI, suggesting they might have evolved 
independently.  In this paper, we describe the occurrence of paternal-specific Rsx 
expression and maternal-specific promoter methylation, as well as histone modification 
profiles for X-linked genes in female opossums.  The similarity of the Rsx expression 
pattern and transcript function to that of the eutherian Xist locus, together with the 
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fundamental association of specific epigenetic marks with X-linked gene activity states 
in both opossum and eutherian mammals is comfortably consistent with a common 
origin for paternal and random XCI.  However, independent origins and convergence of 
Rsx and Xist functions is also a credible possibility, and epigenetic processes are 
common to gene regulatory systems across the biotic world.  Indeed, widespread 
differential promoter DNA methylation for X-linked genes has not been found in 
opossum, platypus (a prototherian mammal) or non-mammalian vertebrates, suggesting 
that DNA methylation-dependent regulation at promoter CpG islands is the acquired 
state in eutherian mammals.  Overall then, the molecular similarities alone do not 
address the issue of the ancestral vs. derived relationship between the two XCI patterns.  
Lacking corresponding data from an appropriate outgroup species to establish the 
evolutionary polarity to these molecular characteristics, the proposal that rXCI arose 
from an ancestral pXCI mechanism remains attractive, but speculative. 
2.3.8 Effective X-Linked Hemizygosity in Female Marsupials: Implications and 
Solutions 
In this study, we found that opossum Rsx is a paternally expressed (maternally 
imprinted) gene not only in EEM but also in fetal brain.  For the annotated opossum X-
linked genes examined, all non-escaper genes are 100% imprinted with monoallelic, 
maternal expression, while escaper genes exhibit biallelic, but unequal expression of 
both alleles, with all but two showing preferential expression from the maternal allele.  
The opossum X thus acts as a chromosome-wide paternal imprinting cluster with a small 
minority of genes escaping imprinting and one maternally imprinted gene (Rsx) in both 
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EEM and somatic tissues.  As a result, the female is effectively hemizygous for the 
majority of X-linked genes, as is the male.  This condition will manifest the presence of 
deleterious recessive mutations on the Xm in all female cells, greatly reducing fitness in 
females, just as in males.  By contrast, rXCI in the somatic tissues of eutherian mammals 
confers some of the advantages of heterozygosity because females express both parental 
alleles at X-linked loci, albeit individually in different cells.  Through rXCI, dosage 
compensation between the two sexes is achieved without sacrificing many of the 
advantages of diploidy.  The theoretical population genetics of this problem has been 
investigated, and conditions for invasion of random X-inactivation into a population 
with imprinted X-inactivation is clearly favored under conditions that depend on 
dominance and the degree of sex-specific selection (Connallon & Clark 2013). 
However, not all opossum X-linked genes are subject to pXCI.  It could be argued 
that the escaping status of some genes is the derived state because ~85% of X-linked 
genes have 100% monoallelic maternal expression and most escaper genes show 
preferential maternal expression.  Such leaky expression might have been established 
during evolution by positive selection, although we cannot rule out other forms of 
selection acting on these loci.  By expressing both alleles, the hemizygosity problem is 
solved; and, by selectively escaping X-inactivation, escaper genes could be up-regulated 
in total expression levels in females.  Furthermore, there is almost no overlap between 
the opossum pXCI escapers and human/mouse rXCI escapers (Table B6) (Carrel & 
Willard 2005; Yang et al. 2010), which could be due to pXCI escapers of marsupials 
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facing different selection pressures from those that impinge upon rXCI escapers of 
eutherian mammals. 
2.4 Methods  
2.4.1 Opossum Tissue Dissection and RNA Extractions 
Embryonic day 13 (E13) fetal brain and extra-embryonic membranes (EEM) were 
dissected from reciprocal F1 crosses (Supplemental Figure S1 and Table S1) of two 
random-bred stocks of Monodelphis domestica, LL1 and LL2 (VandeBerg & Williams-
Blangero 2010).  Fetal sex was determined as described in Chapter V.  Total RNAs were 
extracted using BCP (1-bromo-2 chloropropane), precipitated with isopropanol, and 
resuspended in RNase-free water.  Potential DNA contamination was removed by both 
DNase I treatment and Qiagen RNeasy Plus Mini kit (Qiagen, CA).  See Chapter V for 
further details.   
2.4.2 mRNA-Seq and Data Analysis 
mRNA-seq libraries were made using Illumina TruSeq RNA Sample Prep Kit and 
sequenced on a HiSeq 2000 platform (Illumina Inc., CA).  Image analysis and base 
calling were performed using Illumina software.  RNA-seq reads were aligned to the 
reference genome assembly (MonDom5) using TopHat v1.4.1 (Trapnell et al. 2009) 
with three mismatches allowed.  The metric for total expression level, FPKM 
(Fragments Per Kilobase-pair of exon Model), was calculated for all samples using 
Cufflinks v1.3.0 (Trapnell et al. 2010) based on all mapped reads.  The RNA-seq data 
were deposited in the Gene Expression Omnibus (GEO) database under accession 
number GSE45211. 
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2.4.3 Quantification of Parent-of-Origin Allelic Expression from RNA-Seq Data 
68,000 SNPs were called in combined RNA-seq data from uniquely mapped reads using 
SAMtools software (Li et al. 2009).  Allele-specific expression was quantified as the 
ratio of the number of reference allele-containing reads divided by the total coverage at 
each high-coverage SNP position (≥8 X) in brain and EEM tissues (Wang et al. 2008; 
Wang et al. 2011).  Allele transmission direction was inferred from the parental crosses 
and supplemented using additional information from other LL1 individuals for which 
RNA-seq data was available (data not shown).  See Chapter V. 
2.4.4 Validation of X-Linked Escaper and Non-Escaper Genes by Allele-Specific 
Pyrosequencing 
To verify the escaping status, allele-specific pyrosequencing were performed on all 24 
escaper genes, one non-escaper gene (HPRT1), and one autosomal control gene 
(GPM6B) (Figure 2 and Figure A2) at informative SNP positions confirmed by Sanger 
sequencing.  For non-escaper genes, 20 SNPs (one per gene) were randomly selected and 
genotyped by Sanger sequencing.  All 20 were verified as heterozygous in at least two of 
the four female samples (Appendix B: Table B2).  See Chapter V for further details. 
2.4.5 ChIP-Seq and Data Analysis 
Native-ChIP was conducted on a primary fibroblast cell line (derived from adult 
male ear pinna), fetal brain, and EEM using a method modified from (Dindot et al. 
2009).  Illumina libraries were constructed at Global Biologics, LLC, and sequenced at 
the University of Missouri – Columbia DNA Core Facility and Genomics Resources 
Core Facility at Weill Cornell Medical College.  Raw reads were quality filtered, 
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trimmed, and aligned using Bowtie in the Galaxy suite (Giardine et al. 2005; 
Blankenberg et al. 2010; Goecks et al. 2010).  Aligned reads were visualized on the 
UCSC genome browser (Kent et al. 2002) and IGV (Robinson et al. 2011; 
Thorvaldsdottir et al. 2012) and significant peaks were called using the MACS algorithm 
(Zhang et al. 2008).  See Chapter V for further details.  The ChIP-seq data were 
deposited in the GEO database under accession number GSE45186. 
2.4.6 Bisulfite-Sequencing and PyroMark Assays on Promoter DNA 
Two µg of genomic DNA were treated with EpiTech Bisulfite Kit from Qiagen, Inc.  
Treated DNA was amplified using primers designed by Methyl Primer Express v 1.0 
(Applied Biosystems).  PCR products were cloned using the TopoTA Cloning® Kit 
(Life Technologies) and sequenced by Sanger sequencing.  Methylation percentages at 
promoter CpG sites were also quantified using the Pyromark assay on a PSQ 96MA 
Pyrosequencer (Qiagen, CA).  See Chapter V for further details. 
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CHAPTER III  
CHIP-SEQ IDENTIFIES THE FIRST MARSUPIAL-SPECIFIC IMRPINTED GENE 
 
3.1 Introduction 
Genomic imprinting, generally, is an epigenetic phenomenon whereby certain 
genes show parent-of-origin-specific allelic expression.  It affects a minority of genes in 
the genomes of therian mammals (eutherians and metatherians) but has not been 
detected in prototherians, birds, or other vertebrates.  In human and mouse, 79 and 123 
imprinted genes have been characterized, respectively, with only ~60% of these genes 
sharing imprinted status (Morison et al. 2005).  In addition to interspecific differences, 
imprinted expression of some loci has been shown to vary between cell types, tissues, 
developmental stages, and gene isoforms; and in some cases, ‘leaky’ expression of the 
repressed allele has been observed especially in placenta (Kosaki et al. 2000; Umlauf et 
al. 2004; Dindot et al. 2008; Wang et al. 2011; Bebbere et al. 2013; Wang et al. 2013).  
These variable characteristics compound the difficulty of finding and describing 
imprinted genes, reveal the magnitude of variation present among suites of imprinted 
genes between species, and underscore the dynamic expression patterns of imprinted 
genes within an individual. 
In metatherian (a.k.a. marsupial) mammals, genomic imprinting has been 
examined primarily in the tammar wallaby (Macropus eugenii: Australian family 
Macropodidae), gray short-tailed opossum, (Monodelphis domestica: American family 
Didelphidae), and Virginia opossum (Didelphis virginiana: Didelphidae), wherein only 
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19 genes, each already known to be imprinted in human and/or mouse, have been 
scrutinized in one or another of these species with regard to parent-of-origin specific 
allele expression.  Eight of these 19 loci have been shown to be imprinted in at least one 
of these marsupial species; nine show biallelic expression; and two have no marsupial 
homolog (Renfree et al. 2008; Samollow 2008; Das et al. 2012; Stringer et al. 2012).  Of 
the eight marsupial imprinted genes, only IGF2 and H19 are located in an imprinted 
cluster and associated with an imprinting control region (ICR), both of which are 
hallmarks of imprinted loci in eutherian mammals (Smits et al. 2008; Barlow 2011).  
The remaining six marsupial imprinted genes are individually imprinted, associated with 
no known clusters, and mechanisms that regulate their expression remain unknown. 
Beyond interspecific comparative analyses to infer the evolutionary origins and 
adaptive significance of imprinted genes, the process of genomic imprinting is, per se, 
an invaluable model system for studying the epigenetic regulation of genes generally.  
For example, interspecific comparisons of imprinted and non-imprinted orthologs have 
led to the identification of certain structural features, such as SINEs and LINEs and their 
cis-acting epigenetic elements, that can affect the imprintability of a gene (Greally 2002; 
Murphy & Jirtle 2003; Samollow 2006).  Further, the identification of differential DNA 
methylation between the two parental alleles at imprinted loci in eutherians has not only 
provided insight concerning the epigenetic regulation of these loci, but has also led to the 
development of a paradigm for studying cis-acting mechanisms of gene regulation at 
non-imprinted loci as well (Ferguson-Smith 2011).  Finally, the interaction of genomic 
elements and epigenetic modifications at imprinted loci has revealed links between 
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epigenetic states, chromatin structure, and transcriptional activity.  A comprehensive 
catalogue of imprinted loci across a broader range of therians, including eutherian and 
marsupial species alike, with descriptions of the molecular mechanisms that establish 
and maintain the imprinted state, can illuminate the evolutionary history and 
mechanisms of genomic imprinting generally and perhaps reveal heretofore 
unrecognized selective pressures that act on a gene to target it for imprinted expression. 
Various epigenetic marks have been associated with imprinted genes and ICRs in 
eutherians, most notably cytosine methylation and histone modifications.  Differential 
methylation of cytosine residues at CpG dinucleotides within CpG islands has been 
found at both ICRs and promoter regions of imprinted genes and occurs in a parent-of-
origin-allele-specific manner (Reik & Walter 2001).  Some of these parent-of-origin-
specific differentially methylated regions (DMRs) are established in the germ-line and 
maintained throughout all developmental stages and tissues, whereas other DMRs arise 
after fertilization and occur in tissue-specific or developmental-stage-specific patterns 
(Feil et al. 1994; Shemer et al. 1997).  Furthermore, the loss of DNA methylation at the 
promoter region or ICR of an imprinted gene or imprinted gene cluster leads to the loss 
of the imprinted state, resulting in biallelic expression (Li et al. 1992; Wutz & Barlow 
1998; Anwar et al. 2012). 
Differential histone modification states have also been associated with ICRs and 
promoter regions of imprinted genes.  Transcriptionally repressive modifications such as 
trimethylation of lysine 9 of histone 3 (H3K9me3) and trimethylation of lysine 27 of 
histone 3 (H3K27me3) are present at the ICRs and/or promoters of the repressed allele, 
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whereas transcriptionally active marks such as H3K4me3 and H3K9Ac are present at the 
ICRs and promoters of the actively expressed allele (Yang et al. 2003; Mikkelsen et al. 
2007a; Dindot et al. 2009).  Along with DNA methylation, these histone modifications 
create open or closed chromatin states, which can alter the accessibility of DNA to 
transcriptional machinery, thereby affecting transcription rates.  In addition, certain of 
these transcriptionally opposing histone modifications have been shown to be mutually 
exclusive at identical sites in the promoter regions of active versus repressed alleles at 
imprinted loci (e.g. H3K4me3 vs. H3K9me3; H3K9Ac vs. H3K9me3) suggesting a 
potentially powerful approach for seeking candidate-imprinted loci, independent of 
expression-based SNPs (Regha et al. 2007; Samollow 2008; Dindot et al. 2009). 
Previous searches for imprinted genes in marsupials have focused on a small 
number of loci that are already known to be imprinted in eutherians, and only a few of 
these have sought to describe DNA methylation and histone modification profiles of 
CpG islands at putative promoter regions (Killian et al. 2000; Evans et al. 2005; Suzuki 
et al. 2005; Rapkins et al. 2006; Weidman et al. 2006b; Ager et al. 2007; Suzuki et al. 
2007; Lawton et al. 2008; Smits et al. 2008; Das et al. 2012; Stringer et al. 2012).  Clear 
evidence of differential DNA methylation at marsupial imprinted genes has been found 
at only two loci, and only the DMR at the IGF2-H19 imprinting cluster has been shown 
to regulate transcription of a marsupial imprinted gene (Lawton et al. 2008; Smits et al. 
2008).  In addition, the marsupial X chromosome, which exhibits paternal imprinting for 
most loci in females, is strongly deficient in CpG island methylation (Loebel & Johnston 
1996; Rens et al. 2010).   
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Data addressing histone modifications at promoters and CpG islands of 
marsupial imprinted genes are extremely limited, with only two histone modifications, 
H3K3me2 and H3K9me3, examined for opossum Igf2r, Htr2A, and L3mbtl.  These 
genes exhibit enrichment of H3K4me2 but not H3K9me3 at promoters (Das et al. 2012).  
Fluorescence in-situ hybridization analyses of wallaby and brush-tailed possum 
(Trichosurus vulpecula: Australasian family Phalageridae) X chromosomes using 
antibodies to specific histone modifications showed a whole-chromosome level 
correlation between repressive and activating histone marks on the inactive and active X 
chromosomes, respectively, consistent with a possible role for histone modification 
states in the transcriptional regulation of genes on the marsupial X (Wakefield et al. 
1997; Koina et al. 2009; Rens et al. 2010).  Overall, however, understanding of the role 
of epigenetic processes in the regulation of gene activity in marsupial species has been 
hindered by a lack of genome-wide assessments of marsupial genomes by allele-specific 
expression and histone modification profiling. 
Taking advantage of continuously improving next-generation sequencing 
technologies and the high-quality draft assembly of the M. domestica genome, we are 
now able to search for marsupial-specific imprinted genes and analyze fundamental 
signals of imprinting on a genome-wide basis.  To accomplish this, we conducted 
reciprocal crosses of animals from two M.  domestica stocks and used ChIP-seq to 
perform the first ab initio search for putative gene promoters that are concurrently 
marked by mutually-exclusive, transcriptionally opposing histone modifications as a 
means to identify candidate-imprinted genes. 
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3.2 Methods 
3.2.1 Animals and Tissue Collection 
For the ChIP-seq experiments, animals from two laboratory stocks (LL1 and 
LL2) of the opossum, M. domestica were utilized (VandeBerg & Williams-Blangero 
2010).  For initial ChIP-seq profiling, primary fibroblasts were cultured from ear pinna 
of a male F1 (ID# A0514) from an LL1 X LL2 mating and collected using standard 
methods (Figure A8).  For further experiments, reciprocal crosses were conducted 
between LL1 and LL2 stocks, and primary fibroblast lines were established from ear 
pinnae collected from the parents in each cross, and from four F1 (LL1 X LL2) and four 
F1 (LL2 X LL1) individuals using standard methods (Figure A8B).  All procedures 
involving opossums were approved by the Texas A&M University, College Station, 
Institutional Animal Care and Use Committee (TAMU Animal Use Protocols 2011-141 
and 2011-191). 
3.2.2 Chromatin Immunoprecipitation (ChIP) and ChIP-Seq 
Native-ChIP (N-ChIP) was conducted on low (< 5) passage, primary fibroblasts 
from male A0514 using a method modified from Dindot et al. (2009).  Harvested 
fibroblast cells were washed in PBS and homogenized in 500 µL of Buffer I (0.3 M 
sucrose, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 15 mM Tris, 0.5 mM 
DTT, 0.1 mM PMSF).  The sample was centrifuged for 5 min. at 3000 X g, the 
supernatant was removed, and the pellet was re-suspended in 200 µL of Buffer I.  Cells 
were lysed on ice for 5 minutes by adding 200 µL of Buffer II (Buffer I + 4 µL of 
NP40), and nuclei were isolated by centrifugation for 20 minutes at 10,000 X g through 
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1.5 mL of Buffer III (1.2 M sucrose, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM 
EDTA, 15 mM Tris, 0.5 mM DTT, 0.1 mM PMSF).  The nuclei-enriched pellet was 
washed with Buffer I, centrifuged, and re-suspended in 350 µL of micrococcal nuclease 
digestion buffer (0.32 M sucrose, 4 mM MgCl2, 50 mM Tris, 0.1 mM PMSF).  
Chromatin was digested using 10 units of micrococcal nuclease (Sigma, N5386) for 10 
minutes at 37°C.  The reaction was stopped using 50 µL of 0.5 M EDTA. 
For an input control, 100 µL of digested chromatin was removed before 
treatment with antibodies and the DNA fraction was extracted.  For ChIP, 4.0 µg of 
digested chromatin was incubated at 4°C overnight with one of the following antibodies: 
anti-H3K4me3 (Millipore #07-473), anti-H3K9Ac (Millipore #CS200583), anti-
H3K9me3 (Millipore #07-442), anti-H3K27me3 (Millipore #07-449), or non-specific, 
rabbit IgG (Millipore #12-370).  Antibody-bound chromatin was isolated using 
Dynabeads® Protein A (Invitrogen), washed, and eluted according to manufacturer’s 
specifications.  N-ChIP and input DNA were purified using Qiagen MiniElute Spin 
Columns (Qiagen, CA) and enrichment was verified using real-time PCR (data not 
shown).  Non-indexed Illumina libraries were constructed at Global Biologics, LLC 
(Columbia, MO) and sequenced on an Illumina GAIIx at the University of Missouri – 
Columbia DNA Core Facility using 51- or 101-base chemistry.  Image analysis and base 
calling were performed using Illumina software. 
3.2.3 ChIP-Seq Analysis 
Raw sequence reads were filtered for quality and mapped to the MonDom5 
genome assembly using Bowtie in the Galaxy suite (Giardine et al. 2005; Blankenberg et 
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al. 2010; Goecks et al. 2010).  A seed length of 28 bases was used with a maximum of 2 
mismatches permitted between the seed and reference genome, and only the best 
alignment reported for each read.  Significant peaks of enrichment were identified for 
each histone modification using Model-based Analysis for ChIP-seq (MACS) using the 
input control option (Zhang et al. 2008).  The ChIP-seq data were deposited in the GEO 
database under accession number GSE47723.  Ensembl gene models (release 64) were 
used and annotated CpG island coordinates were obtained from the UCSC genome 
browser (Kent et al. 2002).  Putative promoters were defined as regions 5,000 bases 
upstream to 500 bases downstream of annotated transcription start sites (TSSs).  
Overlaps (minimum of one base pair) between features were assessed using scripts in the 
BEDTools package (Quinlan & Hall 2010).  In order to be considered a candidate-
imprinted gene, the putative promoter of a gene had to be concurrently marked by 
significant H3K4me3, H3K9Ac, and H3K9me3 peaks, and contain an annotated CpG 
island. 
3.2.4 SNP Discovery in Candidate-Imprinted Genes 
PCR primers were designed using Primer3 (Rozen & Skaletsky 2000) to amplify 
600-700 bases of the putative 3’-untranslated region (UTR) of each candidate-imprinted 
gene as well as Igf2r (Table B9).  Genomic DNA (gDNA) was extracted from livers of 
the eight individuals comprising the P generations of each cross using standard protocols 
and was PCR amplified (20 µL reaction volume) for each primer set using AmpliTaq 
Gold polymerase (Invitrogen).  After an initial denaturation of 5 minutes at 95°C, 38 
PCR cycles were conducted at 95°C for 30 seconds, 54°C for 30 seconds, 72°C for 30 
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seconds followed by a final extension for 7 minutes at 72°C.  PCR optimization was 
conducted where necessary.  To confirm PCR amplification, 3 µL of PCR product was 
run and visualized on a 1% agarose gel (data not shown).  All PCR products for each of 
the eight parents were pooled, eight indexed Illumina libraries were created from each 
pool, and 101 bases were sequenced on an Illumina GAIIx at the University of Missouri 
– Columbia DNA Core Facility.  Raw reads were filtered for quality, mapped to the 
MonDom5 genome assembly, and SNPs were called using MPileup in the SAMTools 
package (Li et al. 2009).  Variant regions were required to have a minimum of 20X 
coverage to be considered as candidate SNPs. 
3.2.5 Verification of Imprinting Status 
  Total RNA and gDNA were extracted from six of the eight fibroblast cell lines 
from the F1 generation using standard protocols (two F1 animals, A0703 and A0716, are 
absent from the SNP analysis due to the lack of success in establishing fibroblast lines 
from these animals).  Total RNA was treated with DNase I and converted to cDNA 
using the SMARTer cDNA Synthesis Kit (Clontech).  PCR reactions were conducted as 
previously described, and gDNA and cDNA PCR products were sequenced on an ABI 
3730XL at Beckman-Coulter Genomics, Inc. (Danvers, MA).  Sequences were viewed in 
Sequencher4.10™. 
To quantify maternal/paternal allele expression ratios, pyrosequencing PCR was 
conducted on cDNA from one F1 male and one F1 female from each of the LL1 X LL2 
and LL2 X LL1 crosses.  Pyrosequencing PCR and sequencing primers were designed 
using the PyroMark Assay Design Software Version 2.0.1.15 (Qiagen, CA).  
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Pyrosequencing PCR amplification was carried out in a 40 µl system using Ampli-Taq 
Gold polymerase under the following cycling conditions: 1 cycle of 95o C for 5 min; 45 
cycles of 95o C for 45 sec, 57o C for 30 sec, and 72o C for 20 sec; followed by 1 cycle of 
72o C for 10 min.  PCR products were prepared according to the manufacturer’s protocol 
and loaded on the PSQ 96MA Pyrosequencer with PyroMark Gold Reagents (Qiagen, 
CA) using the Allele Quantification method (AQ).  Two technical replicates were done 
for each gene in each sample.  Overall, variation between replicates was negligible  
(≤ 3%), and the final expression percentages were determined by averaging the results 
from each run.   
3.2.6 Analysis of CpG Island Methylation 
To assess the methylation status of promoter CpG islands, gDNA was isolated 
from fibroblasts from two F1 animals from each reciprocal cross (4 total animals) and 
treated with sodium bisulfite to convert unmethlyated cytosines to uracils using the 
Qiagen EpiTect Bisulfite Kit (Qiagen, Inc).  PCR primers were designed to amplify 
bisulfite converted DNA using Methyl Primer Express Software (Applied Biosystems, 
Inc).  BS-PCR products were gel purified, sub-cloned using the TOPO TA Cloning Kit 
(Invitrogen), and blue/white screened using XGal (40 mg/mL).  For each cloned PCR 
product, plasmids were purified from at least 16 positive white colonies and were 
sequenced at Beckman Coulter Genomics by the Sanger dideoxy-chain termination 
method using the M13 forward primer.  Sequences were inspected and analyzed using 
Sequencher4.10™. 
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3.3 Results 
3.3.1 ChIP-Seq Results 
More than 436 million Illumina reads from male A0514 fibroblasts were 
uniquely mapped to the current M. domestica genome assembly (MonDom5).  The two 
marks of activation (MOAs) examined, H3K4me3 and H3K9Ac, gave 79,412 and 
52,511 unique peaks of enrichment, respectively (MACS, p ≤ 10-5).  The two marks of 
repression (MORs) examined, H3K9me3 and H3K27me3, gave 56,719 and 16,592 
unique peaks of enrichment, respectively (MACS, p ≤ 10-5) (Table B7).  We next 
analyzed the overlap of each histone modification with promoters of annotated genes 
and CpG islands.  Of the 22,030 annotated genes in MonDom5, 13,021 showed 
expression in at least one of four male-fibroblast cell lines as determined by RNA-seq 
(data not shown), and 9,012 (69%) were marked by H3K4me3 (Figure 8A,B).  About 
half of these expressed genes have an annotated CpG island at the promoter and 93% of 
these CpG islands were marked with H3K4me3 regardless of transcriptional state 
(Figure 8B).  Thus, the promoters of the transcribed genes (e.g. Abcd4, Figure 8C) 
showed enrichment for both MOAs and were deficient for MORs, whereas the 
promoters of repressed genes (e.g. Saa Figure 8D) showed a deficiency in MOAs and, in 
some cases, an enrichment of H3K9me3.  The distribution of H3K27me3 was diffuse 
across the genome with most significant peaks occurring in intergenic regions.  
Promoters and gene bodies of biallelically expressed genes and known imprinted genes 
showed a depletion of H3K27me3.  In addition, H3K27me3 has not been shown in other 
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Figure 8.  Summary of fibroblast ChIP-seq results. A) Heatmap of RNA expression, 
H3K4me3, H3K9Ac, H3K9me3, and CpG Islands. Expression was determined 
using RNA-seq data from 4 male fibroblast cell lines. Green = expressed/presence 
of element, Red = not expressed/absence of element. White = not expressed and no 
elements. B) Graph of percentage of genes that are expressed, percentage of 
promoters of expressed genes with indicated histone modifications or CpG island, 
and percentage of CpG islands marked by H3K4me3. K4 = H3K4me3; K9Ac = 
H3K9Ac; K9me3 = H3K9me3, C) and D) Histone profiles across an expressed gene 
(Abcd4) and a repressed gene (Saa). Blue bars = significant peak of enrichment; 
green panels = marks of activation; red panels = marks of repression; black panel = 
input. Gaps (if present) and gene annotations are shown in the bottom panels. 
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species to be mutually exclusive with the MOAs used in this study.  For these reasons 
H3K27me3 was excluded from further examination. 
In addition to the promoters discussed above, we examined overlap of the various 
histone modifications with each other and all annotated-putative promoters (35,105) in 
the MonDom5 assembly.  Of the H3K9Ac peaks, 47,275 (90%) overlapped with an 
H3K4me3 peak by at least one base pair, and 6,410 (11%) H3K9me3 peaks overlapped 
with an H3K4me3 peak (Figure 9A, Table B8).  Additionally, 11,580 (52%) promoter-
associated CpG islands were marked by a significant H3K4me3 peak.   
Of the 35,105 putative promoters, 16,620 (~46%) were marked with H3K4me3, 
7,871 also have an annotated CpG island, and 178 of them were also concurrently 
marked with H3K9Ac and H3K9me3 (Figure 9B).  No X-linked genes met these criteria.  
This is noteworthy because animal A0514 was a male and possessed only a single X 
chromosome; patterns reflective of imprinted expression of X-linked genes would have 
signaled false positive outcomes.  That none was observed provides an internal control 
indicating the accuracy of ChIP-seq procedures in this study.  These 178 autosomal  
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Figure 9.  Venn diagrams representing overlaps of significant histone peaks, 
annotated CpG islands, and putative promoters. A) Significant peaks for H3K4me3 
(dark green), H3K9Ac (light green) and H3K9me3 (red). B) Overlaps of H3K4me3 
(green), annotated CpG islands (yellow), and putative promoters (blue). C) 
Overlaps of H3K4me3+H3K9Ac peaks (green), all three histone modification peaks 
(red), all three histone modification peaks and CpG islands (blue), and all elements 
and putative promoters (light green). 
 
 
B
C
A
  69 
genes with putative promoters marked by two MOAs, one MOR (H3K9me3), and a CpG 
island were considered candidate-imprinted genes and targeted for SNP discovery along 
with Igf2r (Figure 9C).  Igf2r is known to be imprinted in M. domestica, and has a 
promoter CpG island, but it did not show overlapping enrichment of MOAs and 
H3K9me3.  The histone modification states of the remaining annotated opossum 
imprinted genes, Htr2A, L3mbtl, and Mest, were also examined and showed the presence 
of MOAs at their promoters but lacked overlapping MOAs and H3K9me3 (Addition File 
1: Figure S5).  However, informative SNPs for these genes were not present in our 
crosses, precluding our assessment of their imprinted/non-imprinted states.  
Furthermore, the Igf2-H19 imprinted cluster is not present in the current MonDom5 
assembly and consequently was not accessible for this study. 
3.3.2 SNP Search for Candidate-Imprinted Genes 
Primers were designed to target the 3’-UTR for each of the 178 candidate-
imprinted genes and Igf2r, allowing for amplification of both gDNA and cDNA with the 
same primer sets (Table B9) The primer panel was run on liver DNA from the eight 
animals in the P generation to search for ‘trackable’ parent-specific SNPs between the 
reciprocal crosses.  Of the 179 genes tested, 38 - 49 genes, depending on the cross, 
showed at least one such SNP in individual crosses (Tables B10 - B13).  We selected 30 
genes that had a trackable SNP in at least one family in each reciprocal cross, and 21 of 
these showed specific 3’-UTR amplification in cDNA of the F1 generation.  The PCR 
products from gDNA and cDNA of these genes were Sanger sequenced to qualitatively 
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assess monoallelic vs. biallelic gene expression, and 17 of them gave high quality 
sequences from both templates (Tables B10 - B13). 
3.3.3 Meis1 is Paternally Imprinted in M. domestica Fibroblasts 
 Three annotated genes with promoters concurrently marked by the two MOAs 
and H3K9me3 (MOR) were clearly heterozygous for SNP variants in gDNA and showed 
strong allele-biased expression of alleles in cDNA: Meis1 (ENSMODG00000003396), 
Cstb (ENSMODG00000021035), and Rpl17 (ENSMODG00000011184) (Figure 10A-C; 
Table 1, Figure A9).  However, only Meis1 showed parent-of-origin specific expression 
(Figure A10).  Quantification of allele-specific expression by pyrosequencing showed 
92% and 77% expression of the maternal allele for Meis1 for one animal from each 
reciprocal cross (A0695 and A0727 respectively) (Figure 10C).  Four additional F1 
animals were examined for monoallelic expression, and informative animals showed 
strong maternal-allele biased expression with an average of 82% of transcripts 
originating from the maternal allele.  Both Cstb and Rpl17 also exhibited mono-allelic 
expression; however, the pattern was not parent-of-origin-specific, but rather appeared to 
be allele-specific (Figure A10; Table B14).  Igf2r also showed monoallelic expression in 
the one F1 animal (A0695) that was heterozygous for a trackable SNP (Figure A10).   
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Figure 10.  Meis1 is maternally imprinted in M. domestica fibroblasts. A) Histone 
profiles of Meis1. Two MOAs (two green panels), two MORs (two red panels), 
assembly gaps, annotated promoter CpG island, and the gene annotation. 
Significant histone peaks (MACS, p ≤ 10-5) are indicated by blue bars above the 
peaks. B) Enlargement of the promoter region of Meis1. C) Genomic DNA and 
cDNA genotypes of one animal from each reciprocal cross. Percent of maternal 
allele contribution as determined by pyrosequencing is shown in each box. 
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3.3.4 Methylation States of Promoters 
 We next assayed cystosine methylation at promoter CpG islands of the four 
monoallelically expressed genes.  For Meis1, we assayed 16 CpG dinucleotides across 
the promoter and found a hypomethylated state with no evidence of differential 
methylation (Figure 11A).  The promoters of Cstb, Rpl17, and Igf2r were also 
hypomethylated with no differential methylation (for primers see Table B15).  Recently, 
Das et al. (2012) discovered a differentially methylated CpG island in intron 11 of Igf2r 
in the liver, brain, and kidney of M. domestica.  We assayed 18 CpG dinucleotides 
across this same CpG island and found this DMR in fibroblasts as well (Figure A11).  
However, we were unable to assess allele-specific methylation patterns, as a parent-of-
origin specific SNP was not present in this region in our animals.  The hypomethylated 
states of the promoters of Meis1, Cstb, Rpl17, and Igf2r, as well as the DMR in intron 11 
of Igf2r, were also verified in three other F1 animals: A0690 (female), A0716 (male), 
and A0727 (male). 
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Figure 11.  DNA methylation profiles of Meis1 and tissue-specific expression 
pattern. A) Bisulfite converted DNA was cloned and sequenced. Each line 
represents an individual PCR product. The annotated promoter CpG island was 
assayed for DNA methylation. Unfilled circles represent unmethylated cytosines at 
CpG dinucleotides and filled circles represent methylated cytosines. B) 1% agarose 
gel of PCR amplicons (cDNA) generated from liver, brain, and heart mRNA. Igf2R 
is expressed in all three tissues, but Meis1 is not expressed. Ladder = 100bp DNA 
Ladder; Positive control = fibroblast cDNA. 
 
 
3.4 Discussion 
Of the 35,105 putative promoters assayed in our analysis of M. domestica 
fibroblasts, only ~46% (16,320) were marked by H3K4me3.  This fraction is 
considerably smaller than the 74% and 71% of the promoters marked by this expression-
associated modification in cultured human and mouse cells (Guenther et al. 2007; 
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Mikkelsen et al. 2007a), respectively, and is most likely an artifact of inaccuracy in the 
annotation of the M. domestica gene set.  The initial set of predicted protein-coding and 
non-coding genes was produced by analyzing similarity with well-annotated eutherian 
gene sets, a practice that is expected to underrepresent or overlook diverged orthologs, 
paralogs, and marsupial-specific genes (Goodstadt et al. 2007; Mikkelsen et al. 2007b).  
Further annotation has relied on individual sequencing of genes-of-interest, as well as a 
small number of RNA-seq data sets that are enriched for the 3’ ends of genes, leaving 
the 5’ annotation of many genes incomplete or inaccurate.  This issue is underscored by 
a recent, comprehensive RNA-seq study of the M. domestica X chromosome that reveals 
that the 5’ ends of nearly half of the genes on the X chromosome are incorrectly 
annotated in the MonDom5 assembly, with ~30% having a transcription start site more 
than 5 kb upstream from the first annotated 5’ exon (X Wang, KC Douglas, AG Clark, 
PB Samollow, unpublished data).  Annotation issues of this kind, especially at the 5’ 
ends of genes, pose a significant challenge for correlating promoter histone modification 
states with transcriptional states.  In light of this limitation, our results likely 
underestimate the number of opossum promoters marked, either independently or 
concurrently, by MOAs and/or H3K9me3. 
We were, however, able to identify 178 genes that were concurrently marked by 
MOAs and H3K9me3 within 5 kb of an annotated 5’ exon.  Twenty-one of these were 
expressed in fibroblasts and had an informative SNP in each reciprocal cross.  
Importantly, only six of them showed 100% overlap of significant peaks of H3K4me3, 
H3K9Ac, and H3K9me3, and half of these exhibited strongly biased allele expression, of 
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which one, Meis1, was expressed in a parent-of-origin specific manner; i.e., is imprinted.  
The high frequency of monoallelic expression among genes with 100% overlap of 
transcriptionally opposing histone marks suggests that complete peak overlap be adopted 
as an essential criterion in future ab initio searches for imprinted genes in non-eutherian 
species.   
Expression of the MEIS family of genes in eutherians is often strongly 
developmental-stage and cell-type specific and, accordingly, we were unable to detect 
Meis1 transcripts in several adult opossum somatic tissues examined (Figure 4B).  The 
remaining two monoallelically expressed genes, Cstb and Rpl17, showed allele-biased 
expression that was independent of parent-of-origin, emphasizing the importance of 
conducting reciprocal crosses to detect genuine parent-of-origin specific expression 
patterns, a practice that has been absent from many past studies of marsupial imprinted 
genes. 
Assessment of the transcriptional state of these three monoallelically expressed 
genes reveals the first case of an imprinted gene in a marsupial that is not known to be 
imprinted in any other organism, and suggests a role for histone modification states in 
the occurrence of monoallelic-expression of genes in the opossum and perhaps other 
marsupial genomes.  Contrastingly, methylation analysis of DNA from these fibroblasts 
failed to find evidence of DMRs at annotated CpG islands in the promoter regions of this 
novel imprinted gene or either of the two non-imprinted monoallelically expressed 
genes.  This is consistent with past reports that DMRs are rare or absent from marsupial 
orthologs of eutherian imprinted genes. 
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Examination of the four previously known annotated opossum imprinted genes, 
Igf2r, Htr2A, L3mbtl, and Mest failed to detect transcriptionally opposing histone 
modifications at their respective promoters or their gene bodies.  Igf2r is not imprinted in 
humans but is imprinted in mouse, sheep, dog, and marsupials (wallaby and opossums).  
In mouse, the transcriptional regulation of Igf2r is controlled by a DMR in intron 2 and 
by an antisense transcript (Air) (Wutz et al. 1997; Sleutels et al. 2002).  Interestingly, the 
DMR at intron 2 is present in human, mouse, and sheep, but absent in dog and 
marsupials (Wutz et al. 1997; Sleutels et al. 2003).  Transcriptionally opposing histone 
states have been associated with the imprinted state, or lack thereof, in human and 
mouse; but the full-length Air antisense transcript has only been described in mouse (Vu 
et al. 2006; O'Sullivan et al. 2007).  Htr2A and L3mbtl show variation of imprinted 
status in human organs sampled and are associated with certain disease states that 
correlate with aberrant DMRs, but no studies of associated histone states have been 
reported for these loci (Kobayashi et al. 1997; Li et al. 2004; De Luca et al. 2007).   
We were able to assess the imprinting status at the Igf2r locus, but a lack of 
suitable SNP variants in our animals prevented us from analyzing expression patterns of 
Htr2A, L3mbtl, and Mest in the present study.  It is possible that these genes are not 
imprinted in opossum fibroblasts, in which case the absence of transcriptionally 
opposing histone modifications would be expected.  Alternatively, any or all of these 
three genes could be imprinted in opossum fibroblasts but not marked or regulated by 
the specific histone modifications we examined, or DMRs, but rather by some yet-to-be 
identified genomic elements or regulatory mechanisms such as non-coding RNA 
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transcripts.  If so, there could be additional imprinted loci in fibroblasts that went 
undetected by our strategy relying on only four histone marks.   
Although Meis1 showed parent-of-origin-specific allele expression in three 
individual fibroblast cell lines, there was ‘leaky’ expression of the paternal allele in 
some samples.  Leaky expression of the repressed allele has been observed for some 
imprinted genes in eutherians and for some paternally imprinted X-linked genes in 
marsupials (Samollow et al. 1987; Umlauf et al. 2004; Wang et al. 2008; Suzuki et al. 
2009; Wang et al. 2011).  At the G6pd locus, the degree of paternal allele leakiness is 
age-dependent, with adults showing greater levels of paternal leakage than embryos 
(Samollow et al. 1995).  Similarly, studies in eutherians have demonstrated a loss of 
allele-specific gene regulation for X-linked genes in a passage-number-dependent 
manner in primary cell lines (Migeon et al. 1985).  Although we used low passage 
fibroblast cell lines, the cells were originally grown from adult tissue, and the 
combination of adult source and increasing passage could have resulted in higher levels 
of leakiness.  Alternatively, it is possible that the epigenetic regulation of imprinted loci 
in marsupials is not as stable as in eutherians due to the apparent lack of differential 
DNA methylation at these loci.  Furthermore, most studies of marsupial imprinted gene 
expression have not utilized highly sensitive assays, such as pyrosequencing, to measure 
allele-specific expression of imprinted genes; so leaky expression of the repressed allele 
could more prevalent than previously believed. 
The MEIS gene family comprises three homeobox genes in humans (MEIS1, 
MEIS2, MEIS3), which have been implicated as cofactors of Hox proteins and are 
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heavily involved in development, cell proliferation, and disease states.  They have been 
shown to be essential for organ development in mouse, zebrafish, chicken, and 
Drosophila (Moens & Selleri 2006; Choe et al. 2009; Sanchez-Guardado et al. 2011; 
Carbe et al. 2012; Mahmoud et al. 2013).  In the absence of protein functional data, we 
are unable to determine definitively which MEIS gene ortholog is represented by the 
imprinted opossum Meis locus.  Nevertheless, this locus was matched by the Illumina 
reads to the exclusion of other Meis paralogs and comparative synteny analysis shows 
gene content and order of the genomic region flanking this locus is strongly conserved 
with that containing the human MEIS1 and mouse Meis1 genes.  Finally, a reciprocal 
Blast search strategy using the opossum predicted mRNA and amino acid sequences 
from the Ensembl annotation indicates that the opossum-imprinted Meis gene shares the 
greatest sequence similarity with the MEIS1 gene of human, mouse, and rat.  Hence, we 
feel confident that this is the ortholog of MEIS1.  This gene has been shown to regulate 
cell proliferation, growth, and differentiation in embryos and fetuses, and in adult 
animals is active in highly proliferative tissues (Unnisa et al. 2012; Mahmoud et al. 
2013).  These functional characterisitcs and the paternally imprinted state of opossum 
Meis1 are consistent with the conflict model for the evolution of genomic imprinting, 
which is based on competing fitness interests of the paternal and maternal genomes with 
regard to maternal resource allocation to the developing offspring (Moore & Haig 1991; 
Haig 2004).   
  79 
3.5 Conclusion  
In this first comprehensive report on histone profile states in any marsupial 
species, we have described the genomic landscapes for four canonical histone 
modifications, H3K4me3, H3K9Ac, H3K9me3, and H3K27me3 and successfully 
identified a novel imprinted gene in opossum as well as two monoallelically expressed 
genes.  These results demonstrate the practicality of an ab initio strategy for discovering 
imprinted genes in non-eutherian mammals and, potentially, non-mammalian species as 
well.  Overall, the findings support the conclusion that specific histone modifications are 
conserved features that mark the promoters of some imprinted genes in all therians, but 
also suggest that marsupials use multiple epigenetic mechanisms for imprinting, some of 
which are distinct from those known in eutherians; e.g., DNA methylation appears to 
play little, if any, role in regulating the imprinted state in marsupial mammals.  
Furthermore, while the imprinting status of some genes is conserved across therians, 
identification of a marsupial-specific imprinted locus, Meis1, which is not known to be 
imprinted in any eutherian species examined, bolsters the concept that lineage-specific 
differences in selective pressures may have led to phylogenetically distinct variants of 
the imprinting phenomenon.   
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CHAPTER IV  
GENOMIC IMPRPINTING IN FETAL BRAIN AND                                         
EXTRA-EMBRYONIC MEMBRANES 
 
4.1 Introduction 
 In eutherian mammals, imprinted genes have been shown to be enriched in fetal 
and placental tissues as compared to adult tissues (Kosaki et al. 2000; Umlauf et al. 
2004; Dindot et al. 2008; Wang et al. 2011; Bebbere et al. 2013; Wang et al. 2013).  
Using this knowledge and what we have learned from our studies of XCI and fibroblast 
imprinting, we applied both RNA-seq and ChIP-seq approaches to detect novel 
imprinted genes in fetal brain and EEM of M. domestica.  However, the examination of 
autosomal loci in tissues from these M. domestica crosses poses a greater challenge than 
the X-chromosome inactivation study discussed in Chapter II.   
First, the two stocks, LL1 and LL2, share a considerable amount of genetic 
material due to historical matings of LL1 and LL2 stocks to achieve sustainable numbers 
of animals with the LL2 genetic background.  Although it has been estimated that LL2 
animals share 22% or less of their genetic material with LL1 animals (VandeBerg & 
Williams-Blangero 2010), the actual percentages remain unmeasured.  Our method for 
determining monoallelic expression at any locus using RNA-seq data is based on the 
assumption that certain trackable SNPs are stock-specific, homozygous, and fixed in a 
particular stock.  This allows us to assume that the F1 generation is heterozygous at the 
gDNA level at loci-of-interest given the genotypes of the expressed sequences of the P 
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generation.  When alleles are shared between stocks, this assumption is violated, thus 
generating the possibility of concluding that a gene is imprinted when in fact it is not 
(i.e. a false positive).  Furthermore, the risk of a false positive is greater for autosomal 
loci, with a maximum of 4 alleles/ per gene per mating, than for X-linked loci, with a 
maximum of 3 alleles per gene per mating.   
Secondly, it has been shown in mouse and human that histone state profiles are 
highly dynamic throughout early development and can vary at individual loci, with 
undifferentiated cells having many loci that are marked by both active and repressive 
histone modifications (i.e. bivalent loci).  As development proceeds and cells 
differentiate, bivalent loci resolve to a univalent state, becoming marked by either active 
or repressive histone modifications that are, in many instances, cell-type specific 
(Mikkelsen et al. 2007a).  The early stage of development of the fetal brain, and our 
limited knowledge of the cell-type specific developmental patterns of M. domestica, 
make the interpretation of correlations of histone modifications with gene expression 
more challenging than is the case with uniform fibroblast cultures or even fully 
differentiated adult tissues.   
Lastly, assessing the transcriptional and histone states of genes within organs, 
which by definition comprise multiple cell types, is problematic.  We are unable to 
assess cell-type specific imprinting or histone modifications leaving only genes that are 
imprinted in all or the vast majority of cells in the tissue.  Despite these challenges and 
limitations, we were able to utilize the fetal brain and EEM RNA-seq data sets and the 
fetal brain ChIP-seq data sets generated in Chapter II to identify additional candidate-
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imprinted genes in opossum fetal brain and EEM.  All analyses and methods used can be 
found in the methods sections of Chapter II and III or are presented in Chapter V. 
4.2 Results 
4.2.1 Imprinted Genes in Fetal Brain and EEM 
 Employing a conservative search strategy, we identified 22 candidate-imprinted 
genes and a previously known imprinted gene, Ig2r, all of which exhibited monoallelic 
expression in fetal brain and/or EEM according to the RNA-seq data (Table 3).  This set 
of candidate-imprinted genes contains known protein coding genes, non-coding RNAs, 
and genes of unknown biotype.  To confirm heterozygosity in the F1 generation and the 
parent-of-origin of the alleles, candidate-imprinted genes identified were genotyped by 
Sanger sequencing of PCR products generated from gDNA of the P and F1 generations.  
Sanger sequencing results showed that 14 genes were heterozygous in the F1 generation 
and showed trackable parent-of-origin-specific alleles in at least one of the two tissues, 
enabling us to postulate their imprinted status, paternally (Pat.) or maternally (Mat.) 
imprinted (Table 3 and Table B16).  Two genes, Praak1 and Parp4, were not 
heterozygous in the F1 generation and were labeled not assessable (NA), as we were 
unable to assess their imprinting status.  The remaining seven genes were not testable 
(NT) due to the difficulty in obtaining high quality Sanger data.  The 14 genes that did 
give high quality Sanger data and were heterozygous with a trackable, parent-of-origin 
specific SNP in the F1 generation were selected for verification of imprinted status via 
pyrosequencing analysis.  Additionally, we conducted a search for SNPs in the other 
previously known, annotated imprinted genes in M. domestica but did not find a SNP in 
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Htr2a, L3mbtl, Mest, or Meis1; thus we are unable to assess the imprinting status of 
these genes in fetal brain and EEM. 
 
 
Table 3.  Candidate-imprinted genes in fetal brain and EEM as determined by 
RNA-seq. Refseq gene names, Ensemble gene IDs, location of the informative SNP, 
and predicted imprinted status (IS) in fetal brain and EEM are shown. NA = Not 
Annotated; Pat. = Paternally imprinted; Mat. = Maternally imprinted; ND = Not 
Detectable/Low coverage; NA = Not Assessable; NT = Not Testable via Sanger. 
 
Refseq 
Gene Name Ensembl Gene ID 
SNP Location 
Chr           Pos. 
Fetal 
Brain IS 
EEM 
 IS 
Unknown_gene_1  NA 1 432003410 Pat. ND 
Pou5fl NA 1 469390121 Mat. NI 
Npdc1 NA 1 469395728 Mat. Mat. 
Prkaa1 ENSMODG00000003591 2 35625423 NA NA 
Rwdd2 ENSMODG00000018383 2 338813088 Mat. Mat. 
Zfp68 ENSMODG00000008516 2 522422185 Mat. Mat. 
Fam169a ENSMODG00000001914 3 49751281 Pat. Pat. 
Matn2 ENSMODG00000006840 3 362553338 NT NT 
Unknown_gene_5 NA 3 509558241 Mat. Mat. 
Unknown_gene_2 NA 3 525556810 NT NT 
Rpl36al ENSMODG00000024968 4 105027808 Pat. Pat. 
Parp4 ENSMODG00000007894 4 288455210 NA NA 
Lig1 ENSMODG00000013344 4 412759243 NT NT 
Unknown_gene_6 NA 6 291639563 Mat. ND 
Nkrf ENSMODG00000024032 6 291750260 Mat. Mat. 
Fkbp4 ENSMODG00000018354 8 116416577 NT NT 
Smc6 ENSMODG00000011685 Un 22460755 Pat. Pat. 
Xm_001366097.1 ENSMODG00000011693 Un 22534496 Pat. Pat. 
Unknown_gene_7 NA Un 23482575 NT NT 
Csnk1a1 ENSMODG00000018038 Un 28330592 NT NT 
Unknown_gene_3 NA Un 28488850 Pat. ND 
Unknown_gene_4 NA Un 73948586 NT NT 
Igf2r ENSMODG00000007100 2 442547043 Mat. Mat. 
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To independently confirm the expression patterns of the 13 candidate-imprinted 
genes and Igf2r, we designed primers for allele-specific pyrosequencing of these loci.  
Ten of the 14 genes gave specific pyrosequencing PCR products in fetal brain and EEM 
(Table 4), and the pyrosequencing assays confirmed the imprinted state for all ten.  It is 
noteworthy that all of the novel-imprinted genes showed some degree of leaky 
expression from the repressed allele (Table 4).  Figure 12 shows the Sanger, RNA-seq, 
and pyrosequencing results for the maternally imprinted (paternally expressed) gene, 
Nkrf.   
 
 
Table 4.  Summary of pyrosequencing results to confirm imprinted expression. The 
gene name, tissues, biotype, imprinting status, and expression percentages in fetal 
brain and EEM of the expressed allele averaged over two runs is presented. FB = 
Fetal Brain; EEM = Extra-Embryonic Membranes; Mat. = Maternally Imprinted; 
Pat. = Paternally Imprinted; NM = Not Measured; TBD = To Be Determined. 
 
Gene Name Tissue Gene Biotype 
Imprinted 
Allele 
% Expression 
of Active 
Allele (FB) 
% Expression 
of Active 
Allele (EEM) 
Igf2r FB & EEM Coding Mat. 89.60% 91.95% 
Unk_gene_1 FB & EEM Non-coding Pat. 87.50% NM 
Smc6 FB & EEM Coding Pat. 97.09% 96.89% 
Unk_gene_5 FB & EEM TBD Mat. 88.67% 84.15% 
Nkrf FB & EEM Coding Mat. 97.43% 97.30% 
Pou5fl 
(Oct3/4) FB only Coding Mat. TBD TBD 
Npdc1 FB & EEM Coding Mat. 87.75 84.28 
Rwdd2a FB & EEM Coding Mat. 77.43% 82.64% 
Zfp68 FB & EEM Coding Mat. TBD TBD 
Unk_gene_6 FB only TBD Mat. 92.25 64.18% 
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Figure 12.  Nkrf is maternally imprinted in both fetal brain and EEM. (A-B) SNP 
genotyping, RNA-seq allele counts, and pyrosequencing verification for maternally 
imprinted gene Nkrf in opossum fetal brain and EEM. Sanger sequencing 
genotyping (A, B top panels) confirmed that exonic SNP OMSNP0127879 was 
informative in all four F1 embryos: A0579E3 and A0579E4 in LL1 x LL2 cross (A); 
A0571E1 and A0571E4 in the LL2 x LL1 cross (B). Imprinted expression was 
verified by both RNA-seq (left) and allele-specific pyrosequencing strategies (right) 
(A, B bottom panels). 
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4.2.2 Histone Modification at Imprinted Genes in Fetal Brain 
We assessed the presence of two marks of activation (MOAs), H3K4me3 and 
H3K9Ac, and one mark of repression (MOR), H3K27me3, at the putative promoters of 
the candidate-imprinted genes in fetal brain (Table5 and Figure 13).  Of the 23 
candidate-imprinted genes, the promoters of all but two, Pou5fl and Unknown_Gene_7, 
were marked with H3K4me3, and 18 contained an annotated promoter CpG island 
(Table 5).  However, only 10 genes had a significant H3K27me3 peak at the promoter, 
and of these, seven were concurrently marked with H3K4me3 and contained an 
annotated promoter CpG island.  Our findings suggest that H3K4me3 correlates with 
promoters of imprinted genes in opossum whereas H3K27me3 is not as prevalent at 
these loci. 
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Table 5.  The presence of at least one MOA, MOR, and annotated CpG islands at 
putative promoters of candidate-imprinted genes is shown. Genes in bold were 
chosen for pyrosequencing verification. Pat. = Paternally imprinted; Mat. = 
Maternally Imprinted; ND = Not Detectable/Low coverage; NI = Not Imprinted; 
NT = Not Testable via Sanger or pyrosequencing; Y = Present; N = Absent. 
 
 
Gene Name 
Imprinted Status 
Fetal Brain 
Imprinted Status  
EEM MOAs MORs CpG  
Unknown_gene_1  Pat. ND Y Y N 
Pou5fl Mat. NI N Y N 
Npdc1 Mat. Mat. Y N Y 
Prkaa1 NI NI Y Y Y 
Rwdd2 Mat. Mat. Y N Y 
Zfp68 Mat. Mat. Y N Y 
Fam169a Pat. Pat. Y Y Y 
Matn2 NT NT Y Y Y 
Unknown_gene_5 Mat. Mat. Y N N 
Unknown_gene_2 NT NT Y N Y 
Rpl36al Pat. Pat. Y N Y 
Parp4 NI NI Y N N 
Lig1 NT NT Y N Y 
Unknown_gene_6 Mat. ND Y Y Y 
Nkrf Mat. Mat. Y N Y 
Fkbp4 NT NT Y N Y 
Smc6 Pat. Pat. Y Y Y 
Xm_001366097.1 Pat. Pat. Y Y Y 
Unknown_gene_7 NT NT N N Y 
Csnk1a1 NT NT Y Y Y 
Unknown_gene_3 Pat. ND Y - Y 
Unknown_gene_4 NT NT Y Y N 
Igf2r Mat. Mat. Y N Y 
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Figure 13.  Histone modifications across selected candidate-imprinted genes. A) 
Igf2r; B) Unknown_gene_6 and Nkrf; C) Pou5fl and Npdc1; D) Rwdd2a; E) Smc6; 
F) Unknown_gene_1; G) Unknown_gene_5; H) Zfp68. 1 = H3K4me3; 2 = H3K9Ac; 
3 = H3K27me3; 4 = Annotated CpG islands (top) and gene annotation (bottom), if 
present. Revised gene annotation according to our RNA-seq data is presented 
below each box. Arrows indicated direction of transcription. 
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4.2.3 Comparison of Histone State Profiles between Fibroblasts and Fetal Brain 
We found a noticeable difference in peak morphology for H3K9me3 and 
H3K27me3 between fetal brain and fibroblast cell lines.  In fibroblast cells, the profile of 
H3K9me3 exhibits many significant intra- and inter-genic peaks that are associated with 
a subset of promoters; however, the H3K9me3 signal in fetal brain is diffuse with only a 
few significant peaks (Figure 14A).  The H3K27me3 signal in fibroblasts was generally 
diffuse across the autosomes with only a small number of significant peaks at promoters, 
and in most cases, shows a depletion of signal, or trough, at promoters and across gene 
bodies of transcribed genes.  In fetal brain, the distribution of the H3K27me3 signal is 
concentrated at the promoters of genes, is not depleted across gene bodies, and shows, in 
many cases, a significant peak of enrichment at promoters (Figure 14B).  In contrast to 
the two MORs, the distribution and morphology of H3K4me3 peaks show a similar 
distribution between the two tissues (Figure 14D). 
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Figure 14.  Examples of histone peak morphology in ChIP-seq samples from 
fibroblast and fetal brain. Comparison of histone peak morphologies of the region 
of chromosome 2 (456,062,440 - 458,903,191) for H3K9me3 (A), H327me3 (B), and 
H3K4me3 (D). Significant MACS peaks are indicated by blue bars above histone 
profile plots. Areas of H3K27me3 depletion across promoters and gene bodies are 
indicated by asterisks (B). (C) Annotated Ensembl genes (blue bars) and CpG 
islands (black bars) in this region. 
H3K9me3'
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* **
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4.2.4 Smc6 is X-Linked 
The histone modification profile of Smc6 led us to postulate that it was X-linked 
(see Chapter II).  To test this, we conducted DNA-FISH using the BAC clone that 
contains Smc6 (VMRC18:415P26), and it mapped to the opossum X chromosome 
(Figure 15).  This result not only demonstrates our ability to find imprinted genes but 
also illustrates the value of pairing expression data with histone state profiles to correctly 
identify imprinted genes.   
 
 
 
Figure 15.  Smc6 BAC clone maps to the opossum X chromosome using DNA-FISH. 
Red = Smc6 (VMRC16:415P26); Green = X-linked BAC (VMRC18:608C5). 
 
 
4.2.5 DNA Methylation of Promoter CpG Islands for Novel Imprinted Genes  
 To determine if DNA methylation was present at the promoters of novel 
imprinted genes, we quantified DNA methylation percentages at the annotated promoter 
CpG islands for Rwdd2a (13 CpGs assayed) and Unknown_gene_1 (6 CpGs assayed) 
using bisulfite sequencing (Figure 16 and Table 6) and Rwdd2a and Npdc1 using the 
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PyroMark assay (Table 6).  We also included the X-linked gene Smc6 (12 CpGs 
assayed), which is expected to lack promoter CpG island methylation, in the bisulfite 
sequencing analysis. 
 
 
Figure 16.  Summary of bisulfite sequencing results of promoter regions of A) 
Smc6, B) Rwdd2a, and C) Unknown_gene_1 in fetal brain of A0592E1. Each line 
represents a single sequenced clone. Open Circles = Unmethylated Cytosine; Filled 
Circles = Methylated Cytosine. 
 
 
 
A     Smc6  
B             Rwdd2a 
C        Unknown_gene_1 
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Table 6.  Target sequence coordinates for analyses of DNA methylation at 
promoters of novel imprinted genes. Four genes were assayed. BS = Bisulfite 
Sequenced; PM = Pyromark Assay. 
 
Gene Assay Target Location Size Methylated 
State 
Smc6 BS chrUn:22,489,504-22,489,642 139 bp No Meth. 
Unknown_gene_1 BS chr1:432,036,966-432,037,112 147 bp No Meth. 
Rwwd2a BS chr2:338,812,440-338,812,574 135 bp Full Meth. 
Rwwd2a PM chr2:338,812,606-338,812,815 209 bp DMR 
Npdc1 PM chr1:469,421,901-469,422,117 216 bp DMR 
 
 
Our bisulfite sequencing data show that Smc6 and Unknown_gene_1 lack 
promoter DNA methylation as well as a DMR; however, Rwdd2a showed 100% 
methylation at all cytosines examined.  In addition, the Pyromark assay confirmed the 
100% methylated state found at the Rwdd2a region indicated by bisulfite sequencing, but 
also revealed a DMR within the same CpG island, approximately 100 bp downstream of 
the sequence analyzed via bisulfite sequencing.  We also discovered a DMR at the 
promoter CpG island at Npdc1 which is the first report of promoter CpG island 
methylation at any autosomal imprinted gene in opossum.   
4.3 Conclusions and Future Work 
We have conducted the first ab intio search for imprinted genes in the fetal brain 
and EEM of a marsupial and identified 22 novel, candidate-imprinted genes and a 
previously described imprinted gene, Igf2r.  Sanger and pyrosequencing analyses have 
confirmed the imprinted state of 10 of these genes; however, DNA-FISH showed that 
the paternally imprinted gene Smc6, which is annotated on Chromosome Un, is X-linked 
bringing the final count of confirmed, autosomal imprinted genes to nine.  Eight of the 
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nine novel, confirmed-imprinted genes have not been shown to be imprinted in any 
marsupial or eutherian tissues examined making this the first set of marsupial-specific 
imprinted genes discovered in any marsupial tissue.  Interestingly, all of the nine novel-
imprinted genes and Igf2r exhibit some ‘leaky’ expression from the imprinted 
(repressed) allele.  This phenomenon has been well documented for imprinted genes on 
the opossum X chromosome (see Chapter II) and for the opossum, fibroblast-specific 
imprinted gene, Meis1 (see Chapter III).  Leaky expression of imprinted genes, whether 
autosomal or X-linked, appears to be common in opossum; however, the mechanism and 
biological or evolutionary significance of this expression pattern has yet to be 
determined.  One possible explanation for such leaky expression in marsupials could be 
a more relaxed epigenetic regulation of imprinted loci due to a general lack of strong 
differential DNA methylation concomitant with the occurrence of transcriptionally 
opposing histone modifications at the promoters of imprinted loci. 
H3K4me3, a mark-of-activation, was found at the promoters of all but one of the 
confirmed-imprinted genes, Pou5fl; and two genes, Unknown_gene_1 and 
Unknown_gene_6, were simultaneously marked with H3K4me3 and H3K27me3 (a 
mark-of-repression).  Neither of these genes have been previously annotated in the 
opossum genome, and their sequence alignments and characteristics suggest that they are 
novel, non-coding RNAs, although this speculation has not been verified.  In addition, 
the promoter CpG islands of three genes, Rwdd2a, Unknown_gene_1, and Npdc1, have 
been examined for DNA methylation using bisulfite sequencing and Pyromark analyses 
and have given interesting results inasmuch as adjacent sections of CpG islands show 
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different methylation patterns.  We also discovered two novel DMRs at the promoters of 
Rwdd2a and Npdc1, and a fully methylated section less than 100 bp upstream of the 
DMR at Rwdd2a.  Confirmation withstanding, our preliminary data suggests that 
promoter CpG island methylation does correlate with promoters of some marsupial 
imprinted genes and possibly plays a role in regulating imprinting expression in fetal 
brain and EEM.  This differs drastically from X-linked genes (Chapter II) and the 
imprinted and monoallelically expressed genes in fibroblasts (Chapter III) which lacked 
promoter CpG island methylation in all cases (except for Rsx on the X chromosome) and 
represents the first evidence of promoter CpG island methylation for imprinted, 
autosomal genes in opossum.   
 To better understand this set of imprinted genes in opossum fetal brain and EEM, 
more work is needed.  An in-depth annotation of the imprinted genes, both protein-
coding and non-coding RNAs, is ongoing, but the identification of possible targets for 
the non-coding RNAs is also needed.  The newly identified DMRs, as well as promoters 
that appear to lack them, need to be confirmed by both bisulfite sequencing and 
Pyromark assay, and the promoters of more imprinted genes need to be examined to 
fully assess the extent and biological significance of promoter CpG island methylation 
for imprinted loci in opossum.  Furthermore, a search for parent-specific SNPs, which 
will allow the tracking of allele-specific methylation and transcriptionally opposing 
histone modifications, needs to be conducted to assess how well these highly suggestive 
epigenetic features correlate with the transcriptional states of the active and repressed 
(imprinted) alleles generally.  Completion of these experiments is critical to elucidate the 
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possible mechanisms of imprinting in opossum and complete the catalogue of imprinted 
genes in opossum fetal brain and EEM. 
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CHAPTER V  
EXTENDED METHODS 
5.1 Chapter II Extended Methods 
5.1.1 Opossum Lines and Crosses 
Two random-bred stocks of Monodelphis domestica, designated LL1 and LL2 
derived from the Population 1 and Population 2 stocks described by VandeBerg and 
Williams-Blangero (2010) were used to generate reciprocal F1 embryos (Table 7).  The 
LL1 stock was derived as a subgroup from Population 1 ancestors, which is the same 
ancestral stock that furnished DNA for the MonDom5 opossum genome sequence 
(Mikkelsen et al. 2007b); LL2 was derived by admixture of Population 1 and Population 
2 animals and comprises an approximate 1:7 mixture of the Population 1 and Population 
2 genetic backgrounds, respectively (John L. VandeBerg, personal communication).  
Embryos from the parental crosses of LL1 x LL1 and LL2 x LL2 were also collected to 
assist in determining the direction of allelic transmission.  To control for shared alleles 
segregating in the two stocks, the same males were used for the F1 and parental crosses, 
and the females in F1 and parental crosses were full siblings (Figure A1, A-D).  To 
collect prenatal stage animals of known gestational ages, the time of copulation was 
determined by videotaping paired animals as described by Mate et al. (1994) with minor 
modifications.  All procedures involving opossums were approved by the Institutional 
Animal Care and Use Committee of Texas A&M University, College Station (TAMU 
Animal Use Protocols 2011-141 and 2011-191). 
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Table 7.  List of animals, developmental stages, and tissues used for RNA-seq 
experiments. 
 
No. Sample ID* Sex 
Dam 
ID 
Sire 
 ID 
Dam 
Stock 
Sire 
Stock 
Develop. 
 Stage Tissue 
1 A0571_p1 female A0571 A0578 LL2 LL1 E13.0** EEM*** 
2 A0571_p4 female A0571 A0578 LL2 LL1 E13.0 EEM 
3 A0579_p3 female A0579 A0573 LL1 LL2 E13.0 EEM 
4 A0579_p4 female A0579 A0573 LL1 LL2 E13.0 EEM 
5 A0571_b1 female A0571 A0578 LL2 LL1 E13.0 Fetal head 
6 A0571_b4 female A0571 A0578 LL2 LL1 E13.0 Fetal brain 
7 A0579_b3 female A0579 A0573 LL1 LL2 E13.0 Fetal head 
8 A0579_b4 female A0579 A0573 LL1 LL2 E13.0 Fetal brain 
9 A0580_p1 female A0580 A0578 LL1 LL1 E12.5 EEM 
10 A0580_p5 male A0580 A0578 LL1 LL1 E12.5 EEM 
11 A0572_p1 female A0572 A0573 LL2 LL2 E12.5 EEM 
12 A0572_p3 male A0572 A0573 LL2 LL2 E12.5 EEM 
13 A0580_b1 female A0580 A0578 LL1 LL1 E12.5 Fetal head 
14 A0580_b5 male A0580 A0578 LL1 LL1 E12.5 Fetal head 
15 A0572_b1 female A0572 A0573 LL2 LL2 E12.5 Fetal head 
16 A0572_b3 male A0572 A0573 LL2 LL2 E12.5 Fetal head 
*:  “p” = placenta/EEM; “b” = fetal brain/fetal head.**: embryonic day 13. ***: extra-embryonic membranes. 
 
 
5.1.2 Tissue Selection, Dissection, and Sex-Typing 
Based on video evidence of mating, females were euthanized at 13 days post-
copulation (d.p.c.) and the fetuses and respective extra-embryonic membranes (EEM) 
were collected by dissection and placed in either RNAlater (Ambion) or phosphate 
buffered saline (PBS) and stored at -80 oC.  Head/brain and EEM tissues were dissected 
from each fetus (Figure 1A, B).  At this early stage of development, brain size was very 
small; and despite identical gestation times, fetuses within a litter varied in size.  For 
smaller fetuses, the head was further dissected to remove jaws, muzzle, and other non-
cranial structures.  The remaining cranial region and the corresponding EEM tissues 
were used for RNA extraction, whereas the limbs were used for genomic DNA 
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extraction.  For the two largest fetuses (sample_ID: A0571_b4 and A0579_b4), we were 
able to identify and isolate the frontal cortices and other brain structures.   
To avoid maternal cell contamination during the collection of EEM, we followed 
the umbilical cord to the uterine/placenta interface and retreated the scissors ~1-2 mm 
before cutting.  The fetuses were sex-typed using Y-chromosome-specific primers 
(Figure A1.E) developed in collaboration with the Opossum Y chromosome Mapping 
Project (Page Laboratory, Whitehead Institute for Biomedical Research, Cambridge, 
MA) using a Y-specific BAC sequence containing the opossum sex-determining region 
on the Y (Sry) gene (AC239615.3, JN086997.1).  These primers amplify a fragment of 
the Y-linked Sry gene in male cells/tissues in a highly replicable manner but show no 
amplification in female cells/tissues.  Two female fetuses from each reciprocal cross, 
and one male and one female fetus from each stock-specific cross (total of eight 
individuals) were used for RNA extraction. 
5.1.3 Total RNA and Genomic DNA Extractions and QC  
After collection, the tissues were homogenized in TriReagent (Invitrogen) and 
total RNA was extracted using BCP (1-bromo-2 chloropropane), precipitated with 
isopropanol, and resuspended in RNase-free water.  Potential DNA contamination was 
removed by both DNase I treatment and Qiagen RNeasy Plus Mini kit (Qiagen, CA).  
RNA concentrations and A260nm/A280nm ratios were checked with a NanoDrop ND-
1000 Spectrophotometer.  The RNA quality was validated on both 1% agarose gels and 
an Agilent 2100 Bioanalyzer.  To extract genomic DNA, tissue was minced and digested 
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with proteinase K overnight followed by phenol:chloroform extraction, ethanol 
precipitation overnight, and elution in TE.   
5.1.4 Illumina mRNA-Seq and Sequence Alignment 
mRNA-seq libraries were made from brain and EEM RNA samples (1-3 µg total 
RNA input) of the four individuals in reciprocal F1 crosses and four individuals in the 
parental crosses described above, using the Illumina TruSeq RNA Sample Prep Kit 
(Illumina Inc., CA).  The 16 libraries (eight from the F1 crosses and eight from the 
parental crosses) were multiplexed and run on four 51 bp single-end lanes each, on an 
Illumina HiSeq 2000 instrument (Illumina Inc., CA).  Image analysis and base calling 
were performed using Illumina software.  In total, 1.5 billion short reads (76.5 billion 
bps) were generated from the 16 samples.  The q-score and nucleotide distribution QC 
indicated good RNA-seq data quality.  The reads were aligned to the opossum reference 
genome assembly (MonDom5, http://genome.ucsc.edu/) using TopHat v1.4.1 (Trapnell 
et al. 2009) with three mismatches allowed.  Eighty-two percent of the reads were 
uniquely mapped to the opossum reference genome (Table 8).   
5.1.5 Quantification of Total and Parent-of-Origin Allele-Specific Expression from 
X-Linked Gene RNA-Seq Data 
The metric for total gene expression level is derived from counts of transcript 
reads that match specific loci in the reference genome.  This metric, FPKM (Fragments 
Per Kilobase-pair of exon Model), was calculated for all samples using Cufflinks v1.3.0 
(Trapnell et al. 2010) based on all mapped reads from the TopHat alignments.  The 
multiple mapped reads were weighted using the “-u” parameter in Cufflinks.  The 
  101 
expression level was normalized across brain and EEM samples using quartile 
normalization. 
 
 
Table 8.  Summary of Illumina raw and mapped read data for RNA-seq 
experiments. All experiments were run on Illumina HiSeq2000. 
   
No. Sample_ID* read length multiplexing 
# of 
lanes 
total number 
of reads 
uniquely 
mapped 
reads 
mapping 
percentage 
1 A0571_p1 51bp 1-8 8-plex 4 122,984,871 96,491,161 78.46% 
2 A0571_p4 51bp 1-8 8-plex 4 102,676,227 80,265,550 78.17% 
3 A0579_p3 51bp 1-8 8-plex 4 97,126,305 75,901,042 78.15% 
4 A0579_p4 51bp 1-8 8-plex 4 93,176,519 70,214,242 75.36% 
5 A0571_b1 51bp 1-8 8-plex 4 111,441,595 92,237,141 82.77% 
6 A0571_b4 51bp 1-8 8-plex 4 104,401,730 87,413,805 83.73% 
7 A0579_b3 51bp 1-8 8-plex 4 123,279,342 102,502,500 83.15% 
8 A0579_b4 51bp 1-8 8-plex 4 107,001,858 88,789,694 82.98% 
9 A0580_p1 51bp 9-16 8-plex 4 89,170,950 73,057,075 81.93% 
10 A0580_p5 51bp 9-16 8-plex 4 80,905,285 66,088,617 81.69% 
11 A0572_p1 51bp 9-16 8-plex 4 57,906,830 47,408,285 81.87% 
12 A0572_p3 51bp 9-16 8-plex 4 76,082,440 62,107,048 81.63% 
13 A0580_b1 51bp 9-16 8-plex 4 78,348,683 66,295,368 84.62% 
14 A0580_b5 51bp 9-16 8-plex 4 111,042,946 93,760,306 84.44% 
15 A0572_b1 51bp 9-16 8-plex 4 75,672,460 63,848,790 84.38% 
16 A0572_b3 51bp 9-16 8-plex 4 78,107,923 65,288,060 83.59% 
*:  “p” = placenta/EEM; “b” = fetal brain/fetal head 
 
The RNA-seq read coverage and mapping percentages were homogeneous across 
all the samples, rendering the before-normalization and after-normalization M-A plots 
equally informative (Figure A3).  We covered 11,465 Ensembl opossum gene models 
with FPKM≥1 in all eight brain samples and 10,518 gene models in the eight EEM 
samples.  The RNA-seq data were deposited in the Gene Expression Omnibus (GEO) 
database under accession number GSE45211. 
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SNP positions were called in combined RNA-seq data only from reads that 
mapped uniquely to the opossum reference sequence with ≥40 matching reads, using 
SAMtools software (Li et al. 2009).  Problematic SNPs, such as those with a third allele, 
near an indel position, or at the exon-intron junctions, were removed.  In total, 68,000 
SNPs were called.  The reference and alternative allele counts were summarized at high 
quality X-linked SNP positions.  We further selected high-coverage SNPs with ≥8 X 
coverage in at least one of two female F1 individuals in both reciprocal crosses.  
Nineteen additional X-linked genes assigned to MonDom5 ChrUn were also included 
(Table 9).  Retrotransposed X-linked genes were excluded from the analysis (Table 10).   
 
 
Table 9.  X-linked genes on the unmapped scaffold (ChrUN) covered in RNA-seq 
data. 
 
No. Scaffold ID Coordinates on ChrUn Gene name 
1 scaffold_217 5892577-6515230 ABCB7 
2 scaffold_217 5892577-6515230 KIAA2022 
3 scaffold_217 5892577-6515230 RLIM 
4 scaffold_217 5892577-6515230 SLC16A2 
5 scaffold_251 23882535-24256940 RNF170-like 
6 scaffold_251 23882535-24256940 Rab-1B-like 
7 scaffold_251 23882535-24256940 KLHL4 
8 scaffold_251 23882535-24256940 ENSMODG00000022796 
9 scaffold_261 27708438-28006343 MTMR8 
10 scaffold_261 27708438-28006343 XM_001378411.1 
11 scaffold_298 37707632-37883514 FUNDC2 
12 scaffold_298 37707632-37883514 MTCP1 
13 scaffold_298 37707632-37883514 BRCC3 
14 scaffold_298 37707632-37883514 PICALM-like 
15 scaffold_298 37707632-37883514 VBP1 
16 scaffold_298 37707632-37883514 RAB39B 
17 scaffold_352 45973239-46059762 SLC9A6 
18 scaffold_352 45973239-46059762 MMGT1-like 
19 scaffold_1524 75514428-75525886 EMD 
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Table 10.  Retrotransposed X-linked genes excluded from the analysis. 
 
No. Ensembl trans ID Ensembl gene ID Gene name 
1 ENSMODT00000009535 ENSMODG00000007539 HAUS7 
2 ENSMODT00000039334 ENSMODG00000025336 HSP90AB1-transposed 
3 ENSMODT00000039297 ENSMODG00000025324 LUC7L2-transposed 
4 ENSMODT00000008835 ENSMODG00000006990 ENSMODG00000006990 
5 ENSMODT00000021722 ENSMODG00000017105 PABPC1L2B 
6 - - X.288 
7 ENSMODT00000009094 ENSMODG00000007195 RNASET2-transposed 
8 ENSMODT00000026898 ENSMODG00000021142 TAX1BP1-transposed 
11 ENSMODT00000017947 ENSMODG00000014093 SSU72-transposed 
13 ENSMODT00000022195 ENSMODG00000017486 SET-transposed 
14 ENSMODT00000011525 ENSMODG00000009064 KDM2A-transposed 
 
 
 
To quantify allele-specific expression in brain and EEM tissues from the 
reciprocal crosses, we calculated the ratio of reference allele-containing reads divided by 
the total coverage at each identified SNP position (Wang et al. 2008) (Table B1).  The 
transmission directions were inferred from the parental crosses and SNP variant data 
from other LL1 individuals for which RNA-seq data was available (data not shown). 
5.1.6 X-Linked SNP Genotyping by Sanger Sequencing  
To confirm the parental origins of the two alleles at escaper loci, we genotyped 
the F1 individuals and their parents at informative SNP positions using Sanger 
sequencing (Table B2).  Primers targeting informative SNPs were designed using 
Primer3 (http://frodo.wi.mit.edu/).  DNA was PCR amplified using TaqGold® 
polymerase, purified, and Sanger sequenced at Beckman Coulter Genomics (Danvers, 
MA).  Gel purification was necessary for some samples due to the presence of non-
specific PCR products.  Sequences were viewed, aligned, and analyzed using 
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Sequencher 4.10®.  For non-escaper genes, in which expression of only a single allele 
was observed, the possibility that any particular informative SNP might not be 
heterozygous in all F1 individuals had to be considered.  This was necessary because the 
LL1 and LL2 lines are not 100% inbred and some alleles are shared between them at 
segregating loci.  To check whether the SNPs were heterozygous in the female F1 
individuals, we classified the informative SNPs into six classes (Table 11), and 
randomly selected 20 SNPs (one SNP per gene) for genotyping by Sanger sequencing.  
All 20 of these were verified as heterozygous in at least two of the four female samples 
(Table B2).   
 
Table 11.  Informative SNP classes of non-escaper genes. 
 
Class
* Count 
With parental 
crosses support 
Ref. 
allele 
Segregating 
within other LL1 
individuals? 
Class description 
1 75 YES LL1 NO best "fixed" SNPs 
2 9 YES LL2 NO best "fixed" SNPs 
3 49 YES LL1 unknown 2nd best "fixed" SNPs 
4 2 YES LL2 unknown 2nd best "fixed" SNPs 
5 173 NO LL1 NO 2nd best "fixed" SNPs, with less support from the parental cross 
6 24 NO LL2 NO 2nd best "fixed" SNPs, with less support from the parental cross 
*: SNPs outside these six classes belong to class 0. 
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5.1.7 Validation of X-Linked Escaper and Non-Escaper Gene Expression by Allele-
Specific Pyrosequencing 
Fifteen of twenty-four escaper genes possessed more than one informative SNP 
in the RNA-seq dataset.  Judged from the abundances of RNA-seq reads containing 
these linked SNPs, the paternal allelic expression levels are consistent for SNP sites 
within a gene (Table B1).  This agreement between multiple SNPs within the same gene 
provided an internal validation for the allele-specific expression quantification.  To 
verify the escaping status of these genes and obtain an estimate of paternal allelic 
expression levels using an independent method, we performed allele-specific 
pyrosequencing on all 24 escaper genes, one non-escaper gene (HPRT1), and one 
autosomal control gene (GPM6B)  (Figure 2A-D, Figure A2, and Table B2).  
Pyrosequencing PCR and sequencing primers were designed to target informative exonic 
SNP positions within selected genes using PyroMark Assay Design Software Version 
2.0.1.15 (Qiagen, CA).  To eliminate potential amplification bias, all primers were 
checked to guarantee that they did not individually overlap base positions that differed 
between the LL1 and LL2 parents.   
 Pyrosequencing PCR amplification was carried out in 40 µl system using Ampli-
Taq Gold polymerase (Life Technologies) under the following cycling conditions: 1 
cycle of 95o C for 5 min, 45 cycles of 95o C for 45 sec, 57o C for 30 sec, 72o C for 20 sec, 
followed by 1 cycle of 72o C for 10 min.  PCR products were prepared according to the 
manufacturer’s protocol and then loaded on the PSQ 96MA Pyrosequencer (Qiagen, 
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CA) with the PyroMark Gold Reagents (Qiagen, CA) using the Allele Quantification 
method (AQ).  Two technical replicates were done for each gene in each sample.   
5.1.8 Native ChIP-Seq and Data Analysis 
Native-ChIP (N-ChIP) was conducted on a primary fibroblast cell line (derived 
from adult ear pinna), fetal brain, and EEM using a method modified from Dindot et al. 
(2009).  Briefly, total tissue samples of fetal brain and EEM were washed in PBS and 
homogenized in 500 µl of Buffer I (0.3 M sucrose, 60 mM KCl, 15 mM NaCl, 5 mM 
MgCl2, 0.1 mM EDTA, 15mM Tris, 0.5 mM DTT, 0.1 mM PMSF).  The sample was 
centrifuged for 5 min. at 3000g, the supernatant was removed, and the pellet was re-
suspended in 200 µl of Buffer I.  Cells were lysed for 5 minutes on ice by adding 200 µl 
of Buffer II (Buffer I + 4 µl of NP40), and nuclei were isolated by centrifugation of 
lysed cells for 20 min at 10,000Xg through 1.5 ml of Buffer III (1.2 M sucrose, 60 mM 
KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 15 mM Tris, 0.5 mM DTT, 0.1 mM 
PMSF).  The pellet was washed with Buffer I, centrifuged, and re-suspended in 350 µl of 
MNase (micrococcal nuclease) Digestion Buffer (0.32 sucrose, 4 mM MgCl2, 50 mM 
Tris, 0.1 mM PMSF).  Chromatin was digested using 10 units of MNase (Sigma, N5386) 
for 10 min at 37°C.  The reaction was stopped using 50 µl of 0.5 M EDTA.  For input 
control, 100 µl of digested chromatin were removed and stored at -20°C.   
Equal aliquots of the remaining digested chromatin (EEM = 2.0 µg/rxn; fetal 
brain = 11 µg/rxn) were incubated at 4° C overnight with anti-H3K4me3 (Millipore #07-
473), anti-H3K9Ac (Millipore #CS200583), anti-H3K9me3 (Millipore #07-442), anti-
H3K27me3 (Millipore #07-449), or non-specific, rabbit IgG (Millipore #12-370).  
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Antibody-bound chromatin was isolated using Dynabeads® Protein A (Invitrogen), 
washed, and eluted.  N-ChIP and input DNA were purified using the Qiagen MiniElute 
Spin Columns (Qiagen) and enrichment was verified using real-time PCR.  Illumina 
libraries were constructed at Global Biologics, LLC, and sequenced at the University of 
Missouri – Columbia DNA Core Facility and Genomics Resources Core Facility at 
Weill Cornell Medical College (New York, NY).  Raw reads were quality filtered, 
trimmed, and aligned using Bowtie in the Galaxy suite (Giardine et al. 2005; 
Blankenberg et al. 2010; Goecks et al. 2010).  Aligned reads were visualized on the 
UCSC genome browser (Kent et al. 2002) and Integrative Genomics Vizualizer (IGV) 
(Robinson et al. 2011; Thorvaldsdottir et al. 2012) and significant peaks were called 
using the MACS algorithm (Zhang et al. 2008) (Table B3).  The ChIP-seq data were 
deposited in the Gene Expression Omnibus (GEO) database under accession number 
GSE45186. 
5.1.9 Re-Annotation of X-Linked Promoters 
Due to the incompleteness of the annotation of the Monodelphis genome, it was 
necessary to re-annotate the X-linked genes to ensure that the 5’ exons, UTRs and 
putative promoters were located correctly in the corresponding gene model.  We used 
predicted RNA structure from TopHat, the presence of CpG islands (both currently and 
newly annotated), and the presence of H3K4me3 peak to annotate new 5’ exons and 
putative promoters for 312 X-linked genes (results not shown).   
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5.1.10 Bisulfite-Sequencing of Promoter DNA 
Two µg of genomic DNA were treated with bisulfite using the EpiTech Bisulfite 
Kit from Qiagen, Inc.  Treated DNA was PCR amplified using primers designed by 
Methyl Primer Express v 1.0 (Applied Biosystems).  One µl of bisulfite-treated gDNA 
was used in PCR amplification in 50 µl reaction using Ampli-Taq Gold polymerase 
(Life Technologies) under the following cycling conditions: 1 cycle of 95o C for 5 min, 
35 cycles of 95o C for 15 sec, 50° or 55o C for 30 sec, 72o C for 20 sec, followed by 1 
cycle of 72o C for 10 min.  PCR products were cloned using the TopoTA Cloning® Kit 
(Life Technologies).  For each cloned PCR product, plasmids were purified from at least 
16 transformed colonies and Sanger sequenced at Beckman Coulter Genomics (Danvers, 
MA) using the M13 forward primer.  Sequences were viewed, aligned, and analyzed 
using Sequencher 4.10®.   
5.1.11 Quantification of DNA Methylation Percentage Using PyroMark Assays 
Quantification of methylation percentages in individual consecutive CpG sites 
was achieved with high reproducibility by pyrosequencing of bisulfite-treated DNA 
using the Pyromark Assay method.  Bisulfite conversion was carried out on 500 ng 
genomic DNA of fetal brain and EEM samples in both sexes with the Qiagen EpiTect 
Bisulfite Kit (Qiagen, CA).  PyroMark primers were designed to target the CpG islands 
with PyroMark Assay Design Software Version 2.0.1.15 (Qiagen, CA).  PCR products 
were prepared, run, and analyzed on the PSQ 96MA Pyrosequencer (Qiagen, CA) with 
PyroMark CpG software 1.0.11.  Background subtraction was done using the “control 
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peak heights” feature.  Each sample was repeated twice and the average of the runs was 
used for the analysis. 
5.2 Chapter III Extended Methods 
5.2.1 Western Blot Using Histone Antibodies Against M. domestica Proteins 
All antibodies used in this study were created in mouse or rabbit.  To validate 
that the antibodies bind Histone 3 in M. domestica, we extracted protein from female 
liver tissue and ran a Western Blot Analysis.  To enrich for histone proteins, nuclei were 
isolated using a sucrose gradient as described in section 5.1.8 above and placed in 1 mL 
of 0.2 N HCl (acid extraction) overnight at 4o C.  The samples were centrifuged at 6,500 
X g for 10 minutes at 4o C and the supernatant, which contains basic proteins, was 
removed and stored at -20o C.  Protein concentrations were determined using the 
Bradford assay.  Purified preparations (1 µg of total basic protein) and controls  (1 µg of 
total protein extracted from HeLa cells, not acid extracted) were loaded on 1% agaorse 
gels and blotted on nylon membranes and visualized using antibodies against specific 
histone modification states by standard Western Blot techniques.  The expected 17 kDa 
bands revealing the presence of histone proteins were present in all samples and a more 
intense signal was seen in the acid extracted, M. domestica samples (Figure 17). 
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Figure 17.  Western blot analysis using antibodies specific to a posttranslational 
modification of Histone 3. H3K4me3 (Millipore #07-473), H3K9me3 (Millipore #07-
442), and H3K27me3 (Millipore #07-449). 1 – basic proteins extracted using HCl 
from M. domestica liver tissue. 2 – protein extracted from human HeLa cells, not 
acid extracted. The Histone 3 band can be seen at 17 kD in all samples and is 
stronger in the acid extracted, M. domestica samples. 
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CHAPTER VI  
CONCLUSIONS 
 
The aim of my dissertation research was to identify, on a genome-wide scale, 
previously unknown imprinted loci in M. domestica and use my findings to make 
observations concerning the epigenetic and functional characteristics of these genes in 
comparison to what is known about imprinted gene expression in therian mammals 
generally.  More specifically, I wanted to employ a search strategy that was not 
constrained by a priori knowledge of the imprinted states of genes in eutherian 
mammals.  In order to conduct this search, I utilized specific histone modifications that 
have been shown to be associated with imprinted genes in eutherians, as well as genetic 
crosses designed to enrich for stock-specific SNPs, which allowed me to track parent-of-
origin-specific-allele expression patterns.  Using RNA-seq and ChIP-seq approaches, I 
have demonstrated the ability to detect imprinted genes, both X-linked and autosomal, 
based on epigenetic marks and structural characteristics of promoter regions in opossum 
fetal brain, EEM, and fibroblast cells and to predict with considerable accuracy the 
transcriptional states of X-linked and autosomal genes using histone modification 
profiles.   
6.1 Detection of Autosomal and X-Linked Candidate-Imprinted Genes in M. 
domestica by Epigenetic Profiling 
Applying ChIP-seq to a male fibroblast cell line and female fetal brain showed 
that transcriptionally active and repressive histone modifications are associated with the 
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transcriptional states of both autosomal and X-linked genes in M. domestica.  This 
enabled me to use the simultaneous overlap of these marks at annotated loci to identify 
candidate-imprinted and monoallelically expressed genes.  I also observed differences in 
histone modification profiles between fetal brain and fibroblast cells, especially for the 
repressive histone modifications.  By coupling these findings with parent-of-origin-
specific SNP data for individual genes (e.g., Meis1) and genome-wide RNA-seq data, I 
was able to detect the imprinted states (maternal or paternal) of 10 novel imprinted 
genes, the known-imprinted gene Igf2r, and 177 imprinted X-linked loci in the M. 
domestica genome.   
Additionally, I analyzed DNA methylation patterns at promoter CpG islands for 
26 X-linked genes and seven autosomal imprinted genes (including Igf2r).  Overall, X-
linked loci lack DNA methylation with the noteworthy exception of the marsupial-
specific Rsx locus, which has a promoter CpG island DMR that is methylated on the 
maternal strand only (parent-of-origin-specific methylation).  In contrast, two of the 
seven autosomal genes, Rwdd2a and Npdc1, have DNA methylation and/or a DMR at 
promoter CpG islands and one, Igf2r, also has a DMR in a CpG island located in intron 
11.  These are the first reported cases of promoter CpG island methylation for genes that 
are expressed in a parent-of-origin-allele-specific manner in M. domestica and suggests a 
previously undescribed role for DNA methylation at imprinted loci in fetal brain and 
EEM of M. domestica.  These data encourage a more in-depth analysis of DNA 
methylation in these tissues using genome-wide techniques such as whole genome 
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bisulfite sequencing (BS-seq) or methylation dependent immunoprecipitation sequencing 
(MeDIP-seq). 
6.2 Chromosome-Wide Characterization of Paternally Imprinted X-Chromosome 
Inactivation in M. domestica 
6.2.1 Cataloging of Imprinting and Non-Imprinted X-Linked Genes 
The cataloging of X-linked and autosomal imprinted genes in multiple species 
and correlating specific epigenetic marks with the expression patterns of these loci 
enables informed speculation regarding the biological and evolutionary forces that have 
shaped gene expression throughout mammalian evolution.  X-chromosome inactivation 
is a therian-specific phenomenon that has been postulated to be a dosage compensation 
mechanism that maintains equal expression of X-linked genes between males and 
females (Lyon 1961; Ohno 1967; Heard et al. 1997); however, prior to the research 
reported here, no systematic, chromosome-wide assessment of the extent of XCI or its 
epigenetic regulation had been conducted in any marsupial.  I found that most X-linked 
genes of M.  domestica are indeed paternally imprinted; however, ~14% escape 
inactivation.  In eutherians, the percentages of genes that escape XCI vary across 
species, and the suites of genes that escape XCI differ between species.  Adding to this 
complexity, only one gene that escapes pXCI in M.  domestica has a homologue that 
escapes XCI in examined tissues of human or mouse (i.e., the overlap in XCI escaper 
genes between M.  domestica and the best studied eutherian models is virtually 
nonexistent).  Thus, it would appear that the phenomenon of escape from XCI is 
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conserved throughout the therian lineage but that species-specific selective pressures 
have targeted the escape of different genes in different lineages.   
6.2.2 Epigenetic Patterns at Paternally Imprinted X-Linked Genes in M. domestica  
The epigenetic regulation of XCI has been intensively studied in eutherians.  Its 
establishment has been shown to be dependent upon expression of Xist, a cis-acting non-
coding RNA gene which is expressed exclusively from and coats the inactive X 
chromosome preventing the transcription of most of its genes.  This inactive state is 
reinforced by allele-specific DNA methylation and histone modifications (Silva et al. 
2003; Hellman & Chess 2007; Ball et al. 2009).  When I began this study, no Xist 
homologue or functionally analogous gene had been discovered in any metatherian (but 
see below), and only broad scale (i.e., FISH) experiments examining DNA methylation 
and histone modifications on the marsupial X chromosome had been conducted.  Data 
from my research, reported herein, indicate that eutherians and metatherians utilize the 
same repressive histone modification, H3K27me3, to mark individual genes on the 
inactive X chromosome.  Also similar to the eutherian condition, the active histone 
modification, H3K4me3, marks the promoters of actively transcribed X-linked genes; 
however, in contrast to eutherians, DNA methylation at promoter CpG islands is not 
present as a complementary, augmenting repressive mark at inactivated X-linked genes 
of M. domestica.  This suggests that the use of histone modifications to mark the 
inactivated X chromosome was present before the eutherian-metatherian split, but that 
DNA methylation of X-linked genes arose later, as a eutherian-specific epigenetic 
mechanism, possibly to help stabilize the inactive state.  Alternatively, DNA methylation 
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could have been present in the common therian ancestor and subsequently maintained in 
eutherians as an epigenetic regulatory mechanism and lost in metatherians, although this 
situation seems less parsimonious. 
6.2.3 Regulation and Expression of the Marsupial-Specific Rsx Locus  
Recently, Rsx, a functional analog of Xist, was discovered in M. domestica and 
implicated as a central participant in the establishment of XCI in marsupials.  As 
mentioned above, during the establishment of XCI in eutherians, Xist transcripts coat 
and silence the inactive X chromosome; these transcripts also recruit factors such as 
repressive histone modifications and DNA methylation that help maintain the silenced 
state of the chromatin.  In this study, I provide the first documentation of imprinted 
expression for Rsx (expressed from the paternally derived X only), a promoter DMR that 
is methylated exclusively on the maternal chromosome, and the presence of the 
activating histone modification H3K4me3, but absence of the repressive histone 
modification H3K27me3. 
The expression of Rsx from the paternal allele and the presence of an allele-
specific DMR at its promoter parallel the situation in eutherians in that the repressed 
eutherian X chromosome expresses the cis-acting Xist, and DNA methylation is used to 
silence Xist on the active X chromosome.  In contrast, however, the histone modification 
profiles differ greatly between the Rsx and Xist loci.  In eutherians, repressive histone 
marks (i.e., H3K27me3) are associated with the repressed Xist locus and act in 
combination with Tsix, a Xist antisense transcript, and DNA methylation to repress its 
expression on the active X chromosome.  In M. domestica, the repressive histone 
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modifications are absent.  Instead, the histone modification profile of the Rsx locus 
resembles that of an escaper of pXCI inasmuch that its promoter is marked by the active 
histone modification, H3K4me3, but lacks the repressive histone modification, 
H3K27me3.  This suggests that the repressive histone modifications characteristic of 
genes on the eutherian X chromosome do not mark the silenced, maternally derived Rsx 
locus in M. domestica and leaves open the possibility that DNA methylation is the only 
epigenetic regulator of Rsx.   
6.3 Autosomal Imprinted Genes in M. domestica   
6.3.1 Expression 
The expression and epigenetic characteristics of autosomal imprinted loci of M. 
domestica differ in several important ways from those of paternally imprinted X-linked 
loci.  First, the majority (~86%) of paternally imprinted X-linked loci show 100% 
expression from the maternal allele, whereas, all of the confirmed autosomal imprinted 
loci show a substantial level (>10%) of leaky (partial) expression from the repressed 
allele.  Leaky expression of imprinted loci is not confined to metatherian-imprinted 
genes; it has also been documented from some imprinted genes in eutherians (Wang et 
al. 2011; Wang et al. 2013).  The biologic (physiologic) relevance of leaky expression of 
the repressed allele at imprinted loci is not well understood and has sometimes been 
dismissed as an experimental artifact or attributed to a low level of random background 
transcription at individual loci with little to no biological importance.  However, leaky 
expression was observed for all nine marsupial-specific imprinted genes described in this 
study and supports to the idea that leaky expression of the repressed allele is common, at 
  117 
least in M. domestica, and the expression of the repressed allele might be biologically 
relevant.  Future work is needed in both eutherian and metatherian model organisms to 
address this issue.   
6.3.2 Histone States 
The epigenetic characteristics of paternally imprinted X-linked loci of M. 
domestica show a different pattern than those of the autosomal imprinted loci.  For X-
linked loci, the presence of the examined repressive histone modification (H3K27me3) 
correlates positively with the transcriptionally repressed paternal allele, whereas the 
examined active histone modification (H3K4me3) correlates positively with the 
transcriptionally active maternal allele.  Similarly, for autosomal loci active histone 
modifications are present at most imprinted gene promoters; however, the correlation of 
repressive histone modifications at the repressed alleles is not as strong as that found at 
X-linked loci.  Only three of the nine confirmed, imprinted genes (Meis1, 
Unknown_gene_1 and Unknown_gene_6) have histone marks of activation and 
repression occurring simultaneously at their annotated promoters.  In addition, DNA 
methylation is virtually absent at all but two X-linked promoters but has been found at 
two of the four promoters of autosomal imprinted loci examined in this study, both of 
which have a histone mark of activation but lack a mark of repression.   
6.3.3 Differential DNA Methylation  
Historically, only one metatherian imprinted locus, Peg10, has been shown to 
have differential DNA methylation at promoter CpG islands and only two others, Igf2 
and Igf2r, have DMRs in other parts of the gene or region (Suzuki et al. 2007; Smits et 
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al. 2008; Das et al. 2012).  The general paucity of DMRs, coupled with the general lack 
of histone modification data, led some to propose that transcriptionally opposing histone 
modifications might be the fundamental (and perhaps only) epigenetic mechanism 
employed by metatherians to regulate the expression of imprinted loci (Renfree et al. 
2008; Samollow 2008).  The results from my research indicate that active histone 
modifications do indeed mark the promoters of most, if not all, imprinted genes in M. 
domestica; but that, transcriptionally repressive histone modifications and DNA 
methylation are not required for imprinted expression.  Nevertheless, my data also 
indicate that promoters of some metatherian-imprinted loci do show transcriptionally 
opposing histone modifications.  These variable occurrences of epigenetic modifications 
at imprinted loci in M. domestica indicate that the diversity of regulatory mechanisms 
used to establish and maintain the imprinted state can be variable even within a single 
species and underscore the complexity of imprinting regulation across therian lineages. 
6.3.4 Challenges and Opportunities  
The discovery of novel marsupial-imprinted genes provides new opportunities 
for gaining additional insight into the biologic and evolutionary forces that have shaped 
the phenomenon of genomic imprinting in mammals.  Mammalian imprinted genes were 
first discovered in eutherians and shown to have functions important for embryonic and 
fetal growth.  These early discoveries led to the development of theories about why 
certain genes were imprinted (while most are not).  One of these theories, The "Conflict" 
or "Kinship" Theory, emerged in the 1980s and 1990's as the prevailing model for 
selective advantage that could promote imprinting.  It proposes that genomic imprinting 
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evolved in therian mammals (all of which form placental attachments to the mother) in 
response to polygamy, viviparity, and multiple births (Moore & Haig 1991; Haig 2004).  
It juxtaposes the reproductive strategies of males vs. females for maximizing 
reproductive success by noting that offspring of different fathers in multiple-paternity 
litters compete for the same maternal resources.  Maximization of fitness for any one 
father is achieved by his progeny extracting maternal resources better than the progeny 
of other fathers, whereas for the mother, the best strategy is to provide resources 
equitably among all her offspring.  This creates a "conflict" between the paternal and 
maternal genomes for genes that influence resource allocation.  This parental conflict is 
manifested by imprinted genes, which are directly or indirectly involved in fetal growth, 
and is well exemplified by the interplay of IGF2 and IGF2R, which are involved in fetal 
vs. placental growth and development and are reciprocally imprinted; IGF2 being 
expressed from the paternal allele only (maternally imprinted), whereas IGF2R is 
expressed from the maternal allele only (paternally imprinted).   
The Conflict model fits well with known functions of some imprinted genes (e.g., 
IGF2 and IGF2R) and has also been extended to imprinted genes that affect cognition, 
feeding behavior, and social development; however, this model does not explain all 
imprinted genes.  In fact, the Conflict model has not provided explanatory power for the 
parent-of-origin specific expression pattern of most imprinted genes, but in view of the 
logical power and broad acceptance of the Conflict model, few alternative hypotheses as 
to why these genes are imprinted have been proposed (the few that have been proposed 
were quickly dismissed as evolutionarily unstable or logically flawed).  It is possible that 
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some imprinted genes are simply evolutionary “casualties” of their genomic location 
(close proximity to other selected imprinted genes).  While they themselves might not be 
important for fetal growth and/or development, their physical proximity to other selected 
imprinted genes or regions, along with an ability to compensate for monoallelic 
expression by upregulation of the active allele, might be the driving force behind their 
imprinted state.  Alternatively, there could be solid but as yet unidentified biological 
advantages for the imprinting of genes that are not involved in fetal growth and 
development.  In any case, lacking evidence that Conflict Theory can explain all 
imprinting, it seems prudent to remain open to and actively seek alternative hypotheses.   
Following upon this theme, I have described 10 imprinted genes in M. domestica 
(nine novel genes and Igf2r) of which seven are protein coding.  An analysis of the 
functions associated with these protein-coding genes indicates involvement in cell 
proliferation (Meis1), fetal growth (Igf2r), neurological development (Npdc1 and 
Rwdd2a), regulation of immunity (Nkrf), and homeobox genes/transcription factors that 
could potentially control the transcription of many genes at different times throughout 
development (Pou5fl and Zfp68).  However, only two of these genes, Meis1 and Igf2r 
have an obvious and direct connection to fetal or cell growth thus can be explained by 
the Conflict Theory.  My data indicate that, as in eutherians, the imprinting phenomenon 
in marsupials is complex, and although the imprinted state of some genes is conserved 
between eutherians and metatherians, some genes have also been uniquely selected for 
imprinted expression in M. domestica or possibly across the metatherian lineage in 
general.  In establishing a novel method for identifying imprinted genes using ChIP-seq 
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and RNA-seq approaches in M. domestica, I have provided a new way to discover 
imprinted genes in non-eutherian mammals that could be applied to non-placental 
species, including non-mammalian vertebrates as well.  The discovery of imprinted 
genes in a broader range of vertebrate taxa (and perhaps beyond) could provide novel 
insights into the phenomenon of genomic imprinting and help to generate alternative 
hypotheses for its origin and evolutionary advantages. 
6.4 Conclusion 
In conclusion, my dissertation research has produced the first genome-wide 
analysis of four histone modifications in fibroblast cells and female fetal brain, and their 
correlation with the transcriptional states of autosomal and X-linked genes.  It has also 
provided new data concerning the imprinted expression of genes in fibroblasts, fetal 
brain and EEM of M. domestica from autosomal genes and the paternally imprinted X 
chromosome, the imprinted state of which is specific to marsupials.  These data have 
allowed me to describe comprehensively, and for the first time, the phenomena of X-
chromosome inactivation and genomic imprinting in M. domestica, provided new 
insights into the possible biological and evolutionary forces that established and 
maintain these phenomena, and generated new hypotheses for future testing. 
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APPENDIX A 
SUPPLEMENTAL FIGURES 
 
Figure A1. The scheme for the opossum crosses and sex genotyping results for the 
XCI project. 
(A-B) Reciprocal F1 crosses between LL1 and LL2 animals. (C-D) Parental crosses of 
LL1 and LL2 animals. In the four crosses, three LL1 animals and three LL2 animals 
were used. LL1 individuals: A0579 (female) and A0580 (female) are full sibs; LL2 
individuals:  A0571 (female), A0572 (female) and A0573 (male) are full sibs. A (C/T) 
SNP was shown (LL1: T and LL2: C). (E) Sex genotyping results for opossum embryos. 
The samples selected for Illumina RNA-seq are labeled with an asterisk. For expanded 
figure see attached file XCI Supplemental Figures, Figure S1-S2. 
 
Figure A2. RNA-seq, SNP genotyping and pyrosequencing verification results for 
HPRT1, GPM6B and RBMX in opossum fetal brain and EEM samples.  
(A-D) Non-escaper gene HPRT1. (A) F1 cross of LL1 (mother) x LL2 (father). (B) 
Reciprocal F1 cross of LL2 (mother) x LL1 (father). (C) LL1 parental cross. (D) LL2 
parental cross. From the Sanger sequencing genotyping results, the SNP 
(OMSNP0222971) is informative in three embryos (571E1, 571E4 and 572E1). In 
brain/head and EEM tissues of all three individuals, 100% maternal expression was 
observed from both RNA-seq and allele-specific pyrosequencing verification. Therefore, 
HPRT1 is subject to imprinted XCI with zero paternal leakage in both tissues. The target 
sequence for pyrosequencing is (T/C)TTATCTCC.(E-H) Autosomal control gene 
GPM6B. (E) F1 cross of LL1 (mother) x LL2 (father). (F) Reciprocal F1 cross of LL2 
(mother) x LL1 (father). (G) LL1 parental cross. (H)  LL2 parental cross. GPM6B is an 
autosomal gene in opossum on chromosome 7. From the Sanger sequencing genotyping 
results, the SNP (7_27283330) is informative in three embryos (579E3, 579E4 and 
571E4). In brain/head and EEM tissues of all three individuals, biallelic expression was 
observed from both RNA-seq and allele-specific pyrosequencing verification, which is 
expected for autosomal genes with two parental alleles. The target sequence for 
pyrosequencing is (T/C)GAGACT. The Sanger sequencing traces were not shown here 
because an indel polymorphism in the amplicon shifted the trace, but the genotypes 
could be determined by the CodonCode Aligner software.(I-H) Escaper gene RBMX. (I) 
F1 cross of LL1 (mother) x LL2 (father). (J) Reciprocal F1 cross of LL2 (mother) x LL1 
(father). (K) LL1 parental cross. (L) LL2 parental cross. From the Sanger sequencing 
genotyping results, the SNP (OMSNP0156027) is informative in five embryos (579E3, 
579E4, 571E1, 571E4 and 580E1). In brain/head and EEM tissues of all five individuals, 
biallelic expression was observed from both RNA-seq and allele-specific 
pyrosequencing verification. Therefore, RBMX is an escaper of imprinted XCI in both 
tissues. The target sequence for pyrosequencing is G(C/G)TATGGTGGT (on the minus 
strand). For figures of other genes, see attached file XCI Supplemental Figures, Figures 
S4-S28. 
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Figure A3. M-A plot for brain and EEM expression levels before and after 
normalization. For figure, see attached file XCI Supplemental Figures, Figure S3. 
 
Figure A4. Histone modification H3K4me3 and H3K27me3 peaks and coverage 
profile for X chromosome region containing escaper genes in female brain ChIP-
seq data. In each figure, plotted in the top panel are the genome gap locations and the 
H3K27me3 peaks and coverage. Gene models are shown in the middle panel, color-
coded based on their imprinted XCI status (blue: escapers; red: non-escapers; gray: not 
known due to lack of informative SNPs). In the bottom panel are the CpG island 
locations and the H3K4me3 peaks and coverage profile. (A) For the escaper gene 
PLXNA3, H3K4me3 was present at promoter CpG islands, suggesting active 
transcription. H3K27me3 marks were depleted across the gene body, consistent with 
biallelic expression. The downstream gene UBL4A does not have informative SNPs, but 
its histone modification profile suggests it is a candidate escaper (Table B4). The other 
three non-informative genes (ATP6AP1, GDI1 and SLC10A3) were covered with 
H3K27me3 peaks across the entire gene body, consistent with non-escaper status. (B) 
For the escaper gene DKC1, H3K4me3 were present at promoter CpG islands, 
suggesting active transcription. H3K27me3 marks were depleted across the gene body, 
consistent with biallelic expression. For the nonescaper gene MPP1, the H3K27me3 
peaks covered the entire gene body, consistent with monoallelic expression. (C) For the 
escaper gene NUP62, H3K4me3 was present at the promoter CpG island, suggesting 
active transcription. H3K27me3 were depleted across the gene body, consistent with 
biallelic expression. For the nonescaper gene RBM41, the H3K4me3 peak was present 
and the H3K27me3 peaks covered the entire gene body, consistent with monoallelic 
expression. (D) For the three escaper genes in this region (HCFC1, IRAK1 and MECP2), 
H3K4me3 marks were present at promoter CpG islands, suggesting active transcription. 
H3K27me3 marks were depleted across the gene body, consistent with biallelic 
expression. For the two non-escapers (TKTL1 and LOC10002972), the H3K4me3 marks 
were present and the H3K27me3 peaks covered the entire gene body, consistent with 
monoallelic expression. For the rest four genes, there is no informative SNP to infer the 
XCI status from RNA-seq data, but the histone modification profile of NAA10 is 
consistent with escaper status (Table B4). (E) For the escaper gene FRMD7, H3K4me3 
was present at promoter CpG islands, suggesting active transcription. H3K27me3 marks 
were depleted across the gene body, consistent with biallelic expression. For the non-
escaper gene RAP2C, the H3K4me3 peak was present and the H3K27me3 peak covered 
the entire gene body, consistent with monoallelic expression. The histone modification 
profile of the upstream non-informative gene MST4 is consistent with non-escaping 
status. (F) For the three escaper genes (PHF6, FAM122B and FAM122A), H3K4me3 
marks were present at promoter CpG islands, suggesting active transcription. 
H3K27me3 marks were depleted across the gene body, consistent with biallelic 
expression. For the two nonescapers (HPRT1 and MOSPD1), the H3K4me3 marks were 
present and the H3K27me3 peaks covered the entire gene body, consistent with 
monoallelic expression. (G) For the escaper gene RBMX, H3K4me3 mark was present at 
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the promoter CpG island, suggesting active transcription. H3K27me3 marks were 
depleted across the gene body, consistent with biallelic expression. For the two non-
escapers (ARHGEF6 and TM9SF2), the H3K4me3 marks were present and the 
H3K27me3 peaks covered the entire gene body, consistent with monoallelic expression. 
(H) For the escaper gene ATRX, H3K4me3 mark was present at the promoter CpG 
island, suggesting active transcription. H3K27me3 marks were depleted across the gene 
body, consistent with biallelic expression. For the two nonescapers (MAGT1 and 
COX7B), the H3K4me3 marks were present and the H3K27me3 peaks covered the entire 
gene body, consistent with monoallelic expression. The non-informative upstream gene 
FGF16 was covered with H3K27me3 peaks across the entire gene body, consistent with 
nonescaper status. (I) For the two escaper genes (TAF1 and NONO), H3K4me3 marks 
were present at promoter CpG islands, suggesting active transcription. H3K27me3 
marks were depleted across the gene body, consistent with biallelic expression. For the 
three nonescapers (APEX2, ZMYM3 and NLGN3), H3K27me3 peaks covered the entire 
gene body, consistent with monoallelic expression. Three non-informative genes (OGT, 
RHOG and ITGB1BP2) in the H3K27me3 depleted region are consistent with escaper 
status. (J) For the escaper gene CENPI, H3K4me3 mark was present at promoter CpG 
islands, suggesting active transcription. H3K27me3 marks were depleted across the gene 
body, consistent with biallelic expression. For the non-escaper SYTL4, the H3K27me3 
peaks covered the entire gene body, consistent with monoallelic expression. The 
downstream gene CSTF2 does not have informative SNPs, but its histone modification 
profile suggests it is a candidate escaper. The other two non-informative genes 
(TMEM35 and XKRX) were covered with H3K27me3 peaks across the entire gene body, 
consistent with non-escaper status. For expanded figures see attached file XCI 
Supplemental Figures, Figures S29-S44. 
Figure A5. Allele-specific histone modification H3K4me3 for escaper and non-
escaper genes in female brain ChIP-seq data from LL1 x LL2 cross. (A)  Left: the 
5’-end gene model, CpG island location and the H3K4me3 peak/coverage profile for 
escaper gene YIPF6. There is one SNP (X_7594487) under the H3K4me3 peak with 
enough coverage to infer allele-specific histone modification. Middle: Sanger 
sequencing genotyping results in the two embryos (579E10 and 579E11, used for ChIP-
seq experiments) and their parents confirmed that the SNP is informative in both 
embryos. Right: from the ChIP-seq data, we observed 64% of the H3K4me3 reads from 
the maternal allele and 36% from the paternal allele at X_7594487, suggesting both 
parental alleles are active. This is consistent with allele-specific expression profile at 
SNP OMSNP0155108 in the RNA-seq data and SNP OMSNP0155110 from the allele-
specific pyrosequencing results. (B) Left:  the 5’-end gene model, CpG island location 
and the H3K4me3 peak/coverage profile for escaper gene FAM122B. There is one SNP 
(OMSNP0156061) under the H3K4me3 peak with enough coverage to infer allele-
specific histone modification. Middle: Sanger sequencing genotyping results in the two 
embryos (579E10 and 579E11) and their mother confirmed that the SNP is informative 
in both embryos. Right: from the ChIP-seq data, we observed the H3K4me3 reads from 
both parental alleles at OMSNP0156061, suggesting both parental alleles are active. This 
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is consistent with biallelic expression from the allele-specific pyrosequencing results. 
(C) Left:  The 5’-end gene model, CpG island location and the H3K4me3 peak/coverage 
profile for non-escaper gene PNCK. There is one SNP (OMSNP0155237) under the 
H3K4me3 peak with enough coverage to infer allele-specific histone modification. 
Middle: Sanger sequencing genotyping results in the two embryos (579E10 and 
579E11) and their parents confirmed that the SNP is informative in both embryos. 
Right: from the ChIP-seq data, we observed 100% of the H3K4me3 reads from the 
maternal allele at OMSNP0155237, suggesting the on-mark is only present at the 
maternal allele. This is consistent with maternal-specific expression at OMSNP0155237 
and OMSNP0155219 in the RNA-seq data. (D) Left:  The 5’-end gene model, CpG 
island location and the H3K4me3 peak/coverage profile for non-escaper gene GPC4. 
There is one SNP (OMSNP0156005) under the H3K4me3 peak with enough coverage to 
infer allele-specific histone modification. Middle: Sanger sequencing genotyping results 
in the two embryos (579E10 and 579E11) and their parents confirmed that the SNP is 
informative in both embryos. Right: from the ChIP-seq data, we observed 100% of the 
H3K4me3 reads from the maternal allele at OMSNP0156005, suggesting the on-mark is 
only present at the maternal allele. This is consistent with maternal-specific expression at 
OMSNP0156005 and OMSNP0156006 in the RNA-seq data. (E) Left:  The 5’-end gene 
model, CpG island location and the H3K4me3 peak/coverage profile for non-escaper 
gene ITM2A. There is one SNP (OMSNP0156531) under the H3K4me3 peak with 
enough coverage to infer allele-specific histone modification. Middle: Sanger 
sequencing genotyping results in the two embryos (579E10 and 579E11) and their 
parents confirmed that the SNP is informative in both embryos. Right: from the ChIP-
seq data, we observed 100% of the H3K4me3 reads from the maternal allele at 
OMSNP0156531, suggesting the on-mark is only present at the maternal allele. This is 
consistent with maternal-specific expression at OMSNP0156531 in the RNA-seq data. 
(F) Left:  The 5’-end gene model, CpG island location and the H3K4me3 peak/coverage 
profile for two X-linked genes, PDZD11 (+ strand) and KIF4A (- strand). They are 
organized in head-to-tail orientation, and they share one CpG island and one H3K4me3 
peak. PDZD11 is a nonescaper gene (colored in red) and the escaping status for KIF4A 
(colored in gray) is unknown due to lack of informative exonic SNPs. There is one SNP 
(OMSNP0223343) under the H3K4me3 peak with enough coverage to infer allele-
specific histone modification. Middle: Sanger sequencing genotyping results in the two 
embryos (579E10 and 579E11) and their parents confirmed that the SNP is informative 
in both embryos. Right: From the ChIP-seq data, we observed 100% of the H3K4me3 
reads from the maternal allele at OMSNP0223343, suggesting the on-mark is only 
present at the maternal allele. This is consistent with maternal-specific expression of 
PDZD11 at OMSNP0223343 and OMSNP0156925 in the RNA-seq data. For expanded 
figures, see attached file XCI Supplemental Figures, Figures S45-S50. 
Figure A6. Pyrograms for PyroMark analysis of the methylation profile at 
promoter CpG islands of X-linked genes. Pyrograms for PyroMark analysis of the 
methylation profile at escaper gene CD99L2 (A) and non-escaper gene LAS1L (B) 
promoter CpG islands. The bisulfite converted target sequence to analysis is shown on 
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the top for each gene. Methylation percentages for the CpG positions are quantified in 
female fetal brain, male fetal brain, female EEM and male EEM (from top to bottom). 
For pyrograms of more gene promoters, see XCI Supplemental Figures, Figures S51 A-I 
and K-Z. 
Figure A7. Pyrograms for PyroMark analysis of the methylation profile at Rsx 
promoter CpG island. Four PyroMark primer sets were designed to profile the 
methylation at RSX promoter CpG island (A-D). The bisulfite converted target sequence 
to analysis is shown on the top for primer. Methylation percentages for the CpG 
positions are quantified in female fetal brain, male fetal brain, female EEM and male 
EEM (from top to bottom). For expanded pyrograms of RSX promoter see attached file 
XCI Supplemental Figures, Figure 51J. 
Figure A8. Pedigree Information for fibroblast cell lines A) Crosses and animals used 
for ChIP-seq experiments. Animal IDs and stock source (LL1 or LL2) are indicated. B) 
Crosses and animals used for DNA and RNA verification experiments. Animal IDs are 
indicated. Top Panel:  LL1 females crossed with LL2 males. Bottom Panel:  LL2 
females crossed with LL1 males. 
 
Figure A9. Histone modification profile for Cstband Rpl17. Green panels = ChIP-seq 
raw read alignments for H3K4me3 (top) and H3K9Ac (bottom). Red panels = ChIP-seq 
raw read alignments for H3K9me3 (top) and H3K27me3 (bottom). Black panel = Input. 
Blue bars above ChIP-seq panels are areas of significant enrichment determined by 
MACS (p ≤ 10-5). Blue bar in bottom panel represents the gene annotation with the 
direction of transcription indicated by the black arrows. Annotated CpG islands are 
indicated by black bars one panel above the annotation.  
 
Figure A10. Pedigrees and Sanger Sequencing Results for A) Meis1, B) Cstb, C) 
Rpl17, and D) Igf2r from reciprocal crosses. Pedigrees and Sanger Sequencing Results 
for A) Meis1, B) Cstb, C) Rpl17, and D) Igf2r from reciprocal crosses. Animal IDs are 
presented as A0xxx, Sanger sequences generated from cDNA (top) and gDNA (bottom) 
are shown for informative animals. Black arrows indicate positions of informative SNPs. 
Only cDNA data is shown for Rpl17. Lower case letters for Meis1 indicate leaky 
expression of the imprinted allele. Sanger data are not definitive for gene expression and 
were used exclusively to screen for probable heterozygotes for pyromark analysis of 
relative allelic expression. 
 
Figure A11. Histone modification profile and DNA methylation at Igf2r. Promoter, 
CpG island hypomethylation, and a differentially methylated region at the CpG island at 
intron 11 for animal A0694. Top two panels are the histone modifications, H3K4me3 
and H3K9Ac and significant peaks as called by MACS (p ≤ 10-5). 
 
Figure A12. Histone modification profiles at A) Htr2a, B) L3mbtl, and C) Mest. 
Green panels = ChIP-seq raw read alignments for H3K4me3 (top) and H3K9Ac 
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(bottom). Red panels = ChIP-seq raw read alignments for H3K9me3 (top) and 
H3K27me3 (bottom). Black panel = input. Blue bars above ChIP-seq panels are areas of 
significant enrichment determined by MACS (p ≤ 10-5). Blue bar in bottom panel 
represents the gene annotation with the direction of transcription indicated by the black 
arrow. Annotated CpG islands are indicated by black bars one panel above the 
annotation. Gaps in the genome assembly are in the panel above the CpG Island panel 
(only seen in B). 
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Figure A1. 
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Figure A2. 
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Figure A4. 
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Figure A5. 
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Figure A7.
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A0727_cDNA Fragment base #311. Base 217 of 778
A T A K G C A G
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Chromatograms from Contig[0001]
Sequencher™  "16_21035"
A0695_DNA Fragment base #311. Base 216 of 776
A T A T G C A G
A0708_DNA Fragment base #311. Base 218 of 781
A T A K G C A G
A0716_cDNA Fragment base #311. Base 216 of 781
A T A K G C A G
A0716_DNA Fragment base #311. Base 216 of 777
A T A K G C A G
A0727_cDNA Fragment base #311. Base 217 of 778
A T A K G C A G
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T/T  G/T 
G/G  T/T 
T/T  G/G 
G/G  T/T 
Chromatograms from Contig[0001]
S quencher™  "16_21035"
A0695_DNA Fragment base #311. Base 216 of 785
A G A T A T G C A G A G
A0708_cDNA Fragment base #311. Base 217 of 787
A G A T A K G C A G A G
A0708_DNA Fragment base #311. Base 218 of 790
A G A T A K G C A G A G
A07 cDNA Fragment base #311. Base 216 of 790
A G A T A K G C A G A
A0716_DNA Fragment base #311. Base 216 of 786
A G A T A K G C A G A G
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Chromatograms from Contig[0001]
Sequencher™ "16_21035"
A0719_cDNA Fragment base #311. Base 216 of 787
A G A T A G G C A G A G
A0719_DNA Fragment base #311. Base 217 of 791
A G A T A K G C A G A G
A0727_cDNA Fragment base #311. Base 217 of 787
A G A T A K G C A G A G
A0727_DNA Fragment base #311. Base 218 of 789
A G A T A K G C A G A G
A0727_DNA Fragment base #311. Base 217 of 788
A G A T A K G C A G A G
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A G A T A G G C A G A G
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A0727_cDNA Fragment base #311. Base 217 of 787
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A G A T A K G C A G A G
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A0719_cDNA Fragment base #311. Base 216 of 787
A G A T A G G C A G A G
A0719_DNA Fragment base #311. Base 217 of 791
A G A T A K G C A G A G
A0727_cDNA Fragment base #311. Base 217 of 787
A G A T A K G C A G A G
A0727_DNA Fragment base #311. Base 218 of 789
A G A T A K G C A G A G
A0727_DNA Fragment base #311. Base 217 of 788
A G A T A K G C A G A G
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LL1 X LL2 
LL2 X LL1 
RPL17‐ 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cDNA 
DNA 
cDNA 
DNA 
A0690  A0694 
A0708 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 A0727 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 ? 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G/G 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DNA 
Chromatograms from Contig[0001]
Sequencher™  "18_11184"
A0690_cDNA Fragment base #111. Base 60 of 372
G A A G A A C A
• A0690_DNA Fragment base #111. Base 56 of 380 •
G A A R A A C A
A0694_cDNA Fragment base #111. Base 41 of 354
G A A G A A C A
• A0694_DNA Fragment base #111. Base 53 of 337 •
G A A R A A C A
A0695_cDNA Fragment base #111. Base 59 of 343
G A A G A A C A
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Chromatograms from Contig[0001]
Sequencher™  "18_11184"
A0690_cDNA Fragment base #111. Base 60 of 372
G A A G A A C A
• A0690_DNA Fragment base #111. Base 56 of 380 •
G A A R A A C A
A0694_cDNA Fragment base #111. Base 41 of 354
G A A G A A C A
• A0694_DNA Fragment base #111. Base 53 of 337 •
G A A R A A C A
A0695_cDNA Fragment base #111. Base 59 of 343
G A A G A A C A
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Chromatograms from Contig[0001]
Sequencher™  "18_11184"
A0690_cDNA Fragment base #111. Base 60 of 372
G A A G A A C A
• A0690_DNA Fragment base #111. Base 56 of 380 •
G A A R A A C A
A0694_cDNA Fragment base #111. Base 41 of 354
G A A G A A C A
• A0694_DNA Fragment base #111. Base 53 of 337 •
G A A R A A C A
A0695_cDNA Fragment base #111. Base 59 of 343
G A A G A A C A
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Sequencher™  "18_11184"
• A0695_DNA Fragment base #111. Base 59 of 379 •
A A A R A A C A
A0708_cDNA Fragment base #111. Base 59 of 370
G A A G A A C A
• A0708_DNA Fragment base #111. Base 54 of 298 •
A A A A A A C A
A0716_cDNA Fragment base #111. Base 60 of 795
G A A G A A C A
• A0716_DNA Fragment base #111. Base 54 of 335 •
A A A A A C A
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Chromatograms from Contig[0001]
Sequencher™  "18_11184"
A0719_cDNA Fragment base #111. Base 59 of 794
G A A G A A C A
• A0719_DNA Fragment base #111. Base 54 of 547 •
G A A R A A : A
A0727_cDNA Fragment base #111. Base 52 of 365
G A A G A A C A
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A0719_cDNA Fragment base #111. Base 59 of 794
G A A G A A C A
• A0719_DNA Fragment base #111. Base 54 of 547 •
G A A R A A : A
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G A A G A A C A
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Figure A11. 
 
A0563  A0568 A0552 A0573 
A0549 A0566 A0578 A0567 
LL1 X LL2 
LL2 X LL1 
IGF2R – ENSMODG00000007100 
A/A  A/C 
A/A 
A/C 
cDNA 
DNA 
A/A  A/C 
A/A 
A/A 
cDNA 
DNA 
A/A  A/A 
A/A  A/A 
A/A  A/A 
A/A  A/A 
A/A  A/A 
A/A  A/A 
Chromatograms from Contig[0001]
Sequencher™  "1_IGF2R_Samples"
A0690 Fragment base #633. Base 517 of 795
C C C A T A T
A0690_DNA Fragment base #633. Base 516 of 786
C C C A T A T
A0694 Fragment base #633. Base 518 of 789
C C C A T A T
A0694_DNA Fragment base #633. Base 520 of 787
C C C A T A T
A0695 Fragment base #633. Base 519 of 790
C C C A T A T
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Chromatograms from Contig[0001]
Sequencher™  "1_IGF2R_Samples"
• A0695_DNA Fragment base #633. Base 513 of 736 •
C C C C A A A
A0708 Fragment base #633. Base 517 of 791
C C C A T A T
• A0708_DNA Fragment base #633. Base 513 of 785 •
C C C C A A A
A0716 Fragment base #633. Base 518 of 792
C C C A T A T
• A0716_DNA Fragment base #633. Base 513 of 782 •
C C C R T A T
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A0695 
A0690  A0694 
A0708 
A0719  A0727 
Chromatograms from Contig[0001]
Sequencher™  "1_IGF2R_Samples"
A0690 Fragment base #633. Base 517 of 795
C C C A T A T
A0690_DNA Fragment base #633. Base 516 of 786
C C C A T A T
A0694 Fragment base #633. Base 518 of 789
C C C A T A T
A0694_DNA Fragment base #633. Base 520 of 787
C C C A T A T
A0695 Fragment base #633. Base 519 of 790
C C C A T A T
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Chromatograms from Contig[0001]
Sequencher™  "1_IGF2R_Samples"
A0719 Fragment base #633. Base 518 of 792
C C C A T A T
A0719_DNA Fragment base #633. Base 513 of 783
C C C A T A T
A0727 Fragment base #633. Base 518 of 790
C C C A T A T
• A0703_DNA Fragment base #633. Base 512 of 781 •
C C C C T A A
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Chromatograms from Contig[0001]
Sequencher™  "1_IGF2R_Samples"
A0719 Fragment base #633. Base 518 of 792
C C C A T A T
A0719_DNA Fragment base #633. Base 513 of 783
C C C A T A T
A0727 Fragment base #633. Base 518 of 790
C C C A T A T
• A0703_DNA Fragment base #633. Base 512 of 781 •
C C C C T A A
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APPENDIX B 
SUPPLEMENTAL TABLES 
 
Table B1. Chromosome-wide imprinted XCI status profile and Illumina RNA-seq SNP counts in 
opossum fetal brain and EEM. (A) SNP count summary for escaper genes from fetal brain and EEM 
RNA-seq data. (B) Table S1B. SNP count summary for nonescaper genes from fetal brain and EEM RNA-
seq data. (C) chromosome-wide imprinted XCI status profile in opossum fetal brain. (D) Chromosome-
wide imprinted XCI status profile in opossum EEM. For table see attached file Table S1.xlsx. 
Table B2. Allele-specific pyrosequencing verification results for escaper genes and selected non-
escaper genes in brain and EEM. (A) SNP genotyping results in the F1 embryo and their parents by 
Sanger sequencing for selected escaper genes. (B) SNP genotyping results in the F1 embryos by Sanger 
sequencing for selected non-escaper genes. (C) Allele-specific pyrosequencing verification results. For 
table see attached file Table S2.xlsx. 
Table B3. H3K4me3 and H3K27me3 significant peaks on X chromosome in female fetal brain and 
male fibroblasts ChIP-seq data. (A) Significant H3K4me3 peaks on X chromosome in female fetal brain 
ChIP-seq data. (B) Significant H3K27me3 peaks on X chromosome in female fetal brain ChIP-seq data. 
(C)  Significant H3K4me3 peaks on X chromosome in male fibroblasts ChIP-seq data. (D) Significant 
H3K27me3 peaks on X chromosome in male fibroblasts ChIP-seq data. For table see attached file Table 
S3.xlsx. 
Table B4. Candidate escaper genes without informative SNPs to quantify the allele-specific 
expression.  
 
No. gene ID gene name H3K4me3  fold-enrichment 
% of H3K27me3 
coverage 
Female/male 
expression ratio 
1 ENSMODG00000008997 UBL4A 13.21 0.00% 1.26 
2 ENSMODG00000008581 SSR4 18.5 0.00% 1.15 
3 ENSMODG00000011547 NAA10 12.77 4.98% 1.37 
4 ENSMODG00000014984 THOC2 10.13 0.00% 1.07 
5 ENSMODG00000003985 ZFP347L 16.3 1.03% 1.23 
6 ENSMODG00000004615 OGT 17.18 0.00% 1.19 
7 ENSMODG00000004864 KIF4A 12.33 4.85% 1.09 
8 ENSMODG00000009860 CCDC22 13.65 0.00% 1.34 
9 ENSMODG00000009765 KDM5C 13.21 0.00% 1.34 
10 ENSMODG00000011070 RPS4X 8.37 0.00% 1.11 
11 ENSMODG00000011785 CSTF2 18.5 0.00% 1.26 
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Table B5. Average promoter CpG methylation percentages for 5 escaper and 17 non-escaper genes 
in female and male fetal brain and EEM from PyroMark sequencing results.  
Gene name CGI_start CGI_end pXCI status 
# of 
CpGs 
Average CpG methylation percentage 
female 
brain 
male 
brain 
female 
EEM 
male 
EEM 
FLNA 3105210 3105995 Escaper 10 1.43% 1.58% 4.08% 2.46% 
FAM3A 3400962 3401678 Nonescaper 20 4.45% 3.23% 2.40% 1.80% 
AMMECR1 5988670 5989919 Nonescaper 10 0.85% 0.56% 0.69% 0.98% 
BCAP31 11514655 11515266 Nonescaper 8 0.12% 0.37% 0.40% 0.30% 
LAS1L 13387573 13387813 Nonescaper 13 1.10% 0.43% 0.49% 0.35% 
LONRF3 27458981 27459730 Nonescaper 14 1.03% 0.79% 1.64% 0.91% 
ELF4 31571699 31572038 Nonescaper 11 0.29% 0.61% 0.35% 0.03% 
RAP2C 32989986 32990510 Nonescaper 9 2.85% 1.20% 0.72% 3.20% 
GPC4 34223543 34224297 Nonescaper 7 1.97% 5.25% 1.43% 2.91% 
RSX 35651221 35651426 RSX 23 60.57% 95.03% 56.34% 95.92% 
FAM122B 36029151 36029318 Escaper 8 0.63% 0.26% 1.07% 1.87% 
DDX26B 36362206 36362830 Nonescaper 7 1.89% 1.95% 2.69% 9.17% 
MTMR1 39955076 39955459 Escaper 7 1.14% 0.47% 0.19% 1.21% 
CD99L2 40182295 40182801 Escaper 12 0.17% 0.41% 0.65% 0.87% 
GPR50 40418664 40419488 Nonescaper 8 0.23% 0.29% 0.09% 0.28% 
ATP7A 56159948 56160563 Nonescaper 17 1.29% 0.00% 0.22% 0.47% 
FNDC3C1 56480924 56481174 Nonescaper 11 1.99% 0.52% 2.20% 0.92% 
PLS3 67094850 67095761 Nonescaper 9 2.55% 0.39% 1.41% 3.70% 
AMOT 68740642 68741518 Nonescaper 9 40.98% 36.72% 37.15% 58.91% 
TAF1 69944348 69945053 Escaper 10 0.14% 0.25% 0.35% 0.84% 
KCTD12B 71564312 71565156 Nonescaper 11 0.88% 0.86% 4.13% 1.98% 
KLF8 71604414 71607119 Nonescaper 8 4.30% 0.66% 4.71% 1.16% 
IL13RA1 78514312 78514793 Nonescaper 7 0.89% 2.08% 0.00% 2.83% 
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Table B6. Opossum imprinted XCI escapers and the random XCI status for their human/mouse 
ortholog genes.  
 
Gene name Opossum escaping status Human random  XCI status 
Mouse random  
XCI status 
FLNA Escaper Non-escaper Non-escaper 
RPL10 Escaper Non-escaper Non-escaper 
PLXNA3 Escaper Non-escaper Non-escaper 
G6PD Escaper Non-escaper Non-escaper 
IKBKG Escaper Escaper Non-escaper 
DKC1 Escaper Non-escaper Non-escaper 
YIPF6 Escaper NA Non-escaper 
NUP62 Escaper NA Non-escaper 
HCFC1 Escaper Non-escaper Non-escaper 
IRAK1 Escaper Non-escaper Non-escaper 
MECP2 Escaper Non-escaper Non-escaper 
FRMD7 Escaper NA Non-escaper 
PHF6 Escaper Non-escaper Non-escaper 
FAM122B Escaper NA Non-escaper 
FAM122A Escaper NA Non-escaper 
MTMR1 Escaper Non-escaper Non-escaper 
CD99L2 Escaper Non-escaper Non-escaper 
HMGB3 Escaper Non-escaper Non-escaper 
RBMX Escaper Non-escaper Non-escaper 
ATRX Escaper Non-escaper Non-escaper 
ALAS2 Escaper Non-escaper Non-escaper 
TAF1 Escaper Non-escaper Non-escaper 
NONO Escaper Non-escaper Non-escaper 
CENPI Escaper NA Non-escaper 
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Table B7. Summary of ChIP-Seq data for fibroblast cells using 4 histone 
modifications and an input control.  
 
Histone 
Modification 
Raw 
Reads 
(X106) 
Filtered and 
Aligned 
Reads (X106) 
Enrichment 
Peaks 
(p ≤ 10-5) 
Overlap with 
Putative Ensembl 
Gene Promoters2 
H3K4me3 97.0 71.3 79,412 16320 
H3K9Ac 158.4 112.4 56,719 13420 
H3K9me3 74.7 56.9 52,511 (159,734)1 4514 
H3K27me3 157.3 118.0 16, 592 NA 
Input 120.2 78.2 NA NA 
 
1 - significant peaks determined using MACs (p ≤ 10-3) 
2 - 500 bp upstream to 500 bp downstream of first annotated 
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Table B8. Summary overlaps of significant peaks with each other, annotated CpG 
islands, and annotated putative promoters. 
 
 H3K4me3 H3K9Ac H3K9me3 K4me3+K9Ac K4me3+ K9Ac+K9me3 
H3K4me3 
(n=79,412) ---- 45,331 ---- ---- ---- 
H3K9Ac 
(n=52,511) 47,275 ---- ---- ---- ---- 
H3K9me3 
(n=56,719) 6,410 1,615 ---- 1,531 ---- 
Putative 
Promoters 
(n=35,301) 
16,320 10,959 3,163 13,176 253 
CpG Islands 
(n=22,441) 11,580 9,061 188 9,319 240 
Promoters + 
CpG Islands1 
(n=10,814) 
7,871 6,759 773 6,803 136 (178)2 
 
1 – Annotated CpG Islands within the 5.5 kb range of putative annotated promoters 
2 – Number in parenthesis represents overlapping peaks at promoters and CpGs using a 
lower level of significance for H3K9me3 peak calls (p ≤ 10-3)
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Table B9. Candidate-imprinted genes Ensembl Gene ID, Associated common gene 
name if applicable, 3’ UTR coordinates as annotated, and Forward and Reverse 
PCR Primers. 
Ensembl Gene ID Chr Start End Forward Primer Reverse Primer 
ENSMODG00000000633 1 50888333 50889333 GAACCTCATGCAGTCTGTGAAG TGTTTGGTAAGGGAAAGCCTAC 
ENSMODG00000006639 1 78887646 78888646 TTGAACAGCCAGAACTCAAGAA GGTTTACTTCAAACAGCAGCAA 
ENSMODG00000008434 1 86454736 86455736 ACGACAGAAAGGACCAAGTGAT TATAGTTGCCCAAAAACCCATC 
ENSMODG00000010523 1 101428590 101429590 TCCAGAGAAAGGTTCCAGTGTT GGTTTGAAGGCTCTTGCTACAC 
ENSMODG00000011165 1 108942899 108943899 CTGAACCTCTCCCGCATAATAG TGAACTGACTCTTACGGAGCTG 
ENSMODG00000019402 1 117607423 117608423 AGCTATGCTTGGGAGATCAAAG AAGTTCCAGAACCAGTTTCCAA 
ENSMODG00000011135 1 148353086 148354086 CACATGCCAAAGAAGAAAACCT CCCCCAACACAAATAAGAAACA 
ENSMODG00000000464 1 197125347 197126347 TCCGACTTTGTAGAACCCAGAT TTCATTCCAAGCCCACTATTCT 
ENSMODG00000000164 1 198202335 198203335 CCTTCAAGAACAGGGATAAATG GGGGAAAGAAGATGATTGAGAA 
ENSMODG00000000158 1 198271412 198272412 GATTCAGGGTTCCTCTCCTCTT GTAAGAACCATCCAGCCATCTC 
ENSMODG00000003366 1 228646013 228647013 ACTACAGGTCAAAAGGGCAGTC GCCTGGATGTGAAAGTTATCAA 
ENSMODG00000011362 1 275456081 275457081 TTTGATAAGCCTTCTCCTGCTC CCTCATCTCACCACACTCTTTG 
ENSMODG00000011684 1 276674516 276675516 CCCAGCAATTGAATAAAGGAAC CTACCCTTCCCCATAAACCATT 
ENSMODG00000012905 1 285526641 285527641 ACCCCAGTCATCTCTTGTTTGT CTGGAGGACACATGATTTTTCA 
ENSMODG00000012822 1 285630813 285631813 GAACATGGCCTACTGCTTCTTT GCTTTGCCTTTATGTTCCTAGC 
ENSMODG00000010724 1 333227663 333228663 CATGAGGTTTCTCTCACCACTG CCCCCATAGGAAGATTACCAA 
ENSMODG00000023761 1 333244982 333245982 TTCTCTCACCATGGACTCTCAA TCATCCATTCCCAGAGTCAATA 
ENSMODG00000010717 1 333338010 333339010 AGGAAAAGAAGTAGGGTCAGCA TGAGGGGTGGAGAAGAATAAGA 
ENSMODG00000009937 1 342089584 342090584 TGCAGTTGCACTACTAGGCATT CAGACAAGTGGTGGAGAAATTG 
ENSMODG00000009436 1 343914253 343915253 CATGTCCAGTATGAGTGGTGGA ACCACTTTAACAGGGAATGGTG 
ENSMODG00000007182 1 367060313 367061313 TTGCACCAACTAATGGAAAGTG TACAGGGATACTTCGGAGCAGT 
ENSMODG00000006223 1 372593415 372594415 ATACAACCAACCTTGGCAACTC AACCTCCACAACCACAGTCTTT 
ENSMODG00000003806 1 385459213 385460213 GGGGAATGCTTAAGATTTGTGT CACCCCATCCCTAAATGAGAT 
ENSMODG00000001669 1 389035953 389036953 AGAAATGGGGCATCTGAAACTA CACACGTCTGATGAAGGTTTTT 
ENSMODG00000019490 1 401848708 401849708 ACAGGACACCTTTGTGGAACTT GGCATGGTTTGGAGTTACTAGG 
ENSMODG00000019496 1 401900281 401901281 TCCACACATAGATGGCTGTCTT TGAACTCACCACTTCCCTCTCT 
ENSMODG00000012957 1 436892842 436893842 AAACCAGGCTTGGTCTCATAAA AAGTAGGGTGAGCCAAATCCTT 
ENSMODG00000017051 1 472620853 472621853 TTCAGTGTCACCTGCAATTTCT AGGAATGTCCCAACTCAGGTAA 
ENSMODG00000016314 1 495758719 495759719 ATCCCCTTTCTTCACTCGAATA AAAAGAAGGTGGAGCAGTTGTC 
ENSMODG00000016229 1 499725383 499726383 ACTAAGAGGAAGGAAGCGGTCT GCCTTTAATGGAAGGAGGATTC 
ENSMODG00000015575 1 510096298 510097298 CTTGAACTCTCCCACTCTCCTG GAGCTATGCCTCTCATCTCCTG 
ENSMODG00000014618 1 531430233 531431233 AGGAAGCCACAGTTTGAACATT TTCTGAATTCCCCTCAGAGCTA 
ENSMODG00000011515 1 563790769 563791769 TGGGTGCAAATTATGGAGTACA TGCAATTATCGATCCATCTGAG 
ENSMODG00000011328 1 564790600 564791600 GCCCTTTTTCCTTTTACAGCTT ACTCCCATGTCTGGAAGTCAGT 
ENSMODG00000008637 1 589524319 589525319 AGAAGGCAATGCATACAACTCC TCTGAGCAGGAGACTTCCTTTC 
ENSMODG00000006163 1 600377628 600378197 GTGGTCCAGAAATTCTCAGACAG GATATGGCCCTGGAAGGAATTA 
ENSMODG00000005428 1 605428140 605429140 TTTCACGATCACTCCAGAATTG TATTGCCGAGAAACTAGGAGGA 
ENSMODG00000003919 1 621177657 621178657 CCAGGTTACCATAGAGTTTGACC GTGGCCCAAACATCAAGTTAGA 
ENSMODG00000003396 1 624802971 624803971 GAATTGTTTAGGGCGGGTTTAT TCATGCTGACTCTACTGCTTGA 
ENSMODG00000002285 1 631466134 631467134 AAATTGGGTCAAGGGAACTAGG GTAGCTTTTGGCAATCCTGAAC 
  164 
ENSMODG00000001803 1 639694124 639695124 AAGCAAAGCGGAGTAAAATCAG CATCCCAAGTGTGTGATGAAAT 
ENSMODG00000008750 1 662002860 662003860 TTCGTGCCTACATTGTGAGTTT ATGAATGGAATTGGAAGACTCG 
ENSMODG00000008486 1 663121133 663122133 TGAGCTATGGCAGAATTTGGTA ATGTGCATCACTTTCAGCTACA 
ENSMODG00000003201 1 698983517 698984517 TTATTGCCAGGACCTTTTCAGT TGCTACCGGAAACTTTTAATCC 
ENSMODG00000011200 1 704999526 705000526 AGCTCGTCTTACAGCAGAGGAA AGAAGATCAACGGCTTTTTCAC 
ENSMODG00000009450 1 716933050 716934050 GGTGGTTTCTACCACACCAAGT ATACTCAAAGCCAACGAGTGTG 
ENSMODG00000009386 1 717367383 717368383 CCTCCTACAGCATCGAGCAC GGGTGGATTCTTTCGTGATTTA 
ENSMODG00000015604 1 717916461 171917461 AAGTTAAAAACCCTGGGAGGAG AGTTGGGCTCTGCTATTCTGTC 
ENSMODG00000001321 2 57215440 57216440 GGAGGAACAGACAGAACAATCC ACTTCCTCTTTCCCCATGATGT 
ENSMODG00000007194 2 78706632 78707632 AGCATTTATTCAGGTGCTGTCC TTAGTCCAGCAAGAAGTGAGCA 
ENSMODG00000011721 2 82226320 82227320 AGGAAATGTCCATTAGCCAGAA TGCATTCAGTGTTCAAGACTCC 
ENSMODG00000001558 2 109874517 109875517 GGATTTGCATTGCAGACTCTAA TGACATTTGAGCACAGACAGAA 
ENSMODG00000004622 2 131134701 131135701 GTTCAGTGGGAGATGGAAGTTT TATCAATTAGCCCAAGGCAAAG 
ENSMODG00000006246 2 139634610 139635610 ATCTGTGCTCAACAGCATCTTC AACTGCTTCAGCATTCAGATCA 
ENSMODG00000008286 2 154429949 154430949 GGGTAAGTTTACAGGCCAAATG CCAGTCCGAACATAAACTCTCC 
ENSMODG00000014128 2 169499702 169500702 TGCATGTTGGGTGTATCCTAAA CAGCATGGATGAAGACTTTGAG 
ENSMODG00000016946 2 191002496 191003496 CAGCATCATGTAACCTGGAGAA GAGCAGAGACTCAAACTCAGCA 
ENSMODG00000014859 2 194012782 194013782 AGAAGATTCGAGAGGGAGAGGT CTACTGCTCCAAATCCCAAACT 
ENSMODG00000014651 2 194867160 194868160 TAAAACCAGTTTGGGAGGAATG TGCTCAGCCTGAAACTCAAATA 
ENSMODG00000024021 2 206114036 206115036 GCAACCTGCTTATCAAGTCTGA CCGAGAGACAGAGGGAGAGATA 
ENSMODG00000007640 2 213236964 213237964 AATAGCAGGGGAGAAGGGTAAC ACTCCCCACAGGTGAATGTAAA 
ENSMODG00000004465 2 225162279 225163279 ACTCTGACCAAGCAGGTTTAGC CTACCTCACAGGGTTGTTGTGA 
ENSMODG00000003779 2 229916066 229917066 GAAAATTCTTCAGCCTGGAACT GACGATGACCTCTTCTTTCGAG 
ENSMODG00000003743 2 229961937 229962937 GCATGGCCTTCCAATAAAGATA TAAAAATGCAGCCCTTCTATGG 
ENSMODG00000003701 2 229995182 229996182 ACAATGAAGGAGCTAATGCACA CCACCATAAATTCCATTCTGAC 
ENSMODG00000007792 2 254268634 254269634 AGGGCTGATGAAACTCCAGATA TGTCGTGCAAATAAGGGTAGAA 
ENSMODG00000008266 2 260064845 260065845 TCTTCTGGATAGAAGTGGCAAT CAATCAACATACATGGGAGAGG 
ENSMODG00000013704 2 275269390 275270390 GTTCTTTCCCTTCCTTCTAGGC CCCCCAAGACATTCTTCTCTCT 
ENSMODG00000012785 2 285218809 285219809 TAATCCTTATCTCCGGCCTGTA GGCTTTGTAGGTCAGAGGAAGA 
ENSMODG00000018800 2 302215607 302216607 AGGTGCTGGAAAGCAAAGTTAT GATGGATGAGGGAGTTTGTTTC 
ENSMODG00000018721 2 307679005 307680005 AATTGGATGTGCTCTCGAAGAT ACTTTTCTATGGCCAGGGATG 
ENSMODG00000018444 2 332904143 332905143 AAAGAATGGGAAGGGCAGATAG TGTAGTTTGATTCCCCAACTGT 
ENSMODG00000006175 2 451158631 451159631 CAAAAAGCTTGAAGACCTCACA CTGACACGGACTCATCAACAGT 
ENSMODG00000004472 2 459548415 459549415 CACCGGTTTCAAAGTGTCTGTA TTTTGTCATCATCATCCTCGTC 
ENSMODG00000004326 2 460038121 460039121 ACCTAAAACTTCTGCAGGCTCA AATACATAACGGAAGCCAAGGA 
ENSMODG00000005319 2 491245071 491246071 GTTTCAGGAGGTCTGGTTCACT ACTCTGTTCATCTCCCTCCAAC 
ENSMODG00000018801 2 495754229 495755229 GTTCTAAATCACCTGGGCAAAG GTAGGAGCTGGTTTGGCATATC 
ENSMODG00000019221 2 505025234 505026234 CTCGTCGAGTTTCTTTGCTACC AAACAATATGGCCGTGAGAAAC 
ENSMODG00000000570 2 520269915 520270915 TCCTACCCATGAGGGATTTTTA GGGTCTTCACAAAGATCTGCAT 
ENSMODG00000016394 2 520272577 520273577 GAGCCCAGTGACACTATTGAGA GTCCTGCCACTGCAAGATTTAT 
ENSMODG00000023140 2 522386355 522387355 GAATGTGGAAAAGGATTTGGAC CCCATAACTTTCTCCATTCCAG 
ENSMODG00000019470 3 16801021 16802021 TAGAGGGAGTTTTCCTCACCTG GCAAAGACCCTGTCGTTTTAAT 
ENSMODG00000025244 3 49543210 49543819 CTGGTACCGTCCACCTGTTCT GAGGACAGACCTTCATGTGTGA 
ENSMODG00000015548 3 52330287 52331287 ACCATGCTCCAGCATAAGATTT TTTCAGGAACTGGTGAAACAGA 
ENSMODG00000003564 3 69451400 69452400 CAACTACCCCTGCTACATAGGC TCAGACCTCAGAATGGTGAAAA 
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ENSMODG00000000399 3 87470085 87471085 ATCTTCCATTTGCTGGAGACAT GACACAGTGAGTTGGGGTGATA 
ENSMODG00000001446 3 94853941 94854941 TGTGGTTCATCTACCAAAAAGC GTCCACAGGTAGGTGTCACAAT 
ENSMODG00000006950 3 162249049 162250049 TTCAGTCATGATTGTCCTGGTC CACTTCCACAGCAACAGTATCC 
ENSMODG00000006961 3 162533985 162534985 TAAGCCAGGATCAGAACAGAGC CCATCTTATGGGCTATGACAAA 
ENSMODG00000010525 3 194975067 194976067 AAGCTGGTGGAGCTCTCTTCT CAAGTTTCTCCGGAGTATGTCC 
ENSMODG00000020132 3 208749463 208750463 TCGACAACATATATCGCACTCA AGGTAAAACCCCCATTGAAACT 
ENSMODG00000020286 3 232703757 232704757 GTTTGGTACACCACAAGCTTTC TTTTCCTAGGTTCAGGATGTGG 
ENSMODG00000020357 3 240202567 240203567 GATGATGAACTTCGAACTGTGC AGCAGCATGATTTTCTCCAGAT 
ENSMODG00000021462 3 269085279 269086279 ATCTGGACCAAGTGCAAATACC CCCGGTCAATGCTAATAACCTA 
ENSMODG00000006222 3 365999412 366000412 TCTACCAAACTGGCTTTTGACA GCTGAGCAAGGAAACGTAATTT 
ENSMODG00000004746 3 377688004 377689004 CCTCCTAAGTGGTTCAGGAAGA TCAAACCTAGAAGGTTGCCATC 
ENSMODG00000001735 3 404001553 404002553 AGTGAGCTGCTGAGGAAAGAAC TCAAGGAAATCCTTTCAAGCTC 
ENSMODG00000000768 3 421671148 421672148 CCCTTAAGGATGGTTTTCCTCT TGCTGAGGAGTTGGTATGAGAA 
ENSMODG00000000764 3 421755076 421756076 CTCACTGCACATGCTTCATTTT CTGGCCTACACAGCTTTACTGA 
ENSMODG00000006967 3 429190670 429191670 TGTAATTAAGACGCCAGGGAGTA GACTCGAGGACAAGGTGAAGAC 
ENSMODG00000011184 3 437574717 437575717 ACCAGAAATGGGAAAAGCTGTA CAAAAACTTATGGCATGGGAGT 
ENSMODG00000011203 3 437738813 437739813 CAAGAGCTGACCAAGCAGTAGA AATGGAAGAGTCAGGACCTCAA 
ENSMODG00000000718 3 440376529 440377529 GCTACAAGTAGCCTGTGCCTCT AAGTGGCATCAGAGATGAGGTT 
ENSMODG00000001178 3 443006006 443007006 GCCAAATTGGATCAAGTACAGG CTCACTTCACCCGCAGATATTA 
ENSMODG00000001236 3 443062526 443063526 
GAGAAAGTGATGGAAAGAGAGA
GA GGGGATTTCAAGTCCTTTCACT 
ENSMODG00000003841 3 460433663 460434663 ACAAAGGAAGAACTGGCACTTG GGACAGAAATCCAACAAACTCC 
ENSMODG00000003520 3 475399984 475400984 GACCATTACCCTTGAAGTGGAG CTTACCGGCAAAGATCAGTCTC 
ENSMODG00000014519 3 477439465 477440465 AGAACAAAGGGACAAGCAACAT CAGTTGTTGCTCAACTCTGACC 
ENSMODG00000025637 3 499708709 499709709 GGAGAAGGTTCTGGGCTAATCT GACCTTTTGAATGCAGTGAATG 
ENSMODG00000023660 3 501254997 501255997 CAGAGATGTGACCTTTGGCATA GGGAGAAACCTTATGAATGCAA 
ENSMODG00000009557 3 520340337 520341337 ACACGTGTACAGAGGCAGCAC CCACTTTAGGACATCGACATCA 
ENSMODG00000021035 4 10077076 10078076 GGGTGCCGTAAGTTTCTATCAG AAACAAGCCATTGCAACTATCC 
ENSMODG00000021051 4 12639112 12640112 ACCAGAGTGATGTGGTGGAAG AAAGAAGCAAGCACAGTTTTCC 
ENSMODG00000007427 4 41989413 41990413 AAAAACCCCTTTCCACAGTACA AGATTGTGTCTTCTGCAAGCTG 
ENSMODG00000001888 4 62096907 62097907 GCCAATTTCTCCATTCAGTTTC GCATTGCCTCCTGAAAGAAATC 
ENSMODG00000021670 4 62103338 62104338 ACCTGGAAATATGCCTCTCTGA GTCTGTTGGCCATTCTAGATCC 
ENSMODG00000018047 4 67631607 67632607 GAGAGTCCCTCTGTTCTTCCAA CTGAAGCAAGAAACAGTCCAAA 
ENSMODG00000018216 4 83632774 83633774 TTCTTTGCCTTTCCAGATCACT GTTTCACTCAGCAACACTGGTC 
ENSMODG00000000944 4 132780390 132781390 CTAGAAAAACGTGGCGAAGACT ATCTATGCGCACTGAGGAATCT 
ENSMODG00000005628 4 168318450 168319450 TACTCATGGGGAATGTTCACTG CTTTCCAGTCCTGGGGAACTAT 
ENSMODG00000005665 4 168505310 168506310 TACAAAACCCTCACACAGTGGT CAGCAAAGAAAATCTTGGGTCT 
ENSMODG00000009617 4 187738965 187739965 CTCTCAGGTTGGCCTAGAGAAA GGAAGAGGGATCCATGGTAAAG 
ENSMODG00000011664 4 208188190 208189190 CCTTCAGGAATACCAAGTCCAG CTGGAAGGGTCCAAAGTTACAT 
ENSMODG00000012380 4 221510565 221511565 CAGGGATTGCAGTTCATACTCA GTGACAAGAATGAGGCACAAAA 
ENSMODG00000014615 4 245943367 245944367 AGGATATAAGGTGGCCTCAACA CAGCAATGTAATTTGGTTCCAG 
ENSMODG00000000824 4 259665304 259666304 ACATACACACACACGCAGGTTT AAGTCCGTCAAGTGTCATAGCA 
ENSMODG00000004297 4 325137648 325138648 AATCCAGTGGAAGAGAATGGAA CTTGCAAAATCTAGGCACAGAA 
ENSMODG00000004498 4 328701595 328702595 TGCAAGTTTGTCCTGTTGAGTT GTACACCATCTCCCAGCAAGAC 
ENSMODG00000012783 4 359890347 359891347 CTCCTCAACAAAACAAAACACG GCTGACTTTCTTTGGTGGAATC 
ENSMODG00000013020 4 360458330 360459330 TAGCTACAAAACAGCACGCATT GGCCACTAATGGCATAACCATA 
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ENSMODG00000023715 4 385763442 385764442 CACTGCGGACAAATACCTACAA CCCTAGTCATTCTAGCCCAGTG 
ENSMODG00000009049 4 386060673 386061673 AGCTGGAGCTGGAGATGGAG CTGGAAAGGAGGGGTGATTT 
ENSMODG00000002366 4 387524083 387525083 AACTGCCAAATCATGACTTCCT GAGAAACAGAAGGGAAAAAGCA 
ENSMODG00000006096 4 394682732 394683732 CAAAGACGGTCTGGGATTCTAC AGCAATATGAGATGCTCAAACG 
ENSMODG00000023559 4 401589273 401590273 ATCATGCACCTAACTTGTGCTC CACATCAGAGAATTCACACTGGA 
ENSMODG00000017226 4 429135945 429136945 CCTAACAATAAGCCCAAACTGC GAAGAAGGAACTGGGGAAAACT 
ENSMODG00000012053 5 35181234 35182234 CAGCCTTGACAAGTTGAGTGAT GTGCTCAAAGTGGTTCTTACCC 
ENSMODG00000004762 5 79622982 79623982 TGAAGTTCAGCGTCAACAAGAT TTGGGGGAACAAAGTACATAGA 
ENSMODG00000020706 5 168647869 168648869 AGTAAGGAAGATGCTGGGGAAT TGCGTAGATGCTAGGGATACAA 
ENSMODG00000020677 5 170377569 170378569 GGCAAGGAAAACAAAAGTCCTA GGGATGAAACCATAGGTGAACA 
ENSMODG00000000034 5 195763940 195764940 GTTCCTGCAACCCAACATACTT ACCACCAGCTAACACTTTTGTG 
ENSMODG00000000423 5 203290281 203291281 AGTGATGGTGTCTCTGCAGTTG ATAAGGAAACTAAGGCCCATGA 
ENSMODG00000006522 5 242663942 242664942 TGATCACCCTAGTGCAAATGTT ACAACAATCCAACCAATTCCTC 
ENSMODG00000007335 5 247048855 247049855 TGCAAATAGCTCACTGGCTTTA ATTGCACCCTTTCACATTCTCT 
ENSMODG00000008096 5 250096219 250097219 GAACCTGGCTCACCAGATCTAC AACACCAAACTTGACAGCAAGA 
ENSMODG00000026540 5 250107281 250108281 AAAGAAAGAAAGAAGCCCAACC CTCCCTCGTCTATTCCCTTTTC 
ENSMODG00000009646 5 250270154 250271154 AGGAAACGATATCCGAAAGACA AGAGAGCTCAAGGACTGGACTG 
ENSMODG00000013386 6 2293076 2294076 ATACTGTATTGGGCTCCTCTGG TTCTGGCTGAATTTGGAGAGAT 
ENSMODG00000003495 6 15524842 15525842 CAAAGAACGCACTCATCTGAAC AGACTCGCAGTACGAGGAGGAT 
ENSMODG00000003820 6 36296449 36297449 ACCATTTGGGGGTTTTCTTAGT CCCAGGATCAGCTTCAATACAT 
ENSMODG00000025162 6 36333515 36334515 ATATTCTCCTCCCCTCTGCTTC GGTTTCCTGGACACTCTGATCT 
ENSMODG00000005539 6 54243962 54244962 GGGAAGGAAGGGTTAAGCTACA GCAGAGGAAATCCTTGACGTAT 
ENSMODG00000008046 6 62389852 62390852 ATAGCACTTTGCTGTTTGAGCA CTTTTCCAAAGCCCTTACCTTT 
ENSMODG00000002641 6 94039653 94040653 CCTACTTGTGCCATGTAAGTGC AAGTGGTTCCATTTTCAAGCTC 
ENSMODG00000003635 6 102275090 102276090 GGAATAAGGAAGTCACCACTGC ACAAGGAAAAGCTCGAATCAAC 
ENSMODG00000004516 6 236726356 236727356 CAGAGAAGATCCCTCCTCCTTT GGGCTACTTTACAGCTTTTGGA 
ENSMODG00000004830 6 242565134 242566134 AGGTTTTCAGCACCAACTGAAC ATCTGGCTCAGCCTTACTTCAC 
ENSMODG00000004766 7 82619875 82620875 CGACTTTGAAAGCAGGAGAACT CTGATTTGCCTAATTGCTGACA 
ENSMODG00000015025 7 171107979 171108979 GTCTTGAGGCAACTTGAACCTC ATTCTCAAGATGCTGACCATGA 
ENSMODG00000015605 7 178177078 178178078 TCAGTTGCTGATTGTCCATCTT ATCACCAACCATCATTACACCA 
ENSMODG00000015703 7 244712188 244713188 ACGGCCACAAGAGGAAAAAGT CCAAGACAGGAGTCAAGATTCG 
ENSMODG00000014421 8 25879609 25880609 ATGGTACAGGCTTGGACACTTT CAGAGAGTTGGGAGCCATTTAG 
ENSMODG00000020516 8 62627976 62628976 TGTAATGGAGTGATACGCTTGG AAATCCAATATCTCCCCCAACT 
ENSMODG00000017458 8 93333479 93334479 TATTTCAGGGTGTTGATGATGC GCCCTTAACTATTTTCCACTGC 
ENSMODG00000018312 8 114355198 114356198 GACTTCTCGAGAGCCAAAGAAC TCTTCTAGGATTGCCTGAAAGC 
ENSMODG00000018401 8 117841274 117842274 CACTCAGTGGAGTGGAACAAGT CACATCAAAACTGATGGCAAAG 
ENSMODG00000018521 8 122746963 122747963 CTGGCATAACAGCAAACTTGAA CAGATTTTAGGGGGTTACAGGA 
ENSMODG00000016607 8 126406300 126407300 ACCTTACCAAATACCCAGATGC TACCACATTGCTTTTCATCACC 
ENSMODG00000014499 8 190464437 190465437 ATGAAGGCAAGGTACTCTCAGC TAGATTGGCCTTAGGAGATGGA 
ENSMODG00000013750 8 201464609 201465609 CACTTCCAAGCTGCTACCTACC CCATGTTCTTCCTAGCTGTGTG 
ENSMODG00000013737 8 201570807 201571807 CCTTTTGGATCTGCTCAAGAAC AGGCTCAAGGCTTTAGAATGTG 
ENSMODG00000006521 8 232504676 232505676 ATGGTGGTTGAAACTACGACCT ACTGAGAGCTCTGGAATCTGCT 
ENSMODG00000008021 8 244170301 244171301 CTGGAGAGAGGAAAGAAGGCTA GGCAAAGTTAGACTTGGAATGC 
ENSMODG00000009719 8 256334468 256335468 CGCAGAAAGCCATGATACATT TGCTGCTACTGACGTCACAATA 
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ENSMODG00000009818 8 256730655 256731655 CTGAAAATTGCAGTTTGACCAC CAACACCATGATGATCTGGAA 
ENSMODG00000023924 8 304139473 304140473 CATCGACTTCCTCTACCAGGTC GGTGGAATTTGGGAGTTTACAA 
ENSMODG00000021336 Un 7775211 7776211 CATCAAGTTCGACCTGAACAAG ACTAATCACGGTTGGGGAATGT 
ENSMODG00000020581 Un 38479834 38480834 ATTAAACCCCATGAGGAAAACC GCGTTGGTCTGAGTGAATAAAG 
ENSMODG00000007100 2 442547176 442548176 GGGAGAGAAGGAGAGAAAAGGA GAAGCACCCGAGAAACTAAAGA 
 
Table B10. SNP variation detected between individuals A0563 (LL1) X A0573 (LL2).      
42 total SNPs. Genes chosen for SNP confirmation are indicated by an asterisk. 
Chromosome	   Start	   End	   Ensembl	  Gene	  ID	  
SNP	  
POSITION	  	  	  	  	  A0563	  	  	  	  	  	  	  	  	  	  	  	  	  	  A0573	  
CHR1	   50888330	   50889340	   ENSMODG00000000633	   A	   AG	   50888587*	  
CHR1	   108942890	   108943900	   ENSMODG00000011165	   G	   AG	   108943512	  
CHR1	   148353080	   148354090	   ENSMODG00000011135	   A	   AG	   148353432	  
CHR1	   285526640	   285527650	   ENSMODG00000012905	   T	   CT	   285527301*	  
CHR1	   285630810	   285631820	   ENSMODG00000012822	   C	   CT	   285631226	  
CHR1	   333227660	   333228670	   ENSMODG00000010724	   C	   CT	   333227821*	  
CHR1	   333244980	   333245990	   ENSMODG00000023761	   AG	   A	   333245463*	  
CHR1	   333338010	   333339010	   ENSMODG00000010717	   G	   C	   333338396	  
CHR1	   343914250	   343915260	   ENSMODG00000009436	   C	   GC	   343915130*	  
CHR1	   510096290	   510097300	   ENSMODG00000015575	   A	   AT	   510096540	  
CHR1	   589524310	   589525320	   ENSMODG00000008637	   C	   T	   589524693	  
CHR1	   624802970	   624803980	   ENSMODG00000003396	   AG	   A	   624803564*	  
CHR1	   717916460	   717917470	   ENSMODG00000015604	   C	   CT	   717917106	  
CHR2	   78706630	   78707640	   ENSMODG00000007194	   G	   AG	   78707300	  
CHR2	   169499700	   169500710	   ENSMODG00000014128	   AG	   A	   169499823	  
CHR2	   194012780	   194013790	   ENSMODG00000014859	   A	   AG	   194013292	  
CHR2	   275269390	   275270390	   ENSMODG00000013704	   AG	   G	   275269467	  
CHR2	   285218800	   285219810	   ENSMODG00000012785	   C	   A	   285219179*	  
CHR2	   302215600	   302216610	   ENSMODG00000018800	   A	   AC	   285219179*	  
CHR2	   307679000	   307680010	   ENSMODG00000018721	   A	   G	   307679839*	  
CHR3	   16801020	   16802030	   ENSMODG00000019470	   AT	   T	   16801290*	  
CHR3	   49543210	   49543820	   ENSMODG00000025244	   A	   AG	   49543500*	  
CHR3	   421671140	   421672150	   ENSMODG00000000768	   G	   GT	   421671879	  
CHR3	   437574710	   437575720	   ENSMODG00000011184	   G	   T	   437574828*	  
CHR3	   460433660	   460434670	   ENSMODG00000003841	   T	   CT	   460434242*	  
CHR3	   501254990	   501256000	   ENSMODG00000023660	   A	   AG	   501255667	  
CHR4	   12639110	   12640120	   ENSMODG00000021051	   GT	   G	   12639255	  
CHR4	   41989410	   41990420	   ENSMODG00000007427	   T	   A	   41989927	  
CHR4	   62096900	   62097910	   ENSMODG00000001888	   G	   C	   62097383	  
CHR4	   67631600	   67632610	   ENSMODG00000018047	   G	   T	   67632141	  
CHR4	   132780390	   132781390	   ENSMODG00000000944	   G	   AC	   132780626	  
CHR4	   168318450	   168319450	   ENSMODG00000005628	   A	   G	   168319167	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CHR4	   259665300	   259666310	   ENSMODG00000000824	   AG	   G	   259665471*	  
CHR5	   242663940	   242664950	   ENSMODG00000006522	   A	   AT	   242664163	  
CHR6	   236726350	   236727360	   ENSMODG00000004516	   G	   AG	   236726484	  
CHR6	   242565130	   242566140	   ENSMODG00000004830	   G	   A	   242565229	  
CHR7	   244712180	   244713190	   ENSMODG00000015703	   AC	   C	   244712322	  
CHR8	   25879600	   25880610	   ENSMODG00000014421	   C	   CT	   25879766	  
CHR8	   62627970	   62628980	   ENSMODG00000020516	   G	   AG	   62628747*	  
CHR8	   201570800	   201571810	   ENSMODG00000013737	   T	   AG	   201570943	  
CHR8	   244170300	   244171310	   ENSMODG00000008021	   C	   T	   244171254	  
CHR8	   256730650	   256731660	   ENSMODG00000009818	   A	   AT	   256731126*	  
 
Table B11. SNP variation detected between individuals A0552 (LL1) X A0568 (LL2).      
42 total SNPs. Genes chosen for SNP confirmation are indicated by an asterisk. 
Chromosome	   Start	   End	   Ensembl	  Gene	  ID	  
SNP	  
A0552	  	  	  	  	  	  	  	  	  	  	  	  	  	  A0568	   POSITION	  
CHR1	   276674510	   276675520	   ENSMODG00000011684	   AT	   AT	   276675391	  
CHR1	   285526640	   285527650	   ENSMODG00000012905	   T	   CT	   285527301*	  
CHR1	   285630810	   285631820	   ENSMODG00000012822	   A	   AG	   285631526	  
CHR1	   333227660	   333228670	   ENSMODG00000010724	   T	   GT	   333228053*	  
CHR1	   333244980	   333245990	   ENSMODG00000023761	   A	   AG	   333245463*	  
CHR1	   333338010	   333339010	   ENSMODG00000010717	   G	   C	   333338396	  
CHR1	   343914250	   343915260	   ENSMODG00000009436	   C	   CG	   343915130*	  
CHR1	   663121130	   663122140	   ENSMODG00000008486	   CT	   C	   663121514*	  
CHR2	   109874510	   109875520	   ENSMODG00000001558	   C	   CT	   109874653	  
CHR2	   139634610	   139635610	   ENSMODG00000006246	   C	   G	   139635294*	  
CHR2	   194012780	   194013790	   ENSMODG00000014859	   CT	   T	   194013302	  
CHR2	   206114030	   206115040	   ENSMODG00000024021	   AG	   G	   206114857	  
CHR2	   225162270	   225163280	   ENSMODG00000004465	   C	   T	   225162765	  
CHR2	   275269390	   275270390	   ENSMODG00000013704	   AG	   G	   275269467	  
CHR2	   285218800	   285219810	   ENSMODG00000012785	   AC	   C	   285219179*	  
CHR2	   302215600	   302216610	   ENSMODG00000018800	   G	   GT	   302216483*	  
CHR2	   307679000	   307680010	   ENSMODG00000018721	   A	   G	   307679357*	  
CHR2	   332904140	   332905150	   ENSMODG00000018444	   C	   CT	   332904537	  
CHR2	   442547170	   442548180	   ENSMODG00000007100	   A	   A	   442547809*	  
CHR2	   459548410	   459549420	   ENSMODG00000004472	   G	   AG	   459548616	  
CHR2	   505025230	   505026240	   ENSMODG00000019221	   G	   A	   505025646	  
CHR2	   520272570	   520273580	   ENSMODG00000016394	   G	   CG	   520270108	  
CHR3	   49543210	   49543820	   ENSMODG00000025244	   A	   G	   49543500*	  
CHR3	   232703750	   232704760	   ENSMODG00000020286	   G	   AG	   232704431	  
CHR3	   269085270	   269086280	   ENSMODG00000021462	   G	   AG	   269085368*	  
CHR3	   377688000	   377689010	   ENSMODG00000004746	   C	   CT	   377688211	  
CHR3	   437574710	   437575720	   ENSMODG00000011184	   G	   GT	   437574828*	  
CHR3	   437738810	   437739820	   ENSMODG00000011203	   G	   AG	   437739703	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CHR3	   460433660	   460434670	   ENSMODG00000003841	   T	   C	   460434242*	  
CHR4	   10077070	   10078080	   ENSMODG00000021035	   T	   GT	   10077387*	  
CHR4	   12639110	   12640120	   ENSMODG00000021051	   GT	   G	   12639255	  
CHR4	   41989410	   41990420	   ENSMODG00000007427	   T	   AT	   41989927	  
CHR4	   62096900	   62097910	   ENSMODG00000001888	   CT	   C	   62097717	  
CHR4	   67631600	   67632610	   ENSMODG00000018047	   T	   C	   67631863	  
CHR4	   168318450	   168319450	   ENSMODG00000005628	   AG	   A	   168319167	  
CHR4	   259665300	   259666310	   ENSMODG00000000824	   AG	   G	   259665471*	  
CHR5	   250270150	   250271160	   ENSMODG00000009646	   AG	   A	   250270818*	  
CHR6	   2293070	   2294080	   ENSMODG00000013386	   C	   CT	   2293331	  
CHR6	   94039650	   94040660	   ENSMODG00000002641	   AG	   G	   94040117	  
CHR8	   25879600	   25880610	   ENSMODG00000014421	   C	   T	   25879766	  
CHR8	   62627970	   62628980	   ENSMODG00000020516	   CT	   T	   62628670*	  
CHR8	   256730650	   256731660	   ENSMODG00000009818	   A	   AT	   256731126*	  
 
Table B12. SNP variation detected between individuals A0567 (LL2) X A0578 (LL1). 
49 total SNPs. Genes chosen for SNP confirmation are indicated by an asterisk. 
Chromosome	   Start	   End	   Ensembl	  Gene	  ID	  
SNP	  
	  	  A0567	  	  	  	  	  	  	  	  A0578	   POSITION	  
CHR1	   50888330	   50889340	   ENSMODG00000000633	   G	   AG	   50888812*	  
CHR1	   108942890	   108943900	   ENSMODG00000011165	   A	   AG	   108943512	  
CHR1	   148353080	   148354090	   ENSMODG00000011135	   AT	   T	   148354005	  
CHR1	   276674510	   276675520	   ENSMODG00000011684	   T	   AT	   276675391	  
CHR1	   285526640	   285527650	   ENSMODG00000012905	   T	   CT	   285527301*	  
CHR1	   285630810	   285631820	   ENSMODG00000012822	   A	   AG	   285631526	  
CHR1	   333227660	   333228670	   ENSMODG00000010724	   GT	   T	   333228053*	  
CHR1	   333244980	   333245990	   ENSMODG00000023761	   AG	   A	   333245463*	  
CHR1	   333338010	   333339010	   ENSMODG00000010717	   C	   G	   333338396	  
CHR1	   343914250	   343915260	   ENSMODG00000009436	   C	   CG	   343915130*	  
CHR1	   401900280	   401901290	   ENSMODG00000019496	   C	   T	   401900959	  
CHR1	   589524310	   589525320	   ENSMODG00000008637	   C	   CT	   589524693	  
CHR1	   624802970	   624803980	   ENSMODG00000003396	   A	   AG	   624803564*	  
CHR1	   663121130	   663122140	   ENSMODG00000008486	   C	   CT	   663121514*	  
CHR2	   57215440	   57216440	   ENSMODG00000001321	   CT	   T	   57215808	  
CHR2	   78706630	   78707640	   ENSMODG00000007194	   AG	   A	   78706823	  
CHR2	   109874510	   109875520	   ENSMODG00000001558	   C	   CT	   109874653	  
CHR2	   139634610	   139635610	   ENSMODG00000006246	   G	   C	   139635294*	  
CHR2	   206114030	   206115040	   ENSMODG00000024021	   G	   AG	   206114857	  
CHR2	   275269390	   275270390	   ENSMODG00000013704	   G	   AG	   275269467	  
CHR2	   285218800	   285219810	   ENSMODG00000012785	   A	   AC	   285219179*	  
CHR2	   307679000	   307680010	   ENSMODG00000018721	   G	   A	   307679839*	  
CHR2	   442547170	   442548180	   ENSMODG00000007100	   A	   C	   442547809*	  
CHR2	   459548410	   459549420	   ENSMODG00000004472	   A	   AG	   459549205	  
CHR2	   505025230	   505026240	   ENSMODG00000019221	   A	   AG	   505025646	  
CHR2	   522386350	   522387360	   ENSMODG00000023140	   CT	   C	   522386432	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CHR3	   16801020	   16802030	   ENSMODG00000019470	   T	   G	   16801298*	  
CHR3	   49543210	   49543820	   ENSMODG00000025244	   AG	   AG	   49543500*	  
CHR3	   269085270	   269086280	   ENSMODG00000021462	   AG	   G	   269085368*	  
CHR3	   377688000	   377689010	   ENSMODG00000004746	   C	   CT	   377688068	  
CHR3	   437574710	   437575720	   ENSMODG00000011184	   GT	   G	   437574828*	  
CHR3	   437738810	   437739820	   ENSMODG00000011203	   AG	   G	   437739703	  
CHR3	   443006000	   443007010	   ENSMODG00000001178	   T	   CT	   443006178	  
CHR3	   460433660	   460434670	   ENSMODG00000003841	   C	   T	   460434242*	  
CHR3	   499708700	   499709710	   ENSMODG00000025637	   AG	   A	   499709016	  
CHR4	   10077070	   10078080	   ENSMODG00000021035	   GT	   T	   10077387*	  
CHR4	   12639110	   12640120	   ENSMODG00000021051	   G	   GT	   12639255	  
CHR4	   41989410	   41990420	   ENSMODG00000007427	   A	   T	   41989927	  
CHR4	   67631600	   67632610	   ENSMODG00000018047	   CT	   C	   67632076	  
CHR4	   221510560	   221511570	   ENSMODG00000012380	   AG	   A	   221511019	  
CHR4	   259665300	   259666310	   ENSMODG00000000824	   G	   AG	   259665471*	  
CHR5	   250270150	   250271160	   ENSMODG00000009646	   T	   CT	   250270554*	  
CHR6	   2293070	   2294080	   ENSMODG00000013386	   CT	   C	   2293331	  
CHR6	   54243960	   54244970	   ENSMODG00000005539	   T	   C	   54244551*	  
CHR8	   25879600	   25880610	   ENSMODG00000014421	   T	   CT	   25879766	  
CHR8	   62627970	   62628980	   ENSMODG00000020516	   CT	   T	   62628207*	  
CHR8	   201570800	   201571810	   ENSMODG00000013737	   G	   AG	   201571369	  
CHR8	   232504670	   232505680	   ENSMODG00000006521	   A	   AC	   232505189	  
CHR8	   256730650	   256731660	   ENSMODG00000009818	   T	   AT	   256731126*	  
 
 
Table B13. SNP variation detected between individuals A0566 (LL2) X A0549 (LL1).      
38 total SNPs. Genes chosen for SNP confirmation are indicated by an asterisk. 
Chromosome	   Start	   End	   Ensembl	  Gene	  ID	  
SNP	  
A0566	  	  	  	  	  	  	  	  	  A0549	   POSITION	  
CHR1	   50888330	   50889340	   ENSMODG00000000633	   AG	   G	   50888812*	  
CHR1	   285526640	   285527650	   ENSMODG00000012905	   CT	   T	   285527301*	  
CHR1	   285630810	   285631820	   ENSMODG00000012822	   CT	   C	   285631226	  
CHR1	   333227660	   333228670	   ENSMODG00000010724	   GT	   GT	   333228053*	  
CHR1	   343914250	   343915260	   ENSMODG00000009436	   G	   CG	   343915130*	  
CHR1	   624802970	   624803980	   ENSMODG00000003396	   A	   G	   624803564*	  
CHR1	   663121130	   663122140	   ENSMODG00000008486	   C	   CT	   663121514*	  
CHR2	   139634610	   139635610	   ENSMODG00000006246	   CG	   C	   139635294*	  
CHR2	   275269390	   275270390	   ENSMODG00000013704	   CT	   C	   275269633	  
CHR2	   285218800	   285219810	   ENSMODG00000012785	   C	   AC	   285219179*	  
CHR2	   302215600	   302216610	   ENSMODG00000018800	   T	   G	   302216483*	  
CHR2	   307679000	   307680010	   ENSMODG00000018721	   G	   AG	   307679357*	  
CHR2	   332904140	   332905150	   ENSMODG00000018444	   AG	   G	   332904873	  
CHR2	   505025230	   505026240	   ENSMODG00000019221	   A	   AG	   505025646	  
CHR2	   522386350	   522387360	   ENSMODG00000023140	   T	   C	   522386432	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CHR3	   16801020	   16802030	   ENSMODG00000019470	   A	   AT	   16801605*	  
CHR3	   49543210	   49543820	   ENSMODG00000025244	   G	   AG	   49543590*	  
CHR3	   377688000	   377689010	   ENSMODG00000004746	   CT	   C	   377688211	  
CHR3	   421671140	   421672150	   ENSMODG00000000768	   GT	   GT	   421671879	  
CHR3	   443006000	   443007010	   ENSMODG00000001178	   CT	   T	   443006178	  
CHR3	   460433660	   460434670	   ENSMODG00000003841	   C	   CT	   460434242*	  
CHR3	   499708700	   499709710	   ENSMODG00000025637	   G	   AG	   499709016	  
CHR4	   10077070	   10078080	   ENSMODG00000021035	   G	   T	   10077387*	  
CHR4	   41989410	   41990420	   ENSMODG00000007427	   A	   T	   41989927	  
CHR4	   67631600	   67632610	   ENSMODG00000018047	   CT	   C	   67632076	  
CHR4	   132780390	   132781390	   ENSMODG00000000944	   AC	   C	   132780626	  
CHR4	   187738960	   187739970	   ENSMODG00000009617	   CT	   T	   187739279	  
CHR4	   259665300	   259666310	   ENSMODG00000000824	   G	   AG	   259665471*	  
CHR4	   360458330	   360459330	   ENSMODG00000013020	   A	   AT	   360458582	  
CHR5	   242663940	   242664950	   ENSMODG00000006522	   AT	   A	   242664163	  
CHR5	   250270150	   250271160	   ENSMODG00000009646	   A	   A	   250270818*	  
CHR6	   2293070	   2294080	   ENSMODG00000013386	   C	   AC	   2293370	  
CHR6	   36333510	   36334520	   ENSMODG00000025162	   AG	   A	   36333856*	  
CHR6	   54243960	   54244970	   ENSMODG00000005539	   CT	   T	   54244551*	  
CHR6	   94039650	   94040660	   ENSMODG00000002641	   G	   AG	   94040117	  
CHR7	   178177070	   178178080	   ENSMODG00000015605	   CT	   C	   178177875	  
CHR7	   62627970	   62628980	   ENSMODG00000020516	   CT	   T	   62628207*	  
CHR7	   201570800	   201571810	   ENSMODG00000013737	   AT	   T	   201570943	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Table B14. Summary of Pyrosequencing results for Meis1, Cstb, and Rpl17. Animal 
ID and cross type are indicated (1 - A0xxx - LL1 X LL2 and 2 - A0xxx- LL2 X LL1). 
The parental genotypes are shown with maternal allele listed first followed by reference 
(Ref.) and alternative (Alt.) alleles and their respective expression percentages. SNPs 
identified in Supplemental Figure F3 were used to assay allele specific expression for 
Meis1 and Cstb. Genotypes for Rpl17 were inferred from the PCR-Seq data due to the 
lack of quality Sanger reads for the gDNA. 
 
Animal 
ID 
Cross 
Type Gene Genotype 
Ref. 
Allele 
Alter. 
Allele 
% Ref 
Allele 
% Alt 
Allele 
A0690 1 Meis1 A/A A G NM NM 
A0694 1 Meis1 G/G A G 0.0% 100.0% 
A0695 1 Meis1 G/A A G 23.1% 76.9% 
A0719 2 Meis1 A/G A G 74.8% 25.2% 
A0727 2 Meis1 A/G A G 93.2% 6.8% 
A0690 1 Cstb T/G T G 0.0% 100.0% 
A0694 1 Cstb G/T T G 0.0% 100.0% 
A0695 1 Cstb T/T T G 100.0% 0.0% 
A0719 2 Cstb G/T T G 1.6% 98.4% 
A0727 2 Cstb G/T T G 15.6% 84.4% 
A0690 1 Rpl17 G/T G T 0.0% 100.0% 
A0694 1 Rpl17 G/T G T 0.0% 100.0% 
A0695 1 Rpl17 A/T G T 0.0% 100.0% 
A0719 2 Rpl17 G/T G T 0.0% 100.0% 
A0727 2 Rpl17 G/T G T 0.0% 100.0% 
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Table B15. Bisulfite PCR primers for Meis, Cstb, Rpl17, and Igf2r. Primers designed 
using Methyl Primer Express Software (Applied Biosystems, Inc.) to target the promoter 
CpG islands in bisulfite treated DNA. Two primers produced amplicons for Cstb. For 
Igf2r, we designed two primers each for the promoter CpG island and the CpG island at 
intron 11. 
 
Gene CpG Island 
Location 
Forward and Reverse Primers Amplicon 
Size (bp) 
Meis1 chr1:624957358-
624957620 
F-GATTTAGGGTTGGAGAAAGTTAG 
R-CAAAAAAAAAAAAAATCCCTCT 
205 
Cstb_1 chr4:10081961-
10082165 
F-ATTTATTGTTTAAAAGTGGGAGG 
R-AAAAACAAAAAACTCAAATTTCC 
274 
Cstb_2 chr4:10081961-
10082165 
F-ATGGAAGGAAGGAGTTTAGTT 
R-AAATTCTTATCTTAAAAAAATCAACCT 
274 
Rpl17 chr3:437577629-
437578003 
F-GGAAAAAGTTTTTGGAAATTGT 
R-AAAATTAACCAAATAACAACCCC 
175 
Igf2r 
Promoter 
chr2:442405660-
442406525 
F-ATATTGGTTATAGGGATAAGGTTAGG 
R-CATAAACTTCCCAAAATACTTCAC 
283 
Igf2r 
Promoter 
chr2:442405660-
442406525 
F-TTTGAGATGAGTGTTAGAAAATT 
R-AACTAATAACCCCTAATCCATAA 
157 
Igf2r  
Intron 11 
chr2:442405660-
442406525 
F-AAGTGGTAAAAGGTTTTTTAATGTT 
R-AAATCTTTAATCATTTCCTCCC 
224 
Igf2r 
 Intron 11 
chr2:442405660-
442406525 
F-TTTATTTAGTTAAATTGTTTGGAAGAA 
R-AAAAAAACCCAATAAAAAAACC 
161 
 
 
Table B16. SNP genotyping results in the F1 and P generations by Sanger 
sequencing for candidate-imprinted genes. For table see attached file Table S4.xlsx. 
 
